
<html lang="en"     class="pb-page"  data-request-id="7c9c1597-be37-40d5-8f40-6a729cf27272"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-11;pageGroup:string:Publication Pages;article:article:10.1021/jm3011349;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity" /></meta><meta name="dc.Creator" content="Tobias  Ginman" /></meta><meta name="dc.Creator" content="Jenny  Viklund" /></meta><meta name="dc.Creator" content="Jonas  Malmström" /></meta><meta name="dc.Creator" content="Jan  Blid" /></meta><meta name="dc.Creator" content="Rikard  Emond" /></meta><meta name="dc.Creator" content="Rickard  Forsblom" /></meta><meta name="dc.Creator" content="Anh  Johansson" /></meta><meta name="dc.Creator" content="Annika  Kers" /></meta><meta name="dc.Creator" content="Fredrik  Lake" /></meta><meta name="dc.Creator" content="Fernando  Sehgelmeble" /></meta><meta name="dc.Creator" content="Karin J.  Sterky" /></meta><meta name="dc.Creator" content="Margareta  Bergh" /></meta><meta name="dc.Creator" content="Anders  Lindgren" /></meta><meta name="dc.Creator" content="Patrik  Johansson" /></meta><meta name="dc.Creator" content="Fredrik  Jeppsson" /></meta><meta name="dc.Creator" content="Johanna  Fälting" /></meta><meta name="dc.Creator" content="Ylva  Gravenfors" /></meta><meta name="dc.Creator" content="Fredrik  Rahm" /></meta><meta name="dc.Description" content="By use of iterative design aided by predictive models for target affinity, brain permeability, and hERG activity, novel and diverse compounds based on cyclic amidine and guanidine cores were synthe..." /></meta><meta name="Description" content="By use of iterative design aided by predictive models for target affinity, brain permeability, and hERG activity, novel and diverse compounds based on cyclic amidine and guanidine cores were synthe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 20, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3011349" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3011349" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3011349" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3011349" /></link>
        
    
    

<title>Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3011349" /></meta><meta property="og:title" content="Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0033.jpeg" /></meta><meta property="og:description" content="By use of iterative design aided by predictive models for target affinity, brain permeability, and hERG activity, novel and diverse compounds based on cyclic amidine and guanidine cores were synthesized with the goal of finding BACE-1 inhibitors as a treatment for Alzheimer’s disease. Since synthesis feasibility had low priority in the design of the cores, an extensive synthesis effort was needed to make the relevant compounds. Syntheses of these compounds are reported, together with physicochemical properties and structure–activity relationships based on in vitro data. Four crystal structures of diverse amidines binding in the active site are deposited and discussed. Inhibitors of BACE-1 with 3 μM to 32 nM potencies in cells are shown, together with data on in vivo brain exposure levels for four compounds. The results presented show the importance of the core structure for the profile of the final compounds." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3011349"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3011349">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3011349&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3011349&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3011349&amp;href=/doi/10.1021/jm3011349" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4181-4205</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301659n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301694x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tobias++Ginman">Tobias Ginman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenny++Viklund">Jenny Viklund</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonas++Malmstr%C3%B6m">Jonas Malmström</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Blid">Jan Blid</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rikard++Emond">Rikard Emond</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rickard++Forsblom">Rickard Forsblom</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anh++Johansson">Anh Johansson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Annika++Kers">Annika Kers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fredrik++Lake">Fredrik Lake</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fernando++Sehgelmeble">Fernando Sehgelmeble</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karin+J.++Sterky">Karin J. Sterky</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Margareta++Bergh">Margareta Bergh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anders++Lindgren">Anders Lindgren</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrik++Johansson">Patrik Johansson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fredrik++Jeppsson">Fredrik Jeppsson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johanna++F%C3%A4lting">Johanna Fälting</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ylva++Gravenfors">Ylva Gravenfors</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fredrik++Rahm">Fredrik Rahm</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Medicinal Chemistry, <sup>‡</sup>Department of Neuroscience, and <sup>§</sup>Department of DMPK, AstraZeneca R&D Södertälje, SE-151 85, Södertälje, Sweden</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">∥</span> <span class="aff-text">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div><div class="corresp-info"><strong>*</strong>Phone: +46 (0) 70 672 48 97. E-mail: <a href="/cdn-cgi/l/email-protection#fe8792889fd0998c9f889b9098918c8dbe96918a939f9792d09d9193"><span class="__cf_email__" data-cfemail="f881948e99d69f8a998e9d969e978a8bb890978c95999194d69b9795">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3011349&amp;href=/doi/10.1021%2Fjm3011349" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4181–4205</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 5, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 August 2012</li><li><span class="item_label"><b>Published</b> online</span>20 May 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 June 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3011349" title="DOI URL">https://doi.org/10.1021/jm3011349</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4181%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTobias%2BGinman%252C%2BJenny%2BViklund%252C%2BJonas%2BMalmstr%25C3%25B6m%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D11%26contentID%3Djm3011349%26title%3DCore%2BRefinement%2Btoward%2BPermeable%2B%25CE%25B2-Secretase%2B%2528BACE-1%2529%2BInhibitors%2Bwith%2BLow%2BhERG%2BActivity%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4205%26publicationDate%3DJune%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3011349"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3900</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">34</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3011349" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Tobias&quot;,&quot;last_name&quot;:&quot;Ginman&quot;},{&quot;first_name&quot;:&quot;Jenny&quot;,&quot;last_name&quot;:&quot;Viklund&quot;},{&quot;first_name&quot;:&quot;Jonas&quot;,&quot;last_name&quot;:&quot;Malmström&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Blid&quot;},{&quot;first_name&quot;:&quot;Rikard&quot;,&quot;last_name&quot;:&quot;Emond&quot;},{&quot;first_name&quot;:&quot;Rickard&quot;,&quot;last_name&quot;:&quot;Forsblom&quot;},{&quot;first_name&quot;:&quot;Anh&quot;,&quot;last_name&quot;:&quot;Johansson&quot;},{&quot;first_name&quot;:&quot;Annika&quot;,&quot;last_name&quot;:&quot;Kers&quot;},{&quot;first_name&quot;:&quot;Fredrik&quot;,&quot;last_name&quot;:&quot;Lake&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Sehgelmeble&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;J. Sterky&quot;},{&quot;first_name&quot;:&quot;Margareta&quot;,&quot;last_name&quot;:&quot;Bergh&quot;},{&quot;first_name&quot;:&quot;Anders&quot;,&quot;last_name&quot;:&quot;Lindgren&quot;},{&quot;first_name&quot;:&quot;Patrik&quot;,&quot;last_name&quot;:&quot;Johansson&quot;},{&quot;first_name&quot;:&quot;Fredrik&quot;,&quot;last_name&quot;:&quot;Jeppsson&quot;},{&quot;first_name&quot;:&quot;Johanna&quot;,&quot;last_name&quot;:&quot;Fälting&quot;},{&quot;first_name&quot;:&quot;Ylva&quot;,&quot;last_name&quot;:&quot;Gravenfors&quot;},{&quot;first_name&quot;:&quot;Fredrik&quot;,&quot;last_name&quot;:&quot;Rahm&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;4181-4205&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3011349&quot;},&quot;abstract&quot;:&quot;By use of iterative design aided by predictive models for target affinity, brain permeability, and hERG activity, novel and diverse compounds based on cyclic amidine and guanidine cores were synthesized with the goal of finding BACE-1 inhibitors as a treatment for Alzheimer’s disease. Since synthesis feasibility had low priority in the design of the cores, an extensive synthesis effort was needed to make the relevant compounds. Syntheses of these compounds are reported, together with physicochemical properties and structure–activity relationships based on in vitro data. Four crystal structures of diverse amidines binding in the active site are deposited and discussed. Inhibitors of BACE-1 with 3 μM to 32 nM potencies in cells are shown, together with data on in vivo brain exposure levels for four compounds. The results presented show the importance of the core structure for the profile of the final compounds.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3011349&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3011349" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3011349&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3011349" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3011349&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3011349" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3011349&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3011349&amp;href=/doi/10.1021/jm3011349" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3011349" /></input><a href="/doi/pdf/10.1021/jm3011349" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3011349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3011349%26sid%3Dliteratum%253Aachs%26pmid%3D23126626%26genre%3Darticle%26aulast%3DGinman%26date%3D2013%26atitle%3DCore%2BRefinement%2Btoward%2BPermeable%2B%25CE%25B2-Secretase%2B%2528BACE-1%2529%2BInhibitors%2Bwith%2BLow%2BhERG%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D11%26spage%3D4181%26epage%3D4205%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jmcmar.2013.56.issue-11/production/jmcmar.2013.56.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0033.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">By use of iterative design aided by predictive models for target affinity, brain permeability, and hERG activity, novel and diverse compounds based on cyclic amidine and guanidine cores were synthesized with the goal of finding BACE-1 inhibitors as a treatment for Alzheimer’s disease. Since synthesis feasibility had low priority in the design of the cores, an extensive synthesis effort was needed to make the relevant compounds. Syntheses of these compounds are reported, together with physicochemical properties and structure–activity relationships based on in vitro data. Four crystal structures of diverse amidines binding in the active site are deposited and discussed. Inhibitors of BACE-1 with 3 μM to 32 nM potencies in cells are shown, together with data on in vivo brain exposure levels for four compounds. The results presented show the importance of the core structure for the profile of the final compounds.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">New protein/ligand coordinates for <b>19b</b>, <b>41</b>, <b>83</b> and <b>91</b> have been deposited in the PDB with codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b70">4b70</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b72">4b72</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b77">4b77</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b78">4b78</a>, respectively.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a progressive neurodegenerative disease with a huge and growing medical need.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> One of the pathological hallmarks of an AD brain is the presence of amyloid plaques.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The main constituent of these plaques is amyloid-β (Aβ), which is produced by the sequential proteolytic cleavage of amyloid precursor protein (APP).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> β-Site APP cleaving enzyme (BACE-1) is responsible for the first step in the processing of APP, followed by the cleavage by the γ-secretase complex.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8">(4-8)</a> Early onset AD,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> as well as protection from AD,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> is associated with genetic alterations in APP, thus implicating that the amyloid pathway and alterations in the production of Aβ are important for disease. Taken together, this indicates that BACE-1 inhibition, to stop or reduce the production of Aβ, is an attractive approach to find a treatment for Alzheimer’s disease. However, 13 years after the cloning and identification of BACE-1, only a few BACE-1 inhibitors have been tested in the early stages of clinical trials.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a></div><div class="NLM_p">In the search for BACE-1 inhibitors, we have performed several lead generation screening campaigns using various methods, where fragment-based lead generation has been the most successful.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The majority of the interesting structural motifs resulting from these efforts have been based on amidine or guanidine core structures. These have been further developed into lead series through scaffold hopping and optimization of the substituents (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of five amidine or guanidine core structures developed into lead series.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21">(13-21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other groups have also presented amidine or guanidine lead series of BACE-1 inhibitors starting from hits identified from fragment-based or high throughput screens.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22-25)</a> As previously described, the amidine or guanidine moiety interacts efficiently with the catalytic aspartates of BACE-1 via a hydrogen bonding network. This strong interaction has allowed modifications of other parts of the molecule to improve the overall property of the BACE-1 inhibitor.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Many of these reported amidines and guanidines have, after extensive optimization, shown good potencies in cellular assays and reduction of Aβ in plasma.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22-25)</a>Recently, after overcoming problems with limited brain exposure, some compounds have also shown reduction of Aβ in brain.<a onclick="showRef(event, 'ref20 ref21 ref27'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref27">(20, 21, 27)</a> However, the two hydrogen bond donors and the basic center on the amidine/guanidine core are not optimal for high brain exposure and many of the reported amidines suffer from P-glycoprotein (P-gp) mediated transport out of the brain, so-called efflux.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> A low efflux has been shown to be most important to achieve sufficient brain exposure in vivo.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Other properties of the amidine/guanidine inhibitors reported, which limit their exposure in brain, have been large size, high plasma protein binding, or high clearance.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">In addition, the general properties of many of the described BACE-1 inhibitors, featuring a basic functionality and being quite lipophilic, coincide with properties correlated to inhibition of the human ether-a-go-go-related gene (hERG) encoded potassium ion channel.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> So far, only few data points from hERG inhibition have been reported for BACE-1 inhibitors.<a onclick="showRef(event, 'ref20 ref31'); return false;" href="javascript:void(0);" class="ref ref20 ref31">(20, 31)</a></div><div class="NLM_p">This work describes our continued research in amidine- and guanidine-based BACE-1 inhibitors. In light of the above-mentioned challenges, we reasoned that the inherent properties of the cores would be crucial for the profile of the final test compounds, and consequently we focused on refining the amidine-containing core. Furthermore, we recognized the importance of focusing on optimization of the core early in the lead generation phase, since the selection of the core is an important step, defining the framework for future lead optimization.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">We thus set out to address target affinity, permeability, and hERG activity in a multiparameter optimization fashion.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a>Initially, new core structures were designed from the generic amidine structure in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. The design was aided by predictive chemistry, and a workflow based on three in silico models was established to aid in the prioritization of a number of core structures for synthesis.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> First, a novel tool based on quantum mechanical calculations was developed to facilitate predictions of BACE-1 affinity.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Second, a predictive permeability tool was developed, with suggested limits for p<i>K</i><sub>a</sub> and lipophilicity.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Third, to predict hERG activity, a QSAR model based on p<i>K</i><sub>a</sub> and lipophilicity and size was established.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">The new core structures were designed iteratively, with the aim to achieve promising in silico profiles predicting that the final test compounds would have a balanced profile regarding the optimization parameters listed above. With the help of these predictive models, a physicochemical space of interest, spanned by limits in p<i>K</i><sub>a</sub> and lipophilicity, was suggested. Unfortunately, these properties are inversely correlated when it comes to optimization of target activity, permeability, and hERG activity.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In order to cover the interesting physicochemical space, aiming to find cores with the most well-balanced set of properties, a number of cores were designed and selected for synthesis. More details on the selection workflow, predictions, and analyses of how the inherent physicochemical properties of the core structures relate to in vitro data for the test compounds are described in ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">35</a>.</div><div class="NLM_p">The core structures were decorated with a selection of substituents from a predefined set (R1 and R2, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). These substituents were collected from a training set of previous in-house series and literature compounds and were chosen to facilitate core-to-core comparisons of in vitro results for leadlike test compounds via matched pair analysis.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In addition, the R-groups were also selected for contributing equally to target potency and carefully combined in order to keep lipophilicity of the test compounds leadlike, with cLogP between 1 and 3.5.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Thus, we envisaged quick assessments of whether the properties of the new cores were promising enough for further lead optimization efforts.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Amidine substructure with the “core” indicated on green background (A = any atom). The R1 and R2 substituents (and a phenyl group) added to each core were selected to allow for match pair analyses.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The R2-substituent in the meta position is a common feature of known BACE-1 inhibitors for reaching into the S3 subpocket of the active site.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Synthesis feasibility of the cores was intentionally given a lower selection priority. The synthesis method developed for each core was used to synthesize just a few representative compounds, and the diversity of the cores made it difficult to use common intermediates. The core structures representing the synthesized compounds are presented in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Core structures representing the compounds included in this report, divided into four structural subgroups: <b>A</b>, six-membered bicyclic cores; <b>B</b>, six-membered monocyclic cores; <b>C</b>, five-membered bicyclic cores; <b>D</b>, five-membered monocyclic cores. <b>B-ref</b> represents a compound that has reached clinical phase I studies.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> During this work, five of the cores (<b>A-3</b>, <b>B-1</b>, <b>B-2</b>, <b>B-3</b>, and <b>C-1</b>) were independently published by others.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Synthetic Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Within the iterative design cycles using the predictive in silico models, more than 10 cores were selected for synthesis.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The syntheses of compounds representing cores of subtype A were initiated prior to the setup of the predictive workflow.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Herein we describe the successful synthesis of compounds representing all of these cores, divided into their subgroups as described in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Six-Membered Bicyclic Amidines (Core Subtype <b>A</b>)</h3><div class="NLM_p">Our synthesis efforts started by preparing core types <b>A-1</b> and <b>A-2</b>.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Attempts for improvements of this core subtype to decrease the lipophilicity and lower the p<i>K</i><sub>a</sub> were inspired by previous work.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> The synthesis of two examples (<b>8a</b> and <b>8b</b>) is described in detail in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The first step involved a condensation of commercially available 1-(3-bromophenyl)ethanone (<b>1</b>) and 2-hydroxybenzamide (<b>2</b>) under acidic conditions, continuously distilling off the formed water using a Dean–Stark trap to form the lactam <b>3</b>. Thioamide <b>4</b> could then be obtained by treating lactam <b>3</b> with P<sub>2</sub>S<sub>5</sub> in pyridine. Amidine <b>5</b> was then obtained by treating the thioamide <b>4</b> with ammonia in methanol in the presence of a mild oxidant (<i>t</i>-BuOOH). However, the thiolactam <b>4</b> was somewhat prone to hydrolysis which made the conversion to the amidine <b>5</b> hard to control, so a preferred alternative route to amidine <b>5</b> was developed as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Thus, lactam <b>3</b> was converted to the chloroimidate <b>6</b> and the amidine <b>5</b> was then obtained in two steps via the hydroxylamine <b>7</b>. The final compounds could then be obtained by a Suzuki–Miyaura coupling.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Core Subtypes <b>A-1</b> and <b>A-2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>p</i>-toluenesulfonic acid monohydrate, toluene, reflux, Dean–Stark; (b) P<sub>2</sub>S<sub>5</sub>, pyridine, 120 °C; (c) NH<sub>3</sub> (7 M in MeOH), <i>t</i>-BuOOH (aq) (70%); (d) PCl<sub>5</sub>, POCl<sub>3</sub>, 50 °C; (e) MeONH<sub>3</sub>Cl, DIPEA, DMF, 90 °C; (f) zinc, AcOH, rt; (g) pyrimidine-5-ylboronic acid or pyridine-3-ylboronic acid, bis(triphenylphosphine)palladium(II) chloride, Na<sub>2</sub>CO<sub>3</sub> (1 M aq), DME/H<sub>2</sub>O (2:1), 80 °C.</p></p></figure><div class="NLM_p">To evaluate the effect of the size of the nonaromatic substituent, compound <b>9</b>, with a slightly larger R1 group, was synthesized according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> starting from 1-(3-bromophenyl)propan-1-one. It was also interesting to introduce an electron withdrawing fluoride on the fused phenyl ring of the core to lower the p<i>K</i><sub>a</sub>. The syntheses of two such examples (<b>10a</b> and <b>10b</b>) were performed according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0034.gif" alt="" id="fx1" /></img><div class="NLM_p">One strategy that was in common for the different syntheses described below was that the Suzuki–Miyaura reaction was preferably used in the last step to create multiple compounds from a common intermediate. However, some amidines with high p<i>K</i><sub>a</sub> values demanded high catalyst loading to achieve complete conversion, probably because of catalyst poisoning. In this case, the Suzuki–Miyaura reaction was performed on the lactam instead.</div><div class="NLM_p">In the case of cores containing a thioether or a base-sensitive amidine or lactam, the Suzuki–Miyaura reaction was run as the first step. Coupling of the acetophenone <b>1</b> with three various boronic acids (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) gave three intermediates (<b>11a</b>–<b>c</b>) that were commonly used in several syntheses described below. The <i>m</i>-bromide present in all starting materials was substituted for an aryl ring using the corresponding boronic acid, a source of palladium(II), and a base, and the reaction was performed in an aqueous solvent at an elevated temperature. This method is referred to as standard Suzuki–Miyaura conditions in the following text.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>11a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) standard Suzuki–Miyaura conditions using the corresponding boronic acid, a source of palladium(II), and a base. The reaction was run in an aqueous solvent mixture at 80 °C.</p></p></figure><div class="NLM_p">The endo-cyclic oxygen of the 2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-amine core was replaced with sulfur to generate a 2<i>H</i>-benzo[<i>e</i>][1,3]thiazin-4-amine (<b>15</b>) (core type <b>A-3</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The synthesis is described in detail in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The synthesis started from methyl 2-mercaptobenzoate (<b>12</b>) which was condensed with compound<b>11a</b> and ammonia to form the lactam <b>13</b>. The lactam was then converted to the cyclic amidine <b>15</b> in two steps via the thiolactam <b>14</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>11a</b>, NH<sub>3</sub> (7 M in MeOH), 150 °C; (b) P<sub>2</sub>S<sub>5</sub>, pyridine, 120 °C; (c) NH<sub>3</sub> (7 M in MeOH), 90 °C.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Six-Membered Monocyclic Amidines (Core Subtype <b>B</b> and <b>B-ref</b>)</h3><div class="NLM_p">The synthesis of compounds <b>19a</b>,<b>b</b> started with the condensation of compound <b>1</b> with 3-hydroxypropanamide under acidic conditions,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> continuously distilling off the formed water using a Dean–Stark trap to form the lactam <b>16</b>. The lactam was then converted to the cyclic amidine <b>18</b> in two steps via the thiolactam <b>17</b>. In the last step, the bromide (<b>18</b>) was coupled with an aryl ring using standard Suzuki–Miyaura conditions to obtain compounds <b>19a</b>,<b>b</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Core Subtype <b>B-1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-hydroxypropanamide, pTSA, toluene, reflux, Dean–Stark; (b) P<sub>2</sub>S<sub>5</sub>, HMDO, 1,2-dichloroethane, 110 °C; (c) NH<sub>3</sub> (7 M in MeOH), 40 °C; (d) 3-methoxyphenylboronic acid or 3-chlorophenylboronic acid, [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloride dichloromethane complex, cesium carbonate, DME/H<sub>2</sub>O/EtOH (6:3:1), 120 °C.</p></p></figure><div class="NLM_p">To make the corresponding sulfur analogues, methyl 3-mercaptopropanoate (<b>20</b>) was converted to the amide <b>21</b> by treatment with concentrated ammonium hydroxide (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). The amide was then refluxed in toluene together with either compound <b>11a</b> or <b>11b</b> under acidic conditions, continuously removing the formed water by azeotrope distillation to form the lactams <b>22a</b> and <b>22b</b>, respectively. The respective lactams were then converted to the cyclic amidines <b>24a</b> and <b>24b</b> in two steps via the thiolactams <b>23a</b> and <b>23b</b>.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Core Subtype <b>B-2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ammonium hydroxide 25%, rt; (b) <b>11a</b> or <b>11b</b>, pTSA, toluene, reflux, Dean–Stark; (c) P<sub>2</sub>S<sub>5</sub>, HMDO, 1,2-dichloroethane, 110 °C; (d) NH<sub>3</sub> (7 M in MeOH), rt.</p></p></figure><div class="NLM_p">Moving the oxygen and sulfur one position further away from the carbon holding the R1 group changed the synthesis route completely. The synthesis of compound <b>30</b> started with ketone <b>11b</b> which was condensed by heating with potassium cyanide and ammonium carbonate in ethanol to form the hydantoin <b>25</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The hydantoin was then hydrolyzed by barium hydroxide at high temperature to give the amino acid <b>26</b>.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The amino acid <b>26</b> was reduced with BH<sub>3</sub> (generated in situ from sodium borohydride and iodine) in tetrahydrofuran to form the amino alcohol <b>27</b>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The lactam <b>28</b> was formed by coupling the amine <b>27</b> with chloroacetyl chloride and diisopropylethylamine in tetrahydrofuran and subsequent ring closure with aqueous potassium hydroxide.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The lactam <b>28</b> was then converted to the cyclic amidine <b>30</b> in two steps via the thiolactam <b>29</b>.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compound <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, EtOH, 70 °C; (b) Ba(OH)<sub>2</sub>, water, 150 °C; (c) NaBH<sub>4</sub>, I<sub>2</sub>, THF, 0 °C to reflux; (d) (1) chloroacetyl chloride, DIPEA, THF, 0 °C to rt, (2) KOH, water, rt to 60 °C; (e) P<sub>2</sub>S<sub>5</sub>, HMDO, 100 °C; (f) NH<sub>3</sub> (7 M in MeOH), 40 °C.</p></p></figure><div class="NLM_p">The corresponding sulfur analogue (core type <b>B-1</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) followed a similar route. The synthesis of example <b>34</b> is described in detail in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. Compound <b>27</b> was treated with chlorosulfonic acid in diethyl ether to form compound <b>31</b>. Residual reflux in a two-phase system of aqueous sodium hydroxide and toluene afforded the aziridine <b>32</b> by a Wenker reaction.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Treatment with methyl 2-mercaptoacetate gave a ring expansion to the six-member lactam <b>33</b>. Finally, the lactam <b>33</b> was converted to the cyclic amidine <b>34</b> in two steps.</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) chlorosulfonic acid, Et<sub>2</sub>O, rt; (b) NaOH (aq), toluene, reflux; (c) methyl 2-mercaptoacetate, DIPEA, DMF, 60 °C; (d) P<sub>2</sub>S<sub>5</sub>, HMDO, 100 °C; (e) NH<sub>3</sub> (7 M in MeOH), 50 °C.</p></p></figure><div class="NLM_p">Compound <b>37</b>, based on an already known core structure,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> was synthesized to facilitate a match pair analysis (<b>B-ref</b>). The synthesis of compound <b>37</b> is outlined in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>. Acetophenone <b>11b</b>was treated with vinylmagnesium bromide in 2-methyltetrahydrofuran at −78 °C to give the tertiary alcohol <b>35</b>. The alcohol was treated with thiourea under acidic conditions to give compound <b>36</b> which was set up for an acidic ring closure to give the final compound <b>37</b>.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compound <b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) vinylmagnesium bromide, 2-Me-THF, −78 °C to rt; (b) thiourea, HCl, AcOH, 45 °C; (c) MeSO<sub>3</sub>H, TFA, rt.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Five-Membered Bicyclic Amidines (Core Subtype <b>C</b>)</h3><div class="NLM_p">The synthesis of fused thiazole <b>41</b>, an analogue of one of the reference compounds (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), is described in detail in Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>. In the first step, the commercially available compound <b>38</b> was converted to sulfinimide <b>39</b>, a stabilized imine, using 2-methyl-2-propanesulfinamide and titanium(IV) ethoxide which was heated to reflux in 2-methyltetrahydrofuran. The sulfinimide <b>39</b> was then reacted with the C5-anion of 2-methyl-1,3-thiazole-4-carbonitrile.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Upon removal of the protecting group of the amine with hydrochloric acid, compound <b>40</b> was formed by spontaneous ring closure. Finally, the bromide (<b>40</b>) was coupled with an aryl ring using standard Suzuki–Miyaura conditions to yield compound <b>41</b>.</div><figure id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Compound <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-methyl-2-propanesulfinamide, titanium(IV) ethoxide, 2-Me-THF, reflux; (b) (1) 2-methyl-1,3-thiazole-4-carbonitrile, 2,2,6,6-tetramethylpiperidineylmagnesium chloride, lithium chloride (1 M in toluene/THF), THF, −25 °C to rt; (2) HCl (1 M in Et<sub>2</sub>O), MeOH, rt; (c) pyrimidine-5-ylboronic acid, [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) chloride, K<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O/EtOH (6:3:1), 100 °C.</p></p></figure><div class="NLM_p">A related structure having a fused pyrazole in the bicyclic core was also proposed. Having one of its nitrogens at the point of fusion, making it a cyclic guanidine, made the synthesis somewhat different. The synthesis is described in detail in Scheme <a class="ref internalNav" href="#sch10" aria-label="10">10</a>. Starting with ethyl 3-methyl-1<i>H</i>-pyrazole-5-carboxylate (<b>42</b>), the ester was converted to the Weinreb amide <b>43</b> using isopropylmagnesium chloride. The amide was then converted to the ketone <b>44</b> by reaction with the monoanion formed from 1,3-dibromobenzene and <i>n</i>-butyllithium at −78 °C in 2-methyltetrahydrofuran. The ketone <b>44</b> was reacted with 4-methoxyphenylmagnesium bromide with copper(I) iodide as catalyst to form the tertiary alcohol <b>45</b>. Heating the alcohol with thiourea in acetic acid formed the cyclic guanidine <b>46</b>. Finally, the bromide was replaced with an aryl ring using standard Suzuki–Miyaura conditions to yield compound <b>47</b>.</div><figure id="sch10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Compound <b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride, isopropylmagnesium chloride (2 M in THF), 2-Me-THF, −30 °C; (b) 1,3-dibromobenzene, <i>n</i>-butyllithium (1.6 M in hexanes), 2-Me-THF, −78 to −30 °C; (c) 4-methoxyphenylmagnesium bromide (1 M in THF), copper(I) iodide, 2-Me-THF, 0 °C to rt; (d) thiourea, acetic acid, 100 °C; (e) pyrimidine-5-boronic acid, bis(triphenylphosphine)palladium(II) chloride, sodium carbonate (1 M aq), DME/H<sub>2</sub>O (2:1), 80 °C.</p></p></figure><div class="NLM_p">The synthesis of compound <b>54</b>, also bicyclic but where the fused ring is aliphatic, is outlined in Scheme <a class="ref internalNav" href="#sch11" aria-label="11">11</a>. Amide <b>49</b> was first prepared by treating ester <b>48</b> with ammonia in methanol at elevated temperature. The piperidine was Boc-protected to yield compound <b>50</b>. The thioamide was then prepared by treating compound <b>50</b> with phosphorus pentasulfide and hexamethyldisiloxane. The piperidine was deprotected under acidiccondition to obtain <b>52</b>, which was then treated with 3′-bromoacetophenone (<b>1</b>) and ammonia to obtain the racemic bicyclic amidine <b>53</b>. The final step was then a standard Suzuki–Miyaura reaction to obtain diastereomers (<i>R*</i>,<i>S*</i>)-<b>54</b> and (<i>R*</i>,<i>R*</i>)-<b>54</b>after separation.</div><figure id="sch11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0021.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Compounds (<i>R</i>*,<i>S</i>*)-<b>54</b> and (<i>R</i>*,<i>R</i>*)-<b>54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 7 M NH<sub>3</sub> in MeOH, 90 °C, 3 days, 99%; (b) DIPEA, THF/DMF (1:1), di-<i>tert</i>-butyl dicarbonate, rt, on, quant; (c) P<sub>2</sub>S<sub>5</sub>, HMDO, THF, 110 °C, 30 min, 71%; (d) 5 M HCl in <i>i</i>-PrOH, MeOH, rt, on, 67%; (e) 3′-bromoacetophenone (<b>1</b>), 7 M NH<sub>3</sub> in MeOH, 50 °C, on, 29%; (f) 5-fluoropyridin-3-ylboronic acid, cat. (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub>, sat. NaHCO<sub>3</sub>, DME/H<sub>2</sub>O (2:1), 80 °C, 1.5 h, (<i>3R*</i>,8a<i>S</i>*) 15% and (<i>3R*</i>,8a<i>R</i>*) 23%.</p></p></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Five-Membered Monocyclic Amidines (Core Subtype <b>D</b>)</h3><div class="NLM_p">In an effort to investigate smaller cores, monocyclic five-membered cores were synthesized. The synthesis of structure <b>58</b> is described in detail in Scheme <a class="ref internalNav" href="#sch12" aria-label="12">12</a>. In the first step, compound <b>11b</b>was reacted with methyl 2-mercaptoacetate (<b>55</b>) using ammonia and microwave heating to form the lactam <b>56</b>. The lactam was then converted to the cyclic amidine <b>58</b> in two steps via the thiolactam <b>57</b>.</div><figure id="sch12" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0022.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Synthesis of Compound <b>58</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>11b</b>, NH<sub>3</sub> (7 M in MeOH), 150 °C; (b) P<sub>2</sub>S<sub>5</sub>, pyridine, 120 °C; (c) NH<sub>3</sub> (7 M in MeOH), 60 °C.</p></p></figure><div class="NLM_p">However, this route had its limitations and only worked for acetophenones in a satisfactory manner. Trying to use more hindered ketones like substituted benzophenones gave little or no product. The problem was solved by using the preformed imine prior to the cyclization reaction<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and running the reaction without solvent. This method was used in the synthesis of compound <b>64</b> as outlined in Scheme <a class="ref internalNav" href="#sch13" aria-label="13">13</a>. Starting with 1-bromo-3-iodobenzene (<b>59</b>) and pyridine-3-ylboronic acid under standard Suzuki–Miyaura conditions afforded the biaryl <b>60.</b> The bromide (<b>60</b>) was converted to the corresponding anion using <i>n</i>-butyllithium at −78 °C in diethyl ether and was reacted with 4-methoxybenzonitrile to form imine <b>61</b>. The imine <b>61</b> was stirred neat with methyl 2-mercaptoacetate and dimethylamine hydrochloride at room temperature to form the lactam <b>62</b>, which was then converted to the cyclic amidine <b>64</b> in two steps via the thiolactam <b>63</b>.</div><figure id="sch13" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0023.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Synthesis of Compound <b>64</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) pyridine-3-ylboronic acid, bis(triphenylphosphine)palladium(II) chloride, sodium carbonate (1 M aq), DME/H<sub>2</sub>O (2:1), 80 °C; (b) <i>n</i>-BuLi, 4-methoxybenzonitrile, Et<sub>2</sub>O, −78 °C to rt; (c) methyl 2-mercaptoacetate, dimethylamine hydrochloride, rt; (d) P<sub>2</sub>S<sub>5</sub>, pyridine, 120 °C; (e) NH<sub>3</sub> (7 M in MeOH), 60 °C.</p></p></figure><div class="NLM_p">Compound <b>65</b> was prepared following the same reaction sequence as described in Scheme <a class="ref internalNav" href="#sch13" aria-label="13">13</a>, using 3-bromobenzonitrile, 3-methoxyphenylboronic acid, and 4-bromopyridine.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0035.gif" alt="" id="fx2" /></img><div class="NLM_p">To synthesize the corresponding nitrogen analogue 2,5-dihydro-1<i>H</i>-imidazol-4-amine, a monocyclic analogue of <b>54</b>, new chemistry was developed. The synthesis of compound <b>71</b> is described in detail in Scheme <a class="ref internalNav" href="#sch14" aria-label="14">14</a>. 2-Chloroacetamide (<b>66</b>) was reacted with ethylamine to make amine <b>67</b>. It was then protected as the benzyl carbamate <b>68</b>, and the amide was converted to the thioamide <b>69</b> by reaction with phosphorus pentasulfide in dioxane by microwave heating. The protecting group was removed with hydrogen bromide in acetic acid, and intermediate <b>70</b> precipitated in diethyl ether. Compound <b>70</b> was reacted with compound <b>11c</b> in methanol with 7 M ammonia to give the cyclic amidine <b>71</b>. This core suffered from instability. To improve stability, the non-amidine nitrogen was acylated. The synthesis of the acylated analogue of <b>71</b>, compound <b>77</b>, is outlined in Scheme <a class="ref internalNav" href="#sch15" aria-label="15">15</a>. In the same fashion as for the tertiary amine <b>71</b>, the secondary amine <b>76</b> could be made from the aminothioacetamide <b>75</b>, generated from compound <b>74</b>, and ketone <b>11b</b>. The amine could then be acylated with acetic anhydride. Residual treatment with ammonia removed all acylation on the amidine itself to give the final compound <b>77</b>.</div><figure id="sch14" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0024.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Synthesis of Compound <b>71</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethylamine (70% in water), rt; (b) NaHCO<sub>3</sub> (aq), benzyl chloroformate, dioxane, 0 °C to rt; (c) P<sub>2</sub>S<sub>5</sub>, dioxane, 95 °C; (d) HBr (33% in AcOH), rt; (e) <b>11c</b>, NH<sub>3</sub> (7 M in MeOH), 60 °C.</p></p></figure><figure id="sch15" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0025.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 15. Synthesis of Compound <b>77</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaHCO<sub>3</sub> (aq), benzyl chloroformate, dioxane, 0 °C to rt; (b) P<sub>2</sub>S<sub>5</sub>, dioxane, 95 °C; (c) HBr (33% in AcOH), rt; (d) bromide <b>11b</b>, NH<sub>3</sub> (7 M in MeOH), rt; (e) (1) Ac<sub>2</sub>O, TEA, (2) NH<sub>3</sub> (7 M in MeOH).</p></p></figure><div class="NLM_p">To afford a cyclic amidine core without an additional heteroatom in the ring (<b>D-4</b>), compound <b>83</b> was synthesized, as described in detail in Scheme <a class="ref internalNav" href="#sch16" aria-label="16">16</a>. 3-Bromobenzaldehyde (<b>78</b>) was reacted in a Stetter reaction<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> with sodium cyanide and acrylonitrile. The formed ketone <b>79</b> was reacted with the anion prepared from 1-bromo-4-methoxybenzene and <i>n</i>-butyllithium to form the tertiary alcohol <b>80</b>. This was now set up for an intramolecular Ritter reaction,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> which was performed in methanesulfonic acid to form the lactam <b>81</b>. The bromide <b>81</b> was reacted with a boronic acid using standard Suzuki–Miyaura conditions to form the lactam <b>82</b> which was finally converted to the cyclic amidine <b>83</b> in two steps.</div><figure id="sch16" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0026.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 16. Synthesis of Compound <b>83</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch16"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaCN, acrylonitrile, MeCN, rt; (b) 1-bromo-4-methoxybenzene, <i>n</i>-BuLi, THF, −78 °C to 5 °C; (c) MsOH, 60 °C; (d) pyrimidine-5-ylboronic acid, bis(triphenylphosphine)palladium(II) chloride, sodium carbonate (1 M aq), DME/H<sub>2</sub>O (2:1), 80 °C; (e) (1) P<sub>2</sub>S<sub>5</sub>, pyridine, 120 °C, (2) NH<sub>3</sub> (7 M in MeOH), <i>t</i>-BuOOH (70%), rt.</p></p></figure><div class="NLM_p">To make a similar core with a methoxy group in the α-position, another synthesis route was developed. The synthesis of compound <b>91</b> is outlined in Scheme <a class="ref internalNav" href="#sch17" aria-label="17">17</a>. Compound <b>38</b> was first converted to the oxime <b>84</b> with hydroxylamine hydrochloride. In order to activate the oxime, the nitrogen was alkylated with a methylthiomethyl group, which also acted as a protecting group, to form compound <b>85</b>. Reaction with methyl acrylate in a [3 + 2] cycloaddition gave the isoxazolidine <b>86</b>. The protecting group was removed with sulfuric acid to form intermediate <b>87</b> which upon treatment with molybdenum hexacarbonyl afforded the reductive rearrangement to the α-hydroxylactam <b>88</b>. The hydroxy group was alkylated with methyl iodide in the presence of silver oxide to give the α-methoxylactam <b>89</b>. The bromide was reacted with a boronic acid using standard Suzuki–Miyaura conditions to obtain <b>90</b> which was finally converted to the cyclic amidine <b>91</b> in two steps. The diastereomers of <b>91</b> were separated by chiral SFC.</div><figure id="sch17" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0027.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 17. Synthesis of Compound <b>91</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch17"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) hydroxylamine hydrochloride, pyridine, MeOH, 50 °C; (b) DCC, DMSO, TFA, benzene, 0 °C to rt; (c) methyl acrylate, 150 °C; (d) H<sub>2</sub>SO<sub>4</sub>, MeOH, 60 °C; (e) Mo(CO)<sub>6</sub>, MeCN, water, reflux; (f) MeI, Ag<sub>2</sub>O, MeCN, 40 °C; (g) pyridin-3-ylboronic acid, tetrakis(triphenylphosphine)palladium, K<sub>2</sub>CO<sub>3</sub>, dioxane, water, 90 °C; (h) (1) P<sub>2</sub>S<sub>5</sub>, pyridine, 115 °C, (2) NH<sub>3</sub> (7 M in MeOH), <i>t</i>-BuOOH (70% in water), rt.</p></p></figure><div class="NLM_p">To make the five-membered cyclic guanidine core <b>D-6</b>, the synthesis started from methyl 2-amino-2-(3-bromophenyl)propanoate (<b>92</b>), which was acylated with acetic anhydride to form intermediate <b>93</b> which was ring-closed in a Dieckmann condensation to afford the β-ketolactam <b>94</b><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> (Scheme <a class="ref internalNav" href="#sch18" aria-label="18">18</a>). The lactam was decarboxylated with concentrated hydrochloric acid to give the amino ketone <b>95</b> which was reacted with Fmoc isothiocyanate to give the protected thiourea <b>96</b>. The protecting group was removed with ammonia (7 M in MeOH) to afford the free thiourea which then ring-closed to the cyclic thiourea. Addition of <i>tert</i>-butyl hydroperoxide then gave the cyclic guanidine <b>97</b>. In the last step, the bromide was reacted with a boronic acid under standard Suzuki–Miyaura conditions to yield the final compound <b>98</b>. This compound was later demonstrated to be unstable under acidic and neutral conditions.</div><figure id="sch18" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0028.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 18. Synthesis of Compound <b>98</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch18"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ac<sub>2</sub>O, TEA, DCM, 0 °C to rt; (b) NaH, toluene, reflux; (c) conc HCl, reflux; (d) Fmoc isothiocyanate, DCM, rt; (e) (1) NH<sub>3</sub> (7 M in MeOH), rt, (2) <i>t</i>-BuOOH (70%), rt; (f) 3-methoxyphenylboronic acid, bis(triphenylphosphine)palladium(II) chloride, sodium carbonate (1 M aq), DME/H<sub>2</sub>O (2:1), 80 °C.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12184" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12184" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The reported compounds were evaluated for BACE-1 inhibition in a time response fluorescence resonance energy transfer (TR-FRET) protocol. The cell-based assay for BACE-1 inhibition used specific antibodies to monitor reduction of sAPPβ release from human neuronal-derived SH-SY5Y cells. The hERG activity in CHO cells was measured as a first indication for potential cardiotoxicity.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Experimental values for p<i>K</i><sub>a</sub> were determined,<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> and log <i>D</i> was estimated with reversed phase liquid chromatography (eLogD).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Permeability in Caco-2 cells was measured and classified as good (<i>P</i><sub>app</sub> > 25), medium (5 < <i>P</i><sub>app</sub> < 25) or poor (<i>P</i><sub>app</sub> < 5). Susceptibility to P-gp efflux (in MDCK-MDR1 cells) was also determined, and the efflux of the compounds was classified as low (<2), medium (2–3), and high (>3). Finally, the results from both permeability measurements were combined into an “overall permeability” classification of good, medium, or poor. Since both properties are important to have a chance for high brain exposure in vivo, the least favorable result determined the categorization.<a onclick="showRef(event, 'ref19 ref20 ref29'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref29">(19, 20, 29)</a></div><div class="NLM_p">The data are divided into four tables according to the different core subtypes (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). An additional table, with data on previously published series, is included in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. These compounds have the same R1 and R2 substituents as the compounds synthesized here and are used as additional references. With these substituents, we hypothesized that the differences in the in vitro profiles of the compounds would largely be due to the core structures, and thus, the SAR discussions are focused on the cores.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Properties of Core Subtype <b>A</b><a class="ref internalNav" href="#t1fn9" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0029.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE-1,TR-FRET<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">LE FRET</th><th class="colsep0 rowsep0" align="center">BACE-1, sAPPβ<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hERG<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">eLogD <a class="ref internalNav" href="#t1fn3" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub> <a class="ref internalNav" href="#t1fn4" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub> <a class="ref internalNav" href="#t1fn5" aria-label="f">f</a>(10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center">efflux class<a class="ref internalNav" href="#t1fn6" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">overall perm.<a class="ref internalNav" href="#t1fn7" aria-label="h">h</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">5-pyrimidyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">8.1</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">low</td><td class="colsep0 rowsep0" align="left">G</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">0.26</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">low</td><td class="colsep0 rowsep0" align="left">M</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">5-pyrimidyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">5-pyrimidyl</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">low</td><td class="colsep0 rowsep0" align="left">G</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">G<a class="ref internalNav" href="#t1fn8" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">5-pyrimidyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">low</td><td class="colsep0 rowsep0" align="left">G</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn9"><div class="footnote" id="t1fn9"><sup>a</sup><p class="last">nd: not determined.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">IC<sub>50</sub> values are the mean of at least two experiments.</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">Measured in hERG-expressing CHO cells using IonWorks technology.</p></div><div class="footnote" id="t1fn3"><sup>d</sup><p class="last">Determined by reversed phase liquid chromatography.</p></div><div class="footnote" id="t1fn4"><sup>e</sup><p class="last">Determined by pressure-assisted capillary electrophoresis.</p></div><div class="footnote" id="t1fn5"><sup>f</sup><p class="last"><i>P</i><sub>app</sub> is the measured permeability (A to B) through Caco-2 cells.</p></div><div class="footnote" id="t1fn6"><sup>g</sup><p class="last">MDCK-MDR1 efflux data were generated using a Transwell assay.</p></div><div class="footnote" id="t1fn7"><sup>h</sup><p class="last">G = good, M = medium, <i>P</i> = poor.</p></div><div class="footnote" id="t1fn8"><sup>i</sup><p class="last">Efflux was not determined for this compound, so the overall permeability classification is only based on Caco-2 <i>P</i><sub>app</sub>.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Properties of Core Subtype <b>B</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0030.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE-1,TR-FRET<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">LE FRET</th><th class="colsep0 rowsep0" align="center">BACE-1,sAPPβ<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hERG<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">eLogD<a class="ref internalNav" href="#t2fn3" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub> <a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub> <a class="ref internalNav" href="#t2fn5" aria-label="f">f</a>(10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center">efflux class<a class="ref internalNav" href="#t2fn6" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">overall perm.<a class="ref internalNav" href="#t2fn7" aria-label="h">h</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-MeO-phenyl</td><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left">0.63</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">low</td><td class="colsep0 rowsep0" align="left">M</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-chlorophenyl</td><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">6.15</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">P<a class="ref internalNav" href="#t2fn8" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">5-pyrimidyl</td><td class="colsep0 rowsep0" align="left"><b>24a</b></td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">0.41</td><td class="colsep0 rowsep0" align="left">0.040</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left"><0</td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">low</td><td class="colsep0 rowsep0" align="left">G</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-MeO-phenyl</td><td class="colsep0 rowsep0" align="left"><b>24b</b></td><td class="colsep0 rowsep0" align="left">0.63</td><td class="colsep0 rowsep0" align="left">0.38</td><td class="colsep0 rowsep0" align="left">0.063</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">M<a class="ref internalNav" href="#t2fn8" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-MeO-phenyl</td><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">low</td><td class="colsep0 rowsep0" align="left">M</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-MeO-phenyl</td><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">10.5</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">P</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">3-MeO-phenyl</td><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">G<a class="ref internalNav" href="#t2fn8" aria-label="i">i</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">nd; not determined.</p></div><div class="footnote" id="t2fn1"><sup>b</sup><p class="last">IC<sub>50</sub> values are the mean of at least two experiments.</p></div><div class="footnote" id="t2fn2"><sup>c</sup><p class="last">Measured in hERG-expressing CHO cells using IonWorks technology.</p></div><div class="footnote" id="t2fn3"><sup>d</sup><p class="last">Determined by reversed phase liquid chromatography.</p></div><div class="footnote" id="t2fn4"><sup>e</sup><p class="last">Determined by pressure-assisted capillary electrophoresis.</p></div><div class="footnote" id="t2fn5"><sup>f</sup><p class="last"><i>P</i><sub>app</sub> is the measured permeability (A to B) through Caco-2 cells.</p></div><div class="footnote" id="t2fn6"><sup>g</sup><p class="last">MDCK-MDR1 efflux data were generated using a Transwell assay.</p></div><div class="footnote" id="t2fn7"><sup>h</sup><p class="last">G = good, M = medium, <i>P</i> = poor.</p></div><div class="footnote" id="t2fn8"><sup>i</sup><p class="last">Efflux was not determined for this compound, so the overall permeability classification is only based on Caco-2 <i>P</i><sub>app</sub>.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Properties of Core Subtype <b>C</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0031.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">nd; not determined.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> values are the mean of at least two experiments.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Measured in hERG-expressing CHO cells using IonWorks technology.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Determined by reversed phase liquid chromatography.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Determined by pressure-assisted capillary electrophoresis.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last"><i>P</i><sub>app</sub> is the measured permeability (A to B) through Caco-2 cells.</p></div><div class="footnote" id="t3fn7"><sup>Table g</sup><p class="last">MDCK-MDR1 efflux data were generated using a Transwell assay.</p></div><div class="footnote" id="t3fn8"><sup>Table h</sup><p class="last">G = good, M = medium, P = poor.</p></div><div class="footnote" id="t3fn9"><sup>Table i</sup><p class="last">During the assay condition, (<i>R</i>*,<i>R</i>*)-<b>54</b> and (<i>R</i>*,<i>S</i>*)-<b>54</b> epimerized.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Properties of Core Subtype <b>D</b><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0032.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE-1,TR-FRET<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">LE FRET</th><th class="colsep0 rowsep0" align="center">BACE-1, sAPPβ<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hERG<a class="ref internalNav" href="#t4fn2" aria-label="c">c</a> IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">eLogD <a class="ref internalNav" href="#t4fn3" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub> <a class="ref internalNav" href="#t4fn4" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>app</sub> <a class="ref internalNav" href="#t4fn5" aria-label="f">f</a>(10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center">efflux class<a class="ref internalNav" href="#t4fn6" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">overall perm.<a class="ref internalNav" href="#t4fn7" aria-label="h">h</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-MeO-phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">0.33</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">M<a class="ref internalNav" href="#t4fn8" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">4-MeO-phenyl</td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">M<a class="ref internalNav" href="#t4fn8" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">4-pyridyl</td><td class="colsep0 rowsep0" align="left">3-MeO-phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">0.33</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">low</td><td class="colsep0 rowsep0" align="left">M</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>N</i>-acyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-MeO-phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0.26</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">>33</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">low</td><td class="colsep0 rowsep0" align="left">M</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-MeO-phenyl</td><td class="colsep0 rowsep0" align="left">5-pyrimidyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>83</b></td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left"><0.3</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">P<a class="ref internalNav" href="#t4fn8" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-MeO-phenyl</td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left"><i>rac</i>-<b>91</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">8.9</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">P<a class="ref internalNav" href="#t4fn8" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-MeO-phenyl</td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left"><b>Iso1-91</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">P</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-MeO-phenyl</td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left"><b>Iso2-91</b></td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">P</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-MeO-phenyl</td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left"><b>Iso3-91</b></td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">P</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-MeO-phenyl</td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left"><b>Iso4-91</b></td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">0.079</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">high</td><td class="colsep0 rowsep0" align="left">P</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">nd: not determined.</p></div><div class="footnote" id="t4fn1"><sup>b</sup><p class="last">IC<sub>50</sub> values are the mean of at least two experiments.</p></div><div class="footnote" id="t4fn2"><sup>c</sup><p class="last">Measured in hERG-expressing CHO cells using IonWorks technology.</p></div><div class="footnote" id="t4fn3"><sup>d</sup><p class="last">Determined by reversed phase liquid chromatography.</p></div><div class="footnote" id="t4fn4"><sup>e</sup><p class="last">Determined by pressure-assisted capillary electrophoresis.</p></div><div class="footnote" id="t4fn5"><sup>f</sup><p class="last"><i>P</i><sub>app</sub> is the measured permeability (A to B) through Caco-2 cells.</p></div><div class="footnote" id="t4fn6"><sup>g</sup><p class="last">MDCK-MDR1 efflux data were generated using a Transwell assay.</p></div><div class="footnote" id="t4fn7"><sup>h</sup><p class="last">G = good, M = medium, P = poor.</p></div><div class="footnote" id="t4fn8"><sup>i</sup><p class="last">Efflux was not determined for this compound, so the overall permeability classification is only based on Caco-2 <i>P</i><sub>app</sub>.</p></div></div></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Chemical Stability</h3><div class="NLM_p">During the synthesis of core structure <b>C-3</b> (<b>54</b>, Scheme <a class="ref internalNav" href="#sch11" aria-label="11">11</a>), it was realized that <b>54</b> slowly epimerized in the acidic medium used when separating the diastereoisomers by reversed-phase chromatography. No visible decay of the diastereomeric mixture was seen during the acidic purification of <b>53</b> or during the basic conditions in the subsequent Suzuki–Miyaura reaction to <b>54</b>. However, by treatment of <b>53</b> in acidic or basic medium for a prolonged time (more than 1 day), it was apparent that the core structure was not stable but gave 3′-bromoacetophenone and amide <b>49</b>as decomposition products. From these stability findings we believe that the epimerization occurred at the carbon holding the R1 group and not at the α-carbon to the amidine moiety. Data for the two stereoisomers of <b>54</b> ((<i>R*</i>,<i>S*</i>)-<b>54</b> and (<i>R*</i>,<i>R*</i>)-<b>54</b>) are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, but in the cellular assay, with a long incubation time, epimerization occurred during the experiment. Therefore, the two data points reported for the cellular assay represent in both cases a mixture of the four stereoisomers. There was no sign of decomposition under these conditions.</div><div class="NLM_p">Because of the above-mentioned stability problem, all compounds representing new cores were checked for their stability in DMSO as well as in buffer solutions at four different pH values (1, 4.5, 7.4, and 9) over time. All of the cores were stable in DMSO, and (unless otherwise discussed) the cores were stable in the buffer used in the enzymatic and cell assays (pH 4.5 and 7.4, respectively) for the time period needed to perform the experiment. The same is true for the conditions used in the other assays included in this report.</div><div class="NLM_p">As mentioned earlier, <b>71</b> suffered from instability problem showing reversibility back to the acetophenone <b>11c</b> even under the conditions used in the enzymatic assay. For this reason, no data for compound <b>71</b> are reported here. By preparation of <b>77</b>, which was predicted to be more stable because of the electron withdrawing character of the acyl group, stability increased to allow data to be generated without compound decomposition. Data for compound <b>99</b> were excluded in this report, since it was shown to be unstable under acidic and neutral conditions.</div><div class="NLM_p last">It was also noticed that some amidines were slowly hydrolyzed to the lactam under basic (pH 9) conditions. This was first noticed for compounds of subtype <b>B</b>, already in the preparation of the compounds. Neutral conditions had to be used when purifying the compounds by preparative HPLC. When stability was determined as described above, compounds from cores of subtype <b>A</b> also showed some hydrolysis at pH 9 but at a slower pace, whereas compounds with core <b>D-1</b> showed no hydrolysis. Our first hypothesis was that amidines with high p<i>K</i><sub>a</sub> were more susceptible toward hydrolysis, since core subtypes <b>A</b> and <b>B</b> both mainly represent compounds with high p<i>K</i><sub>a</sub> (8–9) and <b>D-1</b> have examples of compounds with a low p<i>K</i><sub>a</sub> (5–6), but the size of the ring might also be a factor. Later findings showed that compounds from core subtype <b>D-4</b>, a five-membered core with high p<i>K</i><sub>a</sub> (<b>10</b>), only showed small amounts of hydrolysis and <b>C-1</b>, a five-membered core with high p<i>K</i><sub>a</sub> (<b>8</b>) and a double bond in the core ring, showed no hydrolysis at all. It might be that the five-membered cores position their R groups so that the amidine is less accessible for hydrolysis. Also, the five-membered cores usually have the larger R1 group that could sterically hinder or slow down hydrolysis.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Target Activity and Crystal Structures</h3><div class="NLM_p">The reported compounds were all active in the enzymatic TR-FRET assay (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), with potencies ranging from 0.32 to 100 μM. Ligand efficiencies (LEs) were between 0.25 and 0.41, and it was encouraging to see that compounds (<b>24b</b>, <b>41</b>, <b>47</b>, <b>54</b>, <b>64</b>, and <b>65</b>) from five different cores (<b>B-2</b>, <b>C-1</b>, <b>C-2</b>, <b>C-3</b>, and <b>D-1</b>) reached potencies below 1 μM. Some compounds (<b>24a</b>, <b>24b</b>, and <b>34</b>) had equal or higher LE than the reference compound <b>37</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Four compounds had promising cellular potencies below 100 nM (Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, compounds <b>24a</b>, <b>24b</b>, <b>41</b>, and <b>Iso4-91</b>), with <b>41</b> (32 nM) as the most potent. There was no correlation between lipophilicity and potency for these compounds.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Also, there was no correlation between p<i>K</i><sub>a</sub> and enzymatic potency despite the important ionic and hydrogen bond interactions with the acidic aspartates (see crystal structures below).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> However, in line with previous reports, an increase in p<i>K</i><sub>a</sub> was linearly correlated to an increase in cellular potency, up to a p<i>K</i><sub>a</sub> of about 8.5 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref19 ref20 ref21 ref55'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref55">(19-21, 55)</a> As reported in the section <a class="ref internalNav" href="#sec3_4" aria-label="Permeability Results and Discussion">Permeability Results and Discussion</a>, a p<i>K</i><sub>a</sub> above 8.5 is negative for cell permeability, which may be the reason for the correlation being reversed at that point.</div><figure id="fig4" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. From a p<i>K</i><sub>a</sub> of 6 to a p<i>K</i><sub>a</sub> of 8.5, there was a linear correlation between p<i>K</i><sub>a</sub> and increase in potency, going from the enzymatic assay to the cell assay, where the potency difference is calculated as pIC<sub>50</sub>(cellular assay) – pIC<sub>50</sub>(TR-FRET). Data on previously published compounds are in agreement with these results (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When the compounds were analyzed according to the four structural subtypes (<b>A</b>–<b>D</b>) as presented in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, it became clear that compounds with core subtype <b>B</b> showed the highest ligand efficiencies, spanning from 0.31 to 0.41. For compounds with five-membered cores, LEs were somewhat lower, compared to the six-membered analogues. However, compounds with the highest enzymatic potencies were found among core subtype <b>C</b>. This higher specific activity could be explained by the extra hydrogen bond interaction with trp76 provided by the larger R1 substituent (see further discussion on crystal structures below).</div><figure id="fig5" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compounds with monocyclic six-membered cores had the highest LEs, while compounds with five-membered cores reached the highest enzymatic activities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To verify that these inhibitors bind as expected in the active site, crystal structures were determined for four compounds in complex with BACE-1. All compounds were soaked as racemates, and only one of the enantiomers was visible in the electron density. Indeed, all compounds bind similarly via the key interactions with the catalytic aspartic acids, and the constant phenyl and R2 aryl are well-defined in the S1 and S3 subpockets of the active site (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a–d)</div><figure id="fig6" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Crystal structures representing four of the cyclic amidine cores, in complex with BACE-1: (a) compound <b>19b</b>, 1.6 Å resolution; (b) compound <b>41</b>, 1.6 Å resolution; (c) compound <b>83</b>, 1.8 Å resolution; (d) compound <b>91</b>, 1.5 Å resolution. (e) Superimposition of a five- and six-membered core showing the angle difference for the R1 substituent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The compounds with five-membered cores all bind to a protein conformation that is similar to the apo-structure.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> In this conformation, the so-called “flap residues” (P70-Y71-T72-Q73-G74) is in an open position, allowing the R1-phenyl with a methoxy group in the para-position to accept a favorable hydrogen bond from the indole of trp76 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b–d). In the crystal structures of <b>41</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b), the additional ring of the bicyclic core is in close contact (3.6 Å) with the aromatic ring of tyr71 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b). This interaction is not seen for the compounds with monocyclic cores (<b>83</b>, <b>91</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b,c). All of this is in accordance with previously reported structures.<a onclick="showRef(event, 'ref19 ref20 ref21 ref29'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref29">(19-21, 29)</a></div><div class="NLM_p">The representative of the six-membered cores (<b>19b</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a) is bound to a different protein conformation, with the flap in closed position and with an internal hydrogen bond between the hydroxyl of tyr71 and the indole of trp76. This protein conformation is also seen in structures of substrate analogues<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> and in previously reported structures of six-membered cyclic guanidines.<a onclick="showRef(event, 'ref13 ref23 ref24 ref59'); return false;" href="javascript:void(0);" class="ref ref13 ref23 ref24 ref59">(13, 23, 24, 59)</a></div><div class="NLM_p">In previous reports, the hydrogen bond with trp76 has been important for affinity of inhibitors with five-membered cores.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> To our knowledge, no inhibitors with six-membered cores have been reported, with aryls in R1 making a direct hydrogen bond to trp76. When the crystal structures of the compounds representing the five-membered cores were overlaid and compared to <b>19b</b>, the attachment point of R1 is in slightly different positions for these core types. The angular difference is approximately 6°, making it unfavorable for aryls in R1 on six-membered cores to reach the hydrogen bond interaction to trp76 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>e). In the literature, other ways are reported to decorate six-membered cores that provide the interaction to trp76.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p last">Another interesting feature displayed by a crystal structure was found in the core of <b>91</b>, soaked without separating the stereoisomers. It has two stereogenic centers, but the electron density was clearly defined for only one of the stereoisomers in the crystal structure (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>d): The methoxy group in the core, just above one of the catalytic aspartates, is pointing toward the prim side of the active site. TR-FRET data on the separated stereoisomers show a big difference in activity between the most potent isomer (<b>Iso4-91</b>, 3.2 μM) and the second best (<b>Iso1-91</b>, 20 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). This high potency difference from a substituent in a solvent accessible area was surprising. However, in a previously reported in-house series, other examples indicating the importance of this region for affinity have been observed. When an isopropyl group was exchanged for a methyl in this area, the activity increased 1 log unit (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S2).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> hERG Results and Discussion</h3><div class="NLM_p">We were pleased to find that most of the compounds reported in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> had reduced hERG activity compared to the references (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Compound <b>24a</b> showed no hERG activity at the highest concentration tested (33 μM). However, most of the compounds showed some inhibition of the hERG channel, with activities ranging from 1 to 20 μM, which could be explained by their inherent structural features, a basic center surrounded by aromatic and lipophilic substituents<a onclick="showRef(event, 'cit30b ref60'); return false;" href="javascript:void(0);" class="ref cit30b ref60">(30b, 60)</a> (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_p">From analysis of the data, it could be seen that our initial hypothesis, i.e., to reduce hERG activity by reducing lipophilicity and p<i>K</i><sub>a</sub>, was verified on a qualitative basis. Thus, an enrichment of highly hERG active compounds was observed in the area with high p<i>K</i><sub>a</sub> and eLogD (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Since these results were generated with a cell based assay,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> permeability of the compounds might affect the activity values. We hypothesize that the less hERG active compounds in the area of p<i>K</i><sub>a</sub> above 9 might be due to a lower permeability of these compounds (see section <a class="ref internalNav" href="#sec3_4" aria-label="Permeability Results and Discussion">Permeability Results and Discussion</a>).</div><figure id="fig7" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. An enrichment of highly hERG active compounds was observed in the area with high p<i>K</i><sub>a</sub> and eLogD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Several compounds with bicyclic core structures displayed high hERG activities (<b>41</b>, <b>8a</b>, <b>9</b>, <b>10a</b>, and <b>15</b>), which were supposed to be largely due to high p<i>K</i><sub>a</sub> and lipophilicity of the cores. Compounds representing core type <b>C-2</b> (<b>47</b>) were proposed to have a decreased risk of being hERG active, owing to the intrinsically low p<i>K</i><sub>a</sub> and lipophilicity of this core. To further improve the chance of reduced effect on the hERG channel, this core was decorated with a polar R2 substituent. Despite these efforts, compound <b>47</b> was active on the hERG channel with an IC<sub>50</sub> of 8.6 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). With this result in hand, core size was hypothesized to be an important factor for hERG activity. Another example of the importance of core size for hERG activity was seen for compounds based on cores of subtype <b>A</b>. Addition of a fluorine atom to the core structure reduced the p<i>K</i><sub>a</sub> by 1 log unit but only resulted in a marginal lowering of the hERG activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <b>8a</b> compared to <b>10a</b>).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Permeability Results and Discussion</h3><div class="NLM_p">Except for the reference compound <b>37</b>, only compounds of subtype <b>A</b> were classified as having a high overall permeability in vitro (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). However, previous publications have shown that a medium overall permeability in vitro at an early stage of development can, after further lead optimization, be developed to reach reasonable in vivo exposure levels in rodent brain.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> When permeability of all compounds in this report was compared to the presumed important physicochemical parameters p<i>K</i><sub>a</sub>, lipophilicity (eLogD), and size (MW),<a onclick="showRef(event, 'cit28b ref61'); return false;" href="javascript:void(0);" class="ref cit28b ref61">(28b, 61)</a> p<i>K</i><sub>a</sub> stood out as the most important parameter. All compounds with high overall permeability were found below a p<i>K</i><sub>a</sub> of 8.5 (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). This was in accordance with medicinal chemistry principles, as well as results on similar, previously reported BACE-1 inhibitors, where a lowering of p<i>K</i><sub>a</sub>had been beneficial for increasing permeability.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> For these compounds, there were no clear correlations for MW or eLogD to permeability. However, these parameters were not varied to the same extent as p<i>K</i><sub>a</sub>, and all compounds had a lipophilicicy and size within a range known to generally ensure high permeability (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).</div><figure id="fig8" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Overview of all compounds in this report. Overall permeability was compared to MW, p<i>K</i><sub>a</sub>, and eLogD .</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When the compounds were analyzed on core subtype level, p<i>K</i><sub>a</sub> stood out again as the most important parameter affecting permeability. Compounds of core subtype <b>A</b> were the only ones with generally high overall permeability, and all of these compounds had a p<i>K</i><sub>a</sub> below 8. Related compounds with monocyclic six-membered cores (subtype <b>B</b>) all had lower MW (<320) but still displayed a low to medium passive permeability in Caco-2 cells, probably because of the generally high p<i>K</i><sub>a</sub> (>8.6). The subtype <b>B</b> reference compound <b>37</b> was different, with a much higher passive permeability in Caco-2 cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and also a lower p<i>K</i><sub>a</sub> of 7. P-gp efflux also appeared to be related to p<i>K</i><sub>a</sub> for compounds of subtype <b>B</b>: compound <b>34</b> had the highest p<i>K</i><sub>a</sub> in the family and also displayed the highest efflux (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">The importance of p<i>K</i><sub>a</sub> for permeability was also observed in the limited data generated for compounds with bicyclic five-membered cores (subtype <b>C</b>); the most basic compound (<b>41</b>) was classified as poorly permeable. Compound <b>41</b> had a higher P-gp efflux than the less basic (and less lipophilic) <b>47</b>, which was classified as having medium overall permeability (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_p">For compounds with monocyclic five-membered cores (subtype <b>D</b>), a connection between high p<i>K</i><sub>a</sub> and poor permeability was again hypothesized from the data, as illustrated by the most basic compounds <b>83</b> and <i>rac</i>-<b>91</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). From the separation of the stereoisomers of <b>91</b>, it was shown that P-gp efflux was equally high for all stereoisomers, indicating that the 3D-structure was of less importance (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_p last">However, there were also exceptions from the trend that low p<i>K</i><sub>a</sub> and high lipophilicity is favorable for permeability: compounds of core type <b>D-1</b> were expected to have a higher overall permeability than medium. All compounds in this series had a low p<i>K</i><sub>a</sub> (5.4–6.9) and were quite lipophilic (eLogD = 2.9–3.6). However, not even the smallest compound in this series (<b>58</b>) exhibited a high permeability (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). This can be compared to the structurally similar compounds of core type <b>B-2</b>, which showed a similar permeability profile but with a much higher p<i>K</i><sub>a</sub> of 9.1, and an eLogD of 0 (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, compound <b>24a</b>).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> In Vivo Brain Exposure</h3><div class="NLM_p">To determine the brain exposure in mice and investigate whether the in vitro measurements of permeability could be used to predict brain exposure, four compounds (<b>24a</b>, <b>37</b>, <b>41</b>, and <b>64</b>) were administered intravenously or per orally in mice at doses of 30–50 μmol/kg. Concentrations in brain and plasma were measured after 1.5 h, and the total and free brain plasma concentration ratios were calculated. (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>)</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo Brain Exposure of Four Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">route of administration<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>brain</sub>/<i>C</i><sub>plasma</sub></th><th class="colsep0 rowsep0" align="center"><i>f</i><sub>u,brain</sub></th><th class="colsep0 rowsep0" align="center"><i>f</i><sub>u,plasma</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>u,brain</sub>/<i>C</i><sub>u,plasma</sub></th><th class="colsep0 rowsep0" align="center">P-gp efflux</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24a</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">0.074</td><td class="colsep0 rowsep0" align="left">0.89</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">low</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">8.9</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">0.07</td><td class="colsep0 rowsep0" align="left">0.64</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">0.02</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left">high</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.01</td><td class="colsep0 rowsep0" align="left">0.007</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">low<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">iv (intravenous), po (per oral).</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">P-gp efflux was estimated from the value of the similar compound <b>65</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</p></div></div></div><div class="NLM_p last">Both compounds <b>24a</b> and <b>64</b> penetrated the blood–brain barrier well and showed a high CNS localization as could be predicted by the low efflux in the MDCK-MDR1 P-gp assay. The compounds had a high total brain/plasma ratio (1.4 and 0.9, respectively), and both <b>24a</b> and <b>64</b> reached reasonable to good free brain/plasma ratios (0.27 and 1.3, respectively). The relatively low brain/plasma ratio for compound <b>41</b> (0.2) was in accordance with the results from the MDCK-MDR1 P-gp assay where the compound was shown to be a P-gp substrate. Since compound <b>37</b> was only used as a reference, it was not tested for P-gp efflux, but CNS localization was high with a free brain/plasma ratio calculated to 0.64.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Combined Profile Discussion</h3><div class="NLM_p">The cores of subtype <b>A</b> had the best permeability profile but were still seen as less promising because of poor LEs and cellular potencies and high hERG activities. Compounds of subtype <b>B</b> were more promising, showing very high LEs and cellular potencies. Of these, core type <b>B-2</b> had the overall most optimal in vitro profile, with high target activity in cell, low hERG activity, and medium overall permeability. Some compounds of this core type showed better results than the clinical candidate references, when the main parameters were compared. In addition, the in vivo brain exposure of compound <b>24a</b> also showed high potential.</div><div class="NLM_p">Compounds of subtype <b>C</b> were highly active on target but were regarded as less promising because of hERG issues. The subtype <b>D</b> family contained the second best core type: <b>D-1</b>, with promising permeability in vitro and in vivo, together with reasonable target activity. Core type <b>D-5</b> was exciting from an activity perspective, with surprisingly high activity differences for the separated stereoisomers. However, this core type did not exhibit a favorable permeability profile.</div><div class="NLM_p">With these novel compounds, we have shown that the properties of the cores have a significant effect on the in vitro profiles of the test compounds and that small structural changes of the cores can potentially lead to large unpredictable variations, especially for target activity. For instance, when compounds <b>24b</b>, <b>34</b>, and <b>37</b> were compared, differing only in the position of the sulfur in the core ring, it was interesting to see that the eLogD values were almost identical whereas the p<i>K</i><sub>a</sub> values varied a lot. Despite the difference in p<i>K</i><sub>a</sub>, compounds <b>34</b> and <b>37</b>had similar activities in both the enzymatic and the cell assays, whereas compound <b>24b</b> was more than three times more potent in the enzymatic assay and more than five times more potent than compound <b>34</b> in the cell assay. Permeability also differed: compound <b>37</b> had almost 10 times better permeability than compound <b>34</b>. The hERG activity on the other hand was similar for all three compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).</div><figure id="fig9" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Matched pair analysis for compounds <b>24b</b>, <b>34</b>, and <b>37</b>, all belonging to core subtype <b>B</b> and containing one sulfur atom in the core structure. The asterisk (∗) indicates that the experimental p<i>K</i><sub>a</sub> was measured for compound <b>24a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, we have verified that the core structures are important for the overall profile of the test compounds. In line with previous reports, increasing p<i>K</i><sub>a</sub> has a positive effect on cellular potency, up to a p<i>K</i><sub>a</sub> of about 8.5. However, this needs to be balanced with the negative effect of a high p<i>K</i><sub>a</sub> when addressing permeability and hERG issues: for these compounds an upper p<i>K</i><sub>a</sub> limit of 8 could be seen to achieve high permeability. To increase the chances of reducing hERG activity, p<i>K</i><sub>a</sub> should be even lower. Another way to reduce hERG activity for these compounds was to reduce lipophilicity.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18870" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18870" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">This work describes our effort toward improved BACE-1 inhibitors by refining the amidine-containing core. The iterative design of the inhibitors was aided by predictive chemistry models, and target affinity, permeability, and hERG activity were addressed in a multiparameter optimization fashion. In total, 13 new cores were designed to individually capture learnings and cover the desired physicochemical space. New synthesis pathways were developed, requiring a major synthesis effort, and knowledge was generated that can be used for further optimization of other core structures. Compounds representing these cores were synthesized with matched pair substituents and evaluated on results from in vitro and in vivo experiments. Four compounds having a cellular potency under 100 nM were found, representing cores from three different subtypes. Many of the new compounds showed a promising hERG profile, and two compounds showed a high CNS localization in vivo. With this exercise, we show that small changes in the core structures may give very different in vitro profiles of the test compounds. Thus, we conclude that it is important to focus on optimization of the core early in the lead generation phase, since the selection of the core is an important step, defining the framework for future lead optimization. This lead generation strategy may be suitable for other drug-design projects.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Chemistry</h3><div class="NLM_p">All solvents used were commercially available and were used without further purification. Reactions were typically run using anhydrous solvents under an inert atmosphere of nitrogen or argon. Starting materials used were available from commercial sources or prepared as described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Room temperature refers to 20–25 °C. Microwave heating was performed in a Biotage Initiator microwave synthesizer at the indicated temperature in the recommended microwave tubes.</div><div class="NLM_p"><sup>1</sup>H NMR spectra were recorded in the indicated deuterated solvent at 400 MHz, and the spectra were obtained unless stated otherwise, using a Bruker av400 NMR spectrometer equipped with a 3 mm flow injection SEI <sup>1</sup>H/D–<sup>13</sup>C probe head with Z-gradients, using a BEST 215 liquid handler for sample injection or using a Bruker DPX400 NMR spectrometer equipped with a four-nucleus probe head (<sup>19</sup>F) with Z-gradients. 500 MHz spectra were recorded using a Bruker 500 MHz Avance III NMR spectrometer. Chemical shifts are given in ppm downfield and upfield from TMS. Resonance multiplicities are denoted s, d, t, q, m, and br for singlet, doublet, triplet, quartet, multiplet, and broad, respectively.</div><div class="NLM_p">Preparative HPLC was performed on a Waters AutoPurification HPLC–UV system with a diode array detector using a Waters XTerra MS C<sub>8</sub> column (19 mm × 300 mm, 7 μm), and a linear gradient of mobile phase B was applied. Mobile phase A consisted of 0.1 M ammonium acetate in water/acetonitrile (95:5), and mobile phase B consisted of acetonitrile. Flow rate was 20 mL/min. Flash chromatography was performed using Merck silica gel 60 (0.040–0.063 mm) or employing a Combi Flash Companion system using RediSep normal-phase flash columns. Column chromatography was performed using Merck silica gel 60 (0.040–0.063 mm).</div><div class="NLM_p">LC–MS analyses were performed on an LC–MS system consisting of a Waters sample manager 2777C, a Waters 1525 μ binary pump, a Waters 1500 column oven, a Waters ZQ single quadrupole mass spectrometer, a Waters PDA 2996 diode array detector, and a Sedex 85 ELS detector. The mass spectrometer was equipped with an electrospray ion source (ES) operated in positive and negative ion mode. For separation a linear gradient was applied starting at 100% 0.1% NH<sub>3</sub> in Milli-Q ending at 100% methanol. The column used was an XBridge C18, 3.0 mm × 50 mm, 5 μm, which was run at a flow rate of 2 mL/min. Or analyses were performed on a LC–MS system consisting of a Waters Alliance 2795 HPLC, a Waters PDA 2996 diode array detector, a Sedex 85 ELS detector, and a ZQ single quadrupole mass spectrometer. The mass spectrometer was equipped with an electrospray ion source (ES) operated in positive and negative ion modes. Separation was performed on an XBridge C18, 3.0 mm × 50 mm, 3.5 μm, run at a flow rate of 1 mL/min. A linear gradient was applied starting at 100% 0.1% NH<sub>3</sub> in Milli-Q ending at 100% methanol.</div><div class="NLM_p">Purity analyses were performed on an Agilent HP1100 system consisting of a G1322A Micro vacuum degasser, a G1312A Binary Pump, a G1367 A well-plate autosampler, a G1316A thermostated column compartment, a G1315C diode array detector, and a 6120, G1978B mass spectrometer. The mass spectrometer was configured with an atmospheric pressure chemical ionization (APCI) ion source operated in positive and negative ion modes. The column used was an XBridge C18 3.0 mm × 100 mm, 3 μm, run at a flow rate of 1.0 mL/min. A linear gradient was used for both the blank and the sample, starting at 100% 10 mM NH<sub>4</sub>OAc in 5% CH<sub>3</sub>CN and ending at 95% CH<sub>3</sub>CN. The blank run was subtracted from the sample run. All tested compounds were purified to >95% purity as determined by reversed phase HPLC, if nothing else is stated.</div><div class="NLM_p">SFC purity analysis was run on a SFC Berger Analytix system with Agilent 1100 PDA detector. The column was a Chiralpak AD-H, 5 μm, 4.6 mm × 250 mm. The column temperature was set to 50 °C. An isocratic condition of 20–30% (2-propanol + 0.1% DEA) and 70–80% CO<sub>2</sub> was applied at a flow rate of 3.0 mL/min. The PDA was scanned from 190 to 600 and 220 nm, and the sample was extracted for purity determination.</div><div class="NLM_p last">SFC preparative chromatography was run on a SFC Berger Multigram II system with a Knauer K-2501 UV detector. The column was a Chiralpak AD-H, 5 μm, 21.2 mm × 250 mm. The column temperature was set to 35 °C. An isocratic condition of 20–30% (2-propanol + 0.1% DEA) and 70–80% CO<sub>2</sub> was applied at a flow rate of 50.0 mL/min. The UV detector was scanned at 220 nm. The UV signal determined the fraction collection.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-Methyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-amine (<b>8a</b>)</h3><div class="NLM_p last">1-(3-Bromophenyl)ethanone (<b>1</b>) (15 mL, 0.11 mol), 2-hydroxybenzamide (<b>2</b>) (10 g, 73 mmol), and<i>p</i>-toluenesulfonic acid monohydrate (1.4 g, 7.3 mmol) were taken up in toluene (50 mL), fitted with a Dean–Stark trap, and heated to reflux for 16 h. The reaction mixture was cooled to 0 °C for30 min. The precipitate was collected by suction filtration, washed with toluene, and dried to yield 22 g of <b>3</b>. A portion of this material (1 g) and phosphorus pentasulfide (1 g, 2.3 mmol) was dissolved in pyridine (7.5 mL). The mixture was heated to 120 °C for 1 h and then cooled to room temperature. The reaction mixture was diluted with 1 M HCl. The mixture was extracted with DCM. The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered and the solvent was evaporated to yield 1.4 g of <b>4</b> (MS (ES+) <i>m</i>/<i>z</i> 334, 336 [M + H]<sup>+</sup>). A portion of this material (0.25 g) was dissolved in ammonia (7 M in MeOH) (4.3 mL, 30 mmol). <i>tert</i>-Butyl hydroperoxide (1.5 mL, 11 mmol) was added, and the mixture was stirred at room temperature for 2 h. The solvents and excess reagents were evaporated. The product was purified by RP-HPLC to yield 23.4 mg of <b>5</b> (MS (ES+) <i>m</i>/<i>z</i> 317, 319 [M + H]<sup>+</sup>). This material was taken up in DME (2 mL) and water (1 mL). Pyrimidin-5-ylboronic acid (18 mg, 0.15 mmol) and bis(triphenylphosphine)palladium(II) chloride (5.2 mg, 7.4 μmol) and sodium carbonate (1 M) (0.18 mL, 0.18 mmol) were added, and the mixture was heated to 80 °C for 2 h. The product was purified by RP-HPLC to yield 12 mg (6%) of the title compound over several steps. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.91 (s, 3 H), 4.30 (br s, 2 H), 6.91 (td, <i>J</i> = 7.58, 1.01 Hz, 1 H), 7.01 (dd, <i>J</i> = 8.21, 0.88 Hz, 1 H), 7.27 (dd, <i>J</i> = 7.83, 1.52 Hz, 1 H), 7.37 (ddd, <i>J</i> = 8.15, 7.39, 1.64 Hz, 1 H), 7.40–7.47 (m, 2 H), 7.68–7.71 (m, 1 H), 7.79–7.82 (m, 1 H), 8.91 (s, 2 H), 9.19 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 317 [M + H]<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-Methyl-2-(3-(pyridin-3-yl)phenyl)-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-amine (<b>8b</b>)</h3><div class="NLM_p last">A portion of <b>7</b> (5 g) was dissolved in POCl<sub>3</sub> (8.8 mL, 94 mmol). PCl<sub>5</sub> (0.66 g, 3.1 mmol) was added, and the mixture was stirred at 50 °C for 3 h. Excess reagent was evaporated. The residue <b>6</b> (MS (ES+) <i>m</i>/<i>z</i> 338 [M + H]<sup>+</sup>) was taken up in DMF (50 mL). DIPEA (14 mL, 79 mmol) and <i>O</i>-methylhydroxylamine (6.6 g, 79 mmol) were added, and the mixture was stirred at 90 °C for 16 h. The solvent was evaporated and the residue poured into brine. The mixture was extracted with diethyl ether. The combined organic phases were dried over MgSO<sub>4</sub>, filtered and the solvents evaporated. The product was purified by column chromatography using EtOAc 0–50% in heptane to yield 6 g of <b>7</b> (MS (ES+) <i>m</i>/<i>z</i> 347, 349 [M + H]<sup>+</sup>). This material was dissolved in acetic acid (50 mL). Zinc (3 g, 46 mmol) was added, and the mixture was stirred at room temperature for 1 h. The reaction mixture was filtered and the filtrate reduced. The product was purified by column chromatography using MeOH 0–10% in DCM to yield 2.3 g of <b>5</b> (MS (ES+) <i>m</i>/<i>z</i> 317, 319 [M + H]<sup>+</sup>). A portion of this material (100 mg) was taken up in DME (2 mL) and water (1 mL). Pyridin-3-ylboronic acid (47 mg, 0.38 mmol), bis(triphenylphosphine)palladium(II) chloride (22 mg, 0.03 mmol), and sodium carbonate (1 M) (0.79 mL, 0.79 mmol) were added, and the mixture was heated to 80 °C for 2 h. The product was purified by acidic RP-HPLC, followed by column chromatography using EtOAc 0–100% in heptane followed by basic RP-HPLC to yield 7.7 mg (3%) of the title compound over several steps. <sup>1</sup>H NMR (400 MHz, MeOD) δ ppm 1.87 (s, 3 H), 6.90 (td, <i>J</i> = 7.64, 1.14 Hz, 1 H), 6.96–7.02 (m, 1 H), 7.32–7.41 (m, 2 H), 7.43–7.52 (m, 3 H), 7.57 (dt, <i>J</i> = 7.83, 1.52 Hz, 1 H), 7.75 (t, <i>J</i> = 1.77 Hz, 1 H), 7.96–8.02 (m, 1 H), 8.50 (dd, <i>J</i> = 4.93, 1.39 Hz, 1 H), 8.69 (d, <i>J</i> = 1.77 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 316 [M + H]<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-Ethyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-amine (<b>9</b>)</h3><div class="NLM_p last">2-(3-Bromophenyl)-2-ethyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4(3<i>H</i>)-one (4 g, 12 mmol) was dissolved in POCl<sub>3</sub> (6.7 mL, 72 mmol). PCl<sub>5</sub> (0.5 g, 2.4 mmol) was added, and the mixture was stirred at 50 °C for 3 h. Excess reagent was evaporated. The residue 2-(3-bromophenyl)-4-chloro-2-ethyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazine was taken up in DMF (50 mL). DIPEA (11 mL, 60 mmol) and <i>O</i>-methylhydroxylamine (5 g, 60 mmol) was added, and the mixture was stirred at 90 °C for 16 h. The solvent was evaporated and the residue poured into brine. The mixture was extracted with diethyl ether. The combined organic phases were dried over MgSO<sub>4</sub>, filtered and the solvents evaporated. The product was purified by column chromatography using EtOAc 0–30% in heptane to yield 2 g of <i>N</i>-(2-(3-bromophenyl)-2-ethyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-yl)-<i>O</i>-methylhydroxylamine (MS (ES+) <i>m</i>/<i>z</i> 361, 363 [M + H]<sup>+</sup>). This material was dissolved in acetic acid (20 mL). Zinc (1 g, 15 mmol) was added, and the mixture was stirred at room temperature for 1 h. The reaction mixture was filtered and the filtrate reduced. The product was purified by column chromatography using MeOH 0–10% in DCM to yield 1.5 g of 2-(3-bromophenyl)-2-ethyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-amine (MS (ES+) <i>m</i>/<i>z</i> 331, 333 [M + H]<sup>+</sup>). A portion of this material (100 mg) was taken up in DME (2 mL) and water (1 mL). Pyrimidin-5-ylboronic acid (45 mg, 0.36 mmol), bis(triphenylphosphine)palladium(II) chloride (21 mg, 0.03 mmol), and sodium carbonate (1 M) (0.76 mL, 0.76 mmol) were added, and the mixture was heated to 80 °C for 2 h. The reaction mixture was extracted with DCM. The combined organic phases were evaporated. The product was purified by RP-HPLC to yield 29 mg (11%) of the title compound at 93% purity, over several steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.90 (t, <i>J</i> = 7.33 Hz, 3 H), 1.92–2.12 (m, 2 H), 6.49 (s, 2 H), 6.85 (td, <i>J</i> = 7.52, 1.14 Hz, 1 H), 7.01 (dd, <i>J</i> = 8.21, 0.88 Hz, 1 H), 7.28–7.35 (m, 1 H), 7.40–7.46 (m, 1 H), 7.52 (dd, <i>J</i> = 7.83, 1.26 Hz, 1 H), 7.53–7.58 (m, 1 H), 7.58–7.65 (m, 1 H), 7.80 (t, <i>J</i> = 1.64 Hz, 1 H), 9.03 (s, 2 H), 9.19 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 331 [M + H]<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-Fluoro-2-methyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-amine (<b>10a</b>)</h3><div class="NLM_p last">2-Fluoro-6-hydroxybenzamide (<b>24</b>) (5 g), 1 (6.4 mL, 48 mmol) and <i>p</i>-toluenesulfonic acid monohydrate (6.7 g, 35 mmol) were taken up in toluene (50 mL), fitted with a Dean–Stark trap, and heated to reflux for 16 h. The reaction mixture was shaken with 1 M LiOH. The phases were separated. The aqueous phase was extracted with DCM. The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered and the solvents evaporated. The product was purified by column chromatography using EtOAc 0–100% heptane to yield 2.2 g of 2-(3-bromophenyl)-5-fluoro-2-methyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4(3<i>H</i>)-one (MS (ES+) <i>m</i>/<i>z</i> 336, 338 [M + H]<sup>+</sup>). This material was dissolved in POCl<sub>3</sub> (7.2 mL, 77 mmol). PCl<sub>5</sub> (0.53 g, 2.6 mmol) was added, and the mixture was stirred at 50 °C for 3 h. Excess reagent was evaporated. The residue 2-(3-bromophenyl)-4-chloro-5-fluoro-2-methyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazine was taken up in DMF (20 mL). DIPEA (5.6 mL, 32 mmol) and <i>O</i>-methylhydroxylamine (2.8 g, 32 mmol) were added, and the mixture was stirred at 90 °C for 16 h. The solvent was evaporated and the residue poured into brine. The mixture was extracted with DCM. The combined organic phases were dried over MgSO<sub>4</sub>, filtered and the solvents evaporated. The product was purified by column chromatography using EtOAc 0–50% in heptane to yield 0.28 g of <i>N</i>-(2-(3-bromophenyl)-5-fluoro-2-methyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-yl)-<i>O</i>-methylhydroxylamine (MS (ES+) <i>m</i>/<i>z</i> 365, 367 [M + H]<sup>+</sup>). This material was dissolved in acetic acid (3 mL). Zinc (0.34 g, 5.20 mmol) was added, and the mixture was stirred at room temperature for 3 h. The reaction mixture was filtered and the filtrate reduced. The residue was taken up in DCM and washed with 1 M LiOH, brine, dried over MgSO<sub>4</sub>, filtered and the solvent evaporated to yield 170 mg of 2-(3-bromophenyl)-5-fluoro-2-methyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-amine (MS (ES+) <i>m</i>/<i>z</i> 335, 337 [M + H]<sup>+</sup>). A portion of this material (85 mg) was taken up in DME (2 mL) and water (1 mL). Pyrimidin-5-ylboronic acid (35 mg, 0.28 mmol), bis(triphenylphosphine)palladium(II) chloride (18 mg, 0.03 mmol), and sodium carbonate (1 M) (0.63 mL, 0.63 mmol) were added, and the mixture was heated to 80 °C for 2 h. The product was purified by RP-HPLC to yield 30 mg (0.4%) of the title compound over several steps. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.92 (s, 3 H), 5.45 (br s, 2 H), 6.65 (dd, <i>J</i> = 11.12, 8.59 Hz, 1 H), 6.85 (d, <i>J</i> = 8.08 Hz, 1 H), 7.29–7.36 (m, 1 H), 7.43–7.50 (m, 2 H), 7.67–7.72 (m, 1 H), 7.79 (s, 1 H), 8.92 (s, 2 H), 9.21 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 335 [M + H]<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5-Fluoro-2-methyl-2-(3-(pyridin-3-yl)phenyl)-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-amine (<b>10b</b>)</h3><div class="NLM_p last">A portion of 2-(3-bromophenyl)-5-fluoro-2-methyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4-amine (85 mg) was taken up in DME (2 mL) and water (1 mL). Pyridin-3-ylboronic acid (34 mg, 0.28 mmol), bis(triphenylphosphine)palladium(II) chloride (18 mg, 0.03 mmol), and sodium carbonate (1 M) (0.63 mL, 0.63 mmol) were added, and the mixture was heated to 80 °C for 2 h. The product was purified by RP-HPLC to yield 41 mg (0.6%) of the title compound at 93% purity, over several steps. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.88 (s, 3 H), 5.28 (br s, 2 H), 6.59 (dd, <i>J</i> = 11.24, 8.46 Hz, 1 H), 6.81 (d, <i>J</i> = 8.08 Hz, 1 H), 7.22–7.48 (m, 4 H), 7.60 (dt, <i>J</i> = 7.52, 1.55 Hz, 1 H), 7.77 (t, <i>J</i> = 1.77 Hz, 1 H), 7.82 (dt, <i>J</i> = 7.96, 1.83 Hz, 1 H), 8.56 (dd, <i>J</i> = 4.80, 1.52 Hz, 1 H), 8.79 (d, <i>J</i> = 2.27 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 334 [M + H]<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Methyl-2-(3-(pyrimidin-5-yl)phenyl)-2<i>H</i>-benzo[<i>e</i>][1,3]thiazin-4-amine (<b>15</b>)</h3><div class="NLM_p last">Compound <b>11a</b> (340 mg, 1.7 mmol) and methyl 2-mercaptobenzoate (1.2 mL, 8.6 mmol) were taken up in ammonia (7 M in MeOH) (2 mL, 14 mmol). The mixture was heated to 150 °C for 3 h by microwave heating and the solvent was evaporated. The product was purified by column chromatography using EtOAc 0–100% in heptane to yield 0.16 g of <b>13</b> (MS (ES+) <i>m</i>/<i>z</i> 334 [M + H]<sup>+</sup>). This material and phosphorus pentasulfide (0.16 g, 0.35 mmol) were taken up in pyridine (1 mL). The mixture was heated to 120 °C for 1 h and then cooled to room temperature. Ammonia (7 M in MeOH) (2.5 mL, 18 mmol) was added, and the mixture was stirred at 90 °C for 16 h. The product was purified by RP-HPLC followed by column chromatography using MeOH (with 7 M NH<sub>3</sub>) 0–10% in DCM to yield 7.2 mg (1.3%) of the title compound over several steps. <sup>1</sup>H NMR (400 MHz, MeOD) δ ppm 1.93 (s, 3 H), 7.14–7.22 (m, 1 H), 7.26–7.36 (m, 2 H), 7.38–7.44 (m, 1 H), 7.47–7.54 (m, 1 H), 7.65–7.75 (m, 2 H), 7.88 (t, <i>J</i> = 1.89 Hz, 1 H), 8.97 (s, 2 H), 9.12 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 333 [M + H]<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-(3′-Methoxybiphenyl-3-yl)-2-methyl-5,6-dihydro-2<i>H</i>-1,3-oxazin-4-amine (<b>19a</b>)</h3><div class="NLM_p last">A mixture of compound <b>18</b> (45 mg, 0.17 mmol), 3-methoxyphenylboronic acid (51 mg, 0.33 mmol), [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloride dichloromethane complex (20 mg, 0.03 mmol), and cesium carbonate (0.16 g, 0.50 mmol) in 1,2-dimethoxyethane/water/ethanol (6:3:1, 5 mL) was heated at 120 °C for 20 min by microwave heating. When cooled to ambient temperature, the mixture was concentrated and the residue partitioned between dichloromethane–water (4:1, 15 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated and the product purified by RP-HPLC to yield 3.4 mg (5%) of the title compound as the acetate salt. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm (s, 3 H) 2.22–2.32 (m, 1 H), 2.77 (ddd, <i>J</i> = 17.50, 10.56, 7.25 Hz, 1 H), 3.69 (td, <i>J</i> = 11.35, 3.78 Hz, 1 H), 3.88 (s, 3 H), 3.93 (dd, <i>J</i> = 11.35, 7.25 Hz, 1 H), 6.91 (dd, <i>J</i> = 8.20, 2.21 Hz, 1 H), 7.16 (s, 1 H), 7.22 (d, <i>J</i> = 7.57 Hz, 1 H), 7.33–7.40 (m, 1 H), 7.42–7.50 (m, 2 H), 7.55 (d, <i>J</i> = 7.25 Hz, 1 H), 7.75 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-(3′-Chlorobiphenyl-3-yl)-2-methyl-5,6-dihydro-2<i>H</i>-1,3-oxazin-4-amine (<b>19b</b>)</h3><div class="NLM_p last">A mixture of <b>18</b> (45 mg, 0.17 mmol), 3-chlorophenylboronic acid (52 mg, 0.33 mmol), [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloride dichloromethane complex (14 mg, 0.02 mmol), and cesium carbonate (0.16 g, 0.50 mmol) in 1,2-dimethoxyethane/water/ethanol (6:3:1, 5 mL) was heated at 120 °C for 20 min by microwave heating. When cooled to ambient temperature, the mixture was concentrated and the residue partitioned between dichloromethane–water (4:1, 15 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated and the product purified by RP-HPLC to yield 4.5 mg (8%) of the title compound as the acetate salt. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 1.80 (s, 3 H), 2.34 (d, <i>J</i> = 16.39 Hz, 1 H), 2.81 (ddd, <i>J</i> = 17.26, 10.32, 7.41 Hz, 1 H), 3.69 (td, <i>J</i> = 11.35, 3.47 Hz, 1 H), 3.96 (dd, <i>J</i> = 11.35, 6.94 Hz, 1 H), 7.30–7.41 (m, 2 H), 7.43–7.56 (m, 4 H), 7.62 (s, 1 H), 7.74 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 301 [M + H]<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-Methyl-2-(3-(pyrimidin-5-yl)phenyl)-5,6-dihydro-2<i>H</i>-1,3-thiazin-4-amine (<b>24a</b>)</h3><div class="NLM_p last">Methyl 3-mercaptopropanoate (8.0 g, 67 mmol) was dissolved in ammonium hydroxide 25% (0.14 L, 0.89 mol), and the obtained solution was stirred at room temperature for 8 h. The mixture was concentrated, coevaporated with toluene, and dried at reduced pressure and over P<sub>2</sub>O<sub>5</sub> to yield 7 g of <b>21</b>. A portion of this material (315 mg), <b>11a</b> (495 mg, 2.5 mmol), and pTSA (43 mg, 0.22 mmol) in toluene (25 mL) was refluxed for 8 h using a Dean–Stark trap. The mixture was concentrated at reduced pressure. The product was purified by column chromatography using EtOAc 60–100% in heptane to yield 225 mg of <b>22a</b> (MS (ES+) <i>m</i>/<i>z</i> 286 [M + H]<sup>+</sup>). This material, phosphorus pentasulfide (175 mg, 0.79 mmol), and hexamethyldisiloxane (0.5 mL, 2.4 mmol) were taken up in dry 1,2-dichloroethane (2 mL) and heated to 110 °C for 1 h by microwave heating. The mixture was filtered through a pad of silica gel, eluted with EtOAc, and concentrated at reduced pressure. The product was purified by column chromatography using EtOAc 0–50% in heptane to yield 105 mg of <b>23a</b> (MS (ES+) <i>m</i>/<i>z</i> 302 [M + H]<sup>+</sup>). This material was taken up in ammonia (7 M in MeOH) (21 mL, 147 mmol) in a 50 mL round-bottom flask which was sealed with a septum. The reaction mixture was stirred at room temperature overnight. The product was purified by RP-HPLC to yield 37 mg (3%) of the title compound over several steps. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.80 (s, 3 H), 2.25 (t, <i>J</i> = 6.31 Hz, 2 H), 2.42 (dt, <i>J</i> = 13.64, 6.90 Hz, 1 H), 2.76 (dt, <i>J</i> = 13.48, 5.56 Hz, 1 H), 5.94 (br s, 2 H), 7.44–7.49 (m, 1 H), 7.52–7.57 (m, 1 H), 7.63 (dt, <i>J</i> = 7.57, 1.42 Hz, 1 H), 7.80 (t, <i>J</i> = 1.73 Hz, 1 H), 9.09 (s, 2 H), 9.20 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 285 [M + H]<sup>+</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-(3′-Methoxybiphenyl-3-yl)-2-methyl-5,6-dihydro-2<i>H</i>-1,3-thiazin-4-amine (<b>24b</b>)</h3><div class="NLM_p last">A mixture of compound <b>21</b> (0.84 g), 5 (1.8 g, 8 mmol) and pTSA (0.136 g, 0.72 mmol) in toluene (25 mL) was refluxed for 8 h using a Dean–Stark trap. The reaction mixture was concentrated at reduced pressure. The product was purified by column chromatography using EtOAc 60–100% in heptane to yield 0.5 g of <b>22b</b>. A portion of this intermediate material (260 mg), phosphorus pentasulfide (184 mg, 0.83 mmol), and hexamethyldisiloxane (0.52 mL, 2.5 mmol) were taken up in dry 1,2-dichloroethane (2 mL) and heated to 110 °C for 1 h by microwave heating. The mixture was filtered through a pad of silica gel, eluted with EtOAc, and concentrated at reduced pressure. The product was purified with column chromatography using EtOAc 0–50% in heptane to yield 100 mg of <b>23b</b> (MS (ES+) <i>m</i>/<i>z</i> 330 [M + H]<sup>+</sup>). This material was taken up in ammonia (7 M in MeOH) (20 mL, 140 mmol) in a 50 mL round-bottom flask that was sealed with a septum. The reaction mixture was stirred at room temperature for 16 h. The product was purified by RP-HPLC to yield 5.4 mg (0.4%) of the title compound as the acetate salt, over several steps. <sup>1</sup>H NMR (500 MHz, MeOD) δ ppm 1.99 (s, 3 H), 2.54–2.67 (m, 1 H), 2.81–2.99 (m, 3 H), 3.83 (s, 3 H), 6.92 (dd, <i>J</i> = 8.20, 2.21 Hz, 1 H), 7.11 (t, <i>J</i> = 2.05 Hz, 1 H), 7.16 (d, <i>J</i> = 8.20 Hz, 1 H), 7.35 (t, <i>J</i> = 7.88 Hz, 1 H), 7.44–7.49 (m, 2 H), 7.52–7.59 (m, 1 H), 7.66 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 313 [M + H]<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-(3′-Methoxybiphenyl-3-yl)-5-methyl-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-amine (<b>30</b>)</h3><div class="NLM_p last">A solution of <b>29</b> (0.25 g, 0.81 mmol) in ammonia (7 M in MeOH) (1.8 mL, 81 mmol) was stirred at 40 °C for 3 days. The product was purified by RP-HPLC to yield 95 mg (27%) of the title compound as the acetate salt. <sup>1</sup>H NMR (500 MHz, MeOD) δ ppm 1.78 (s, 3 H), 3.85 (s, 3 H), 3.91–4.04 (m, 2 H), 4.59 (s, 2 H), 6.94 (dd, <i>J</i> = 8.20, 2.21 Hz, 1 H), 7.15 (t, <i>J</i> = 2.05 Hz, 1 H), 7.19 (d, <i>J</i> = 7.57 Hz, 1 H), 7.36 (t, <i>J</i> = 8.04 Hz, 1 H), 7.40–7.45 (m, 1 H), 7.50 (t, <i>J</i> = 7.72 Hz, 1 H), 7.59 (d, <i>J</i> = 7.57 Hz, 1 H), 7.62–7.65 (m, 1 H). MS (ES+) <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 5-(3′-Methoxybiphenyl-3-yl)-5-methyl-5,6-dihydro-2<i>H</i>-1,4-thiazin-3-amine (<b>34</b>)</h3><div class="NLM_p last">A mixture of <b>33</b> (0.36 g, 1.2 mmol), phosphorus pentasulfide (0.28 g, 1.3 mmol), and hexamethyldisiloxane (0.73 mL, 3.5 mmol) in 1,2-dichloroethane (3 mL) was heated at 100 °C for 1 h. The mixture was purified by column chromatography using DCM to yield 170 mg. This material was stirred in ammonia (7 M in MeOH) (7.4 mL, 52 mmol) at 50 °C for 3 days. The product was purified by RP-HPLC to yield 71 mg (31%) of the title compound as the acetate salt. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 1.86 (s, 3 H), 3.07 (d, <i>J</i> = 13.87 Hz, 1 H), 3.21 (d, <i>J</i> = 13.87 Hz, 1 H), 3.26–3.32 (m, 1 H), 3.40–3.46 (m, 1 H), 3.88 (s, 3 H), 6.92 (dd, <i>J</i> = 8.20, 2.21 Hz, 1 H), 7.13 (t, <i>J</i> = 1.89 Hz, 1 H), 7.18 (d, <i>J</i> = 7.88 Hz, 1 H), 7.34 (d, <i>J</i> = 7.88 Hz, 1 H), 7.36–7.40 (m, 1 H), 7.45 (t, <i>J</i> = 7.72 Hz, 1 H), 7.50–7.54 (m, 1 H), 7.56 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 313 [M + H]<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-(3′-Methoxybiphenyl-3-yl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>37</b>)</h3><div class="NLM_p last">Compound <b>11b</b> (2 g, 8.8 mmol) was dissolved in dry 2-methyltetrahydrofuran (25 mL). The mixture was cooled to −78 °C before vinylmagnesium bromide (19.5 mL, 19.5 mmol) was added. The mixture was stirred for 1 h and was then allowed to reach room temperature. Saturated aqueous NH<sub>4</sub>Cl solution was added, and the mixture was extracted with EtOAc. The organic layer was washed with saturated NaHCO<sub>3</sub> and brine. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and the solvent was evaporated. The product was purified by column chromatography using EtOAc 10–50% in heptane to yield 1.85 g of <b>35</b>. This material was dissolved in acetic acid (30 mL). Thiourea (0.61 g, 8 mmol) and HCl (8 mL, 8 mmol) (1 M in acetic acid) were added. The solution was stirred at 45 °C for 16 h. The solvent was evaporated and the product crystallized from a mixture of MeOH and diethyl ether to yield 1.47 g of <b>36</b> (MS (ES+) <i>m</i>/<i>z</i> 313 [M + H]<sup>+</sup>). A portion of this material (0.5 g) was taken up in TFA (5 mL, 65 mmol). Methanesulfonic acid (0.23 mL, 3.5 mmol) was added dropwise during cooling on an ice bath. The solution was stirred at room temperature for 1 h. The solution was concentrated under reduced pressure. The residue was dissolved in DCM and washed with saturated NaHCO<sub>3</sub>. The organic phase was filtered and the solvent evaporated. The product was purified by column chromatography using MeOH (with 7 M NH<sub>3</sub>) 0–6% in DCM to yield 0.2 g (21%) of the title compound over several steps. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.45 (s, 3 H), 1.75 (ddd, <i>J</i> = 13.79, 10.32, 3.63 Hz, 1 H), 2.08 (ddd, <i>J</i> = 13.40, 6.31, 3.31 Hz, 1 H), 2.55 (ddd, <i>J</i> = 12.14, 10.40, 3.63 Hz, 1 H), 2.91 (ddd, <i>J</i> = 12.22, 6.70, 3.78 Hz, 1 H), 3.82 (s, 3 H), 5.84 (br s, 2 H), 6.93 (dd, <i>J</i> = 8.20, 1.89 Hz, 1 H), 7.10–7.15 (m, 1 H), 7.18 (d, <i>J</i> = 7.88 Hz, 1 H), 7.33–7.42 (m, 3 H), 7.47 (dt, <i>J</i> = 7.09, 1.81 Hz, 1 H), 7.57–7.63 (m, 1 H). MS (ES+) <i>m</i>/<i>z</i> 313 [M + H]<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 6-(4-Methoxyphenyl)-2-methyl-6-[3-(pyrimidin-5-yl)phenyl]-6<i>H</i>-pyrrolo[3,4-<i>d</i>][1,3]thiazol-4-amine (<b>41</b>)</h3><div class="NLM_p last">A mixture of <b>40</b> (64 mg, 0.15 mmol), pyrimidine-5-ylboronic acid (29 mg, 0.23 mmol), [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) chloride (6.4 mg, 7.8 μmol), potassium carbonate (43 mg, 0.31 mmol), DME (2 mL), H<sub>2</sub>O (1 mL), and EtOH (0.33 mL) under an argon atmosphere was heated to 100 °C for 15 min using a microwave reactor. The reaction mixture was filtered through diatomaceous earth, which was washed with EtOAc, and then the filtrate was evaporated. Purification by RP-HPLC yielded 27 mg (43%) of the title compound. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.75 (s, 3 H), 3.69 (s, 3 H), 6.77 (br s, 2 H), 6.81–6.87 (m, 2 H), 7.30–7.35 (m, 2 H), 7.43–7.53 (m, 2 H), 7.60–7.65 (m, 1 H), 7.69–7.72 (m, 1 H), 9.00 (s, 2 H), 9.19 (s, 1 H); LCMS (ES+) <i>m</i>/<i>z</i> 414 [M + H]<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-(4-Methoxyphenyl)-2-methyl-4-(3-(pyrimidin-5-yl)phenyl)-4<i>H</i>-imidazo[1,5-<i>b</i>]pyrazol-6-amine (<b>47</b>)</h3><div class="NLM_p last">To a solution of <b>46</b> (15 mg, 0.04 mmol) and pyrimidine-5-ylboronic acid (5.4 mg, 0.04 mmol) in DME (0.6 mL)/water (0.3 mL) was added sodium carbonate (1 M aq) (0.091 mL, 0.09 mmol) followed by bis(triphenylphosphine)palladium(II) chloride (2.6 mg, 3.7 μmol), and the mixture was heated at 80 °C for 1 h 40 min. Water and DCM were added and the phases separated. The aqueous phase was extracted with DCM (3×). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent wasevaporated. The mixture was purified by column chromatography using MeOH 0–5% in DCM to yield 11 mg (75%) of the title product. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.29 (s, 3 H), 3.69 (s, 3 H), 6.80–6.86 (m, 3 H), 7.17 (br s, 2 H), 7.42–7.49 (m, 3 H), 7.64 (t, <i>J</i> = 8.35 Hz, 2 H), 7.83 (t, <i>J</i> = 1.58 Hz, 1 H), 9.05 (s, 2 H), 9.19 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 397 [M + H]<sup>+</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (3<i>R*</i>,8a<i>S*</i>)-3-(3-(5-Fluoropyridin-3-yl)phenyl)-3-methyl-3,5,6,7,8,8a-hexahydroimidazo[1,5-<i>a</i>]pyridin-1-amine and (3<i>R*</i>,8a<i>R*</i>)-3-(3-(5-Fluoropyridin-3-yl)phenyl)-3-methyl-3,5,6,7,8,8a-hexahydroimidazo[1,5-<i>a</i>]pyridin-1-amine ((3<i>R*</i>,8a<i>S*</i>)-<b>54</b> and (3<i>R*</i>,8a<i>R*</i>)-<b>54</b>)</h3><div class="NLM_p"><i>rac</i>-3-(3-Bromophenyl)-3-methyl-3,5,6,7,8,8a-hexahydroimidazo[1,5-<i>a</i>]pyridin-1-amine (<b>53</b>) (14 mg, 50 μmol), 5-fluoropyridin-3-ylboronic acid (8 mg, 50 μmol), and bis(triphenylphosphine)palladium(II) chloride (2 mg, 2 μmol) were taken up in dimethoxyethane (0.4 mL) and water (0.2 mL). Sodium carbonate (12 mg, 0.11 mmol) was added, and the mixture was heated at 80 °C for 1.5 h. The cooled solution was filtered and purified by RP-HPLC to give (3<i>R*</i>,8a<i>S*</i>)-3-(3-(5-fluoropyridin-3-yl)phenyl)-3-methyl-3,5,6,7,8,8a-hexahydroimidazo[1,5-<i>a</i>]pyridin-1-amine (2.4 mg, 16%) and (3<i>R*</i>,8a<i>R*</i>)-3-(3-(5-fluoropyridin-3-yl)phenyl)-3-methyl-3,5,6,7,8,8a-hexahydroimidazo[1,5-<i>a</i>]pyridin-1-amine (3.4 mg, 23%).</div><div id="sec5_17_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (3<i>R*</i>,8a<i>S*</i>)-<b>54</b></h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.65 (t, <i>J</i> = 1.6 Hz, 1 H), 8.45 (d, <i>J</i> = 2.5 Hz, 1 H), 7.88 (m, 1 H), 7.59 (m, 1 H), 7.48–7.53 (m, 2 H), 7.39 (dt, <i>J</i> = 7.8, 1.2 Hz, 1 H), 3.08 (m, 1 H), 2.87 (dd, <i>J</i> = 11.2, 2.7 Hz, 1 H), 2.00 (dd, <i>J</i> = 11.9, 2.8 Hz, 1 H), 1.80 (m, 1 H), 1.74 (s, 3 H), 1.63 (td, <i>J</i> = 11.2, 2.8 Hz, 1 H), 1.36–1.57 (m, 3 H), 1.10 (qt, <i>J</i> = 12.9, 4.3 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 325 [M + H]<sup>+</sup>.</div></div><div id="sec5_17_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (3<i>R*</i>,8a<i>R*</i>)-<b>54</b></h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.67 (t, <i>J</i> = 1.5 Hz, 1 H), 8.45 (d, <i>J</i> = 2.5 Hz, 1 H), 7.90 (m, 1 H), 7.85 (t, <i>J</i> = 1.5 Hz, 1 H), 7.67 (m, 1 H), 7.59 (m, 1 H), 7.48 (t, <i>J</i> = 7.7 Hz, 1 H), 3.34 (m, 1 H), 2.78 (m, 1 H), 2.46 (td, <i>J</i> = 11.2, 2.5 Hz, 1 H), 2.09 (dd, <i>J</i> = 12.0, 2.5 Hz, 1 H), 1.92 (m, 1 H), 1.63 (m, 1 H), 1.51 (s, 3 H), 1.31–1.49 (m, 3 H). MS (ES+) <i>m</i>/<i>z</i> 325 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-(3′-Methoxybiphenyl-3-yl)-2-methyl-2,5-dihydrothiazol-4-amine (<b>58</b>)</h3><div class="NLM_p last">Compound <b>11b</b> (0.85 g, 3.76 mmol) and methyl 2-mercaptoacetate (<b>55</b>) (1.7 mL, 19 mmol) were taken up in ammonia (7 M in MeOH) (10 mL, 70 mmol). The mixture was heated to 150 °C for 3 h by microwave heating. The product was purified by column chromatography using EtOAc 0–100% in heptane to yield 0.32 g of <b>56</b> (MS (ES+) <i>m</i>/<i>z</i> 300 [M + H]<sup>+</sup>). This material and phosphorus pentasulfide (0.32 g, 0.71 mmol) were taken up in pyridine (1.5 mL). The mixture was heated to 120 °C for 1 h. The reaction mixture was cooled to room temperature, and ammonia (7 M in MeOH) (6.0 mL, 42 mmol) was added. The mixture was stirred at 60 °C for 16 h. The product was purified by RP-HPLC to yield 34 mg (3%) of the title compound over several steps. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 2.03 (s, 3 H), 3.87 (s, 3 H), 3.89–4.01 (m, 2 H), 4.83 (br s, 2 H), 6.90 (ddd, <i>J</i> = 8.21, 2.53, 0.88 Hz, 1 H), 7.13–7.16 (m, 1 H), 7.18–7.21 (m, 1 H), 7.33–7.41 (m, 2 H), 7.42–7.48 (m, 2 H), 7.69 (t, <i>J</i> = 1.77 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 299 [M + H]<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-(4-Methoxyphenyl)-2-(3-(pyridin-3-yl)phenyl)-2,5-dihydrothiazol-4-amine (<b>64</b>)</h3><div class="NLM_p last">1-Bromo-3-iodobenzene (<b>59</b>) (5 g, 18 mmol), pyridin-3-ylboronic acid (2.4 g, 19 mmol), and bis(triphenylphosphine)palladium(II) chloride (0.62 g, 0.88 mmol) were taken up in DME (30 mL) and water (15 mL). Sodium carbonate (1 M) (44 mL, 44 mmol) was added, and the mixture was stirred at 80 °C for 2 h. The reaction mixture was extracted with EtOAc. The combined organic phases were dried over MgSO<sub>4</sub>, filtered and the solvents evaporated. The product was purified by column chromatography using EtOAc 0–50% in heptane to yield 2.1 g of <b>60</b> (MS (ES+) <i>m</i>/<i>z</i> 234, 236 [M + H]<sup>+</sup>). This material was dissolved in Et<sub>2</sub>O (40 mL) and THF (10 mL) and cooled to −78 °C. <i>n</i>-BuLi (1.6 M in hexanes) (5.7 mL, 9.1 mmol) was added and the solution stirred for 30 min. 4-Methoxybenzonitrile (1.2 g, 9.1 mmol) was added in Et<sub>2</sub>O (20 mL) at −78 °C, and the mixture was allowed to warm to room temperature over 30 min. Ammonium acetate (0.70 g, 9.1 mmol) dissolved in MeOH (20 mL) was added. The solvents were evaporated, and the residue was dissolved in DCM and water. The phases were separated, and the aqueous phase was extracted with DCM. The combined organic phase was washed with brine and dried over MgSO<sub>4</sub>, filtered and the solvent evaporated to yield 3 g of <b>61</b> (MS (ES+) <i>m</i>/<i>z</i> 289 [M + H]<sup>+</sup>). This material and methyl 2-mercaptoacetate (0.93 mL, 10 mmol) were mixed and stirred at room temperature for 16 h. Dimethylamine hydrochloride (45 mg, 0.55 mmol) was added, and the mixture was stirred for 3 days. The mixture was taken up in DCM and MeOH and evaporated onto silica. The product was isolated by column chromatography using EtOAc (with 10% MeOH) 0–100% in heptane to yield 0.1 g of <b>62</b> (MS (ES+) <i>m</i>/<i>z</i> 363 [M + H]<sup>+</sup>). This material and phosphorus pentasulfide (0.1 g, 0.23 mmol) were taken up in pyridine (2 mL). The mixture was stirred at 120 °C for 1 h. Ammonia (7 M in MeOH) (1.6 mL, 11 mmol) was added, and the mixture was stirred at 60 °C for 16 h. The solvent was evaporated. The product was purified by RP-HPLC followed by column chromatography using EtOAc (with 10% MeOH) 0–100% in heptane to yield 17 mg (0.26%) of the title compound over several steps. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 3.79 (s, 3 H), 3.97 (s, 2 H), 5.29 (br s, 2 H), 6.81–6.86 (m, 2 H), 7.34 (ddd, <i>J</i> = 7.83, 4.80, 0.76 Hz, 1 H), 7.38–7.45 (m, 4 H), 7.45–7.51 (m, 1 H), 7.72 (t, <i>J</i> = 1.64 Hz, 1 H), 7.82–7.89 (m, 1 H), 8.57 (dd, <i>J</i> = 4.80, 1.52 Hz, 1 H), 8.82 (dd, <i>J</i> = 2.40, 0.63 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 362 [M + H]<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2-(3′-Methoxybiphenyl-3-yl)-2-(pyridin-4-yl)-2,5-dihydrothiazol-4-amine (<b>65</b>)</h3><div class="NLM_p last">3-Bromobenzonitrile (2 g, 11 mmol), 3-methoxyphenylboronic acid (1.8 g, 12 mmol), and bis(triphenylphosphine)palladium(II) chloride (0.39 g, 0.55 mmol) were taken up in DME (20 mL) and water (10 mL). Sodium carbonate (1 M) (27 mL, 27 mmol) was added, and the mixture was heated to 80 °C for 2 h. The reaction mixture was extracted with DCM. The combined organic phases were dried over MgSO<sub>4</sub>, filtered and the solvents evaporated. The product was purified by column chromatography using EtOAc 0–100% in DCM to yield 2.1 g of 3′-methoxybiphenyl-3-carbonitrile (MS (APCI+) <i>m</i>/<i>z</i> 210 [M + H]<sup>+</sup>). This material was dissolved in THF (40 mL) and added to a solution of 4-bromopyridine (1.6 g, 9.9 mmol), made fresh by washing a solution of 4-bromopyridinium chloride in DCM with saturated Na<sub>2</sub>CO<sub>3</sub> and drying over MgSO<sub>4</sub>, filtering, and evaporating the solvent, dissolved in Et<sub>2</sub>O (40 mL), and cooled to −78 °C. <i>n</i>-BuLi (1.6 M in hexanes) (6.2 mL, 10 mmol) had previously been added, and the solution was stirred for 30 min. The 3′-methoxybiphenyl-3-carbonitrile (2.1 g) was added at −78 °C, and the mixture was stirred for 30 min before allowing it to warm to room temperature over 30 min. Ammonium acetate (0.77 g, 9.9 mmol) dissolved in MeOH (20 mL) was added. The solvents were evaporated, and the residue was dissolved in DCM and water. The phases were separated, and the aqueous phase was extracted with DCM. The combined organic phase were washed with brine and dried over MgSO<sub>4</sub>, filtered, and the solvent was evaporated to yield 2.6 g of (3′-methoxybiphenyl-3-yl)(pyridin-4-yl)methanimine (MS (APCI+) <i>m</i>/<i>z</i> 289 [M + H]<sup>+</sup>). A portion of this material (1.5 g) and methyl 2-mercaptoacetate (0.47 mL, 5.3 mmol) were mixed and stirred at room temperature for 16 h. The mixture was taken up in DMF and MeOH. The product was isolated by RP-HPLC. The product was purified by column chromatography using EtOAc/acetone, 1:1, 0–100% in heptane to yield 68 mg of 2-(3′-methoxybiphenyl-3-yl)-2-(pyridin-4-yl)thiazolidin-4-one (MS (ES+) <i>m</i>/<i>z</i> 363 [M + H]<sup>+</sup>). This material and phosphorus pentasulfide (68 mg, 0.15 mmol) were taken up in pyridine (1 mL). The mixture was stirred at 120 °C for 1 h. Ammonia (7 M in MeOH) (1 mL, 7 mmol) was added, and the mixture was stirred at 60 °C for 16 h. The solvents were evaporated and the product was purified by RP-HPLC to yield 17 mg (0.7%) of the title compound over several steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.80 (s, 3 H), 3.90 (s, 2 H), 6.70 (br s, 2 H), 6.95 (dt, <i>J</i> = 8.15, 1.23 Hz, 1 H), 7.06–7.09 (m, 1 H), 7.12 (m, <i>J</i> = 0.76 Hz, 1 H), 7.35–7.41 (m, 5 H), 7.51 (m, <i>J</i> = 5.40, 3.50, 2.00 Hz, 1 H), 7.68 (d, <i>J</i> = 1.01 Hz, 1 H), 8.42–8.51 (m, 2 H). MS (ES+) <i>m</i>/<i>z</i> 362 [M + H]<sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 1-Ethyl-2-methyl-2-(3-(pyridin-3-yl)phenyl)-2,5-dihydro-1<i>H</i>-imidazol-4-amine (<b>71</b>)</h3><div class="NLM_p last">Compound <b>68</b> (4.1 g, 18 mmol) and phosphorus pentasulfide (1.9 g, 4.4 mmol) were taken up in dioxane (20 mL). The mixture was stirred for 2 h at 95 °C by microwave heating. The reaction mixture was poured into 50% brine and extracted with DCM. The combined organic phases were dried over MgSO<sub>4</sub>, filtered and the solvents evaporated. The product was purified by column chromatography using EtOAc 0–50% in DCM to yield 1.5 g of <b>69</b> (MS (ES+) <i>m</i>/<i>z</i> 253 [M + H]<sup>+</sup>). This material was taken up in hydrobromic acid (33% in acetic acid) (15 mL, 86 mmol). The mixture was stirred at room temperature for 20 min. The reaction mixture was slowly added to stirring diethyl ether (75 mL). The precipitate was isolated by suction filtration to yield 1.3 g of <b>70</b> (MS (ES+) <i>m</i>/<i>z</i> 119 [M + H]<sup>+</sup>). A portion of this material (0.3 g) was added one-third at a time to a solution of <b>11c</b> (100 mg, 0.51 mmol) in ammonia (7 M in MeOH) (2.9 mL, 20 mmol). The mixture was heated at 60 °C, and the mixture was stirred for 1 h between each addition. The product was purified by column chromatography using MeOH (with 7 M NH<sub>3</sub>) 0–10% in DCM to yield 17 mg (12%) of the title compound at 94% purity. <sup>1</sup>H NMR (500 MHz, MeOD) δ ppm 1.05 (t, <i>J</i> = 7.09 Hz, 3 H), 1.66 (s, 3 H), 2.31 (dq, <i>J</i> = 11.66, 7.25 Hz, 1 H), 2.59 (dq, <i>J</i> = 11.86, 7.08 Hz, 1 H), 3.57–3.74 (m, 2 H), 7.46–7.60 (m, 4 H), 7.74 (s, 1 H), 8.09 (dt, <i>J</i> = 7.88, 1.73 Hz, 1 H), 8.52 (dd, <i>J</i> = 4.73, 1.26 Hz, 1 H), 8.79 (d, <i>J</i> = 2.21 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 281 [M + H]<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1-(4-Amino-2-(3′-methoxybiphenyl-3-yl)-2-methyl-2,5-dihydro-1<i>H</i>-imidazol-1-yl)ethanone (<b>77</b>)</h3><div class="NLM_p last">Sodium bicarbonate (12 g, 0.14 mol) was dissolved in water (60 mL) and cooled to 0 °C. Dioxane (60 mL) was added followed by 2-aminoacetamide hydrochloride (<b>72</b>) (8 g, 72 mmol). Benzyl chloroformate (10 mL, 72 mmol) was added dropwise. The mixture was stirred at room temperature for 16 h. The formed precipitate was collected by suction filtration and washed with water to yield 6.5 g of <b>73</b>. The filtrate was concentrated and the precipitate collected by suction filtration and washed with water to yield another 5.8 g of <b>73</b>. These materials were taken up in dioxane (90 mL), and phosphorus pentasulfide (6.6 g, 15 mmol) was added. The mixture was stirred for 1 h at 95 °C. The reaction mixture was poured into 50% brine and extracted with DCM. The combined organic phases were dried over MgSO<sub>4</sub>, filtered and the solvents evaporated. The product was purified by column chromatography using EtOAc 0–50% in DCM to yield 2.2 g of <b>74</b> (MS (ES+) <i>m</i>/<i>z</i> 253 [M + H]<sup>+</sup>). A portion of this material (0.33 mg) was taken up in hydrobromic acid (33% in acetic acid) (3.8 mL, 22 mmol). The mixture was stirred at room temperature for 20 min. The precipitate was isolated by suction filtration and washed with diethyl ether to yield 0.33 mg of <b>75</b>. This material and <b>11b</b> (0.14 g, 0.63 mmol) were dissolved in ammonia (7 M in MeOH) (3.6 mL, 25 mmol) and stirred at room temperature for 16 h. The product was purified by RP-HPLC to yield 45 mg of <b>76</b>(MS (ES+) <i>m</i>/<i>z</i> 282 [M + H]<sup>+</sup>). This material was dissolved in DCM (2 mL). Et<sub>3</sub>N (0.044 mL, 0.32 mmol) was added followed by acetic anhydride (0.029 mL, 0.32 mmol). The mixture was stirred at room temperature for 16 h. Ammonia (7 M in MeOH) (0.9 mL, 6.3 mmol) was added, and the mixture was stirred at room temperature for 6 days. The product was purified by column chromatography using MeOH (with 7 M NH<sub>3</sub>) 0–10% in DCM to yield 30 mg (13%) of the title compound, as the acetate salt, over several steps. Rotamers present: (major) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 1.75 (s, 3 H), 2.01 (s, 3 H), 3.85 (s, 3 H), 4.42–4.60 (m, 1 H), 4.96 (br s, 1 H), 5.70–6.02 (m, 1 H), 6.90 (dd, <i>J</i> = 8.20, 2.21 Hz, 1 H), 7.06–7.10 (m, 1 H), 7.11–7.16 (m, 1 H), 7.27–7.30 (m, 1 H), 7.31–7.44 (m, 3 H), 7.50 (dd, <i>J</i> = 7.72, 1.10 Hz, 1 H), 7.51–7.55 (m, 1 H); (minor) <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 2.01 (s, 3 H), 2.04 (s, 3 H), 3.84 (s, 3 H), 4.31–4.40 (m, 1 H), 4.96 (br s, 1 H), 5.70–6.02 (m, 1 H), 6.87 (dd, <i>J</i> = 7.88, 2.21 Hz, 1 H), 7.06–7.10 (m, 1 H), 7.11–7.16 (m, 1 H), 7.31–7.44 (m, 5 H), 7.51–7.55 (m, 1 H). MS (ES+) <i>m</i>/<i>z</i> 324 [M + H]<sup>+</sup>.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-(4-Methoxyphenyl)-2-(3-(pyrimidin-5-yl)phenyl)-3,4-dihydro-2<i>H</i>-pyrrol-5-amine (<b>83</b>)</h3><div class="NLM_p last">Compound <b>82</b> (100 mg, 0.29 mmol) was dissolved in pyridine (1 mL). Phosphorus pentasulfide (100 mg, 0.22 mmol) was added, and the mixture was stirred at 120 °C for 1 h. The mixture was cooled to room temperature, and ammonia (7 M in MeOH) (1.7 mL, 12 mmol) and <i>tert</i>-butyl hydroperoxide (70% in water) (0.6 mL, 4.3 mmol) were added. The mixture was stirred at room temperature for 16 h. The solvents were evaporated and the product was purified by column chromatography using MeOH (with 7 M NH<sub>3</sub>) 0–10% in DCM to yield 49 mg (49%) of the title compound. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 2.53–2.76 (m, 4 H), 3.76 (s, 3 H), 4.60 (br s, 2 H), 6.81 (d, <i>J</i> = 8.51 Hz, 2 H), 7.30 (d, <i>J</i> = 8.51 Hz, 2 H), 7.35–7.49 (m, 3 H), 7.61 (s, 1 H), 8.90 (s, 2 H), 9.15 (s, 1 H). MS (ES+) <i>m</i>/<i>z</i> 345 [M + H]<sup>+</sup>.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 4-Methoxy-2-(4-methoxyphenyl)-2-(3-(pyridin-3-yl)phenyl)-3,4-dihydro-2<i>H</i>-pyrrol-5-amine (<b>91</b>)</h3><div class="NLM_p">A mixture of <b>90</b> (0.25 g, 0.67 mmol) and phosphorus pentasulfide (0.24 g, 0.53 mmol) in pyridine (15 mL) was heated at 115 °C for 50 min. To the reaction mixture were added ammonia (7 M in MeOH) (9.6 mL, 67 mmol) and <i>tert</i>-butyl hydroperoxide (70% in water) (0.96 mL, 10 mmol). The mixture was stirred at ambient temperature for 60 h. Water and DCM were added, and the layers were separated. The aqueous phase was extracted with DCM (3 × 70 mL). The combined organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and the solvent evaporated. The residue was purified by column chromatography using MeOH (with 7 M ammonia) 0–10% in DCM to yield 0.19 g (76%) of the title compound at 90% purity. <sup>1</sup>H NMR (500 MHz, MeCN-<i>d</i><sub>3</sub>) δ ppm 1.97 (d, <i>J</i> = 3.78 Hz, 1 H), 2.28 (dd, <i>J</i> = 12.61, 8.20 Hz, 1 H), 3.26 (dd, <i>J</i> = 12.61, 6.94 Hz, 1 H), 3.34 (d, <i>J</i> = 1.89 Hz, 3 H), 3.73 (d, <i>J</i> = 4.73 Hz, 1 H), 4.33 (dd, <i>J</i> = 8.20, 6.94 Hz, 1 H), 5.02 (br s, 2 H), 6.77–6.85 (m, 2 H), 7.29–7.33 (m, 1 H), 7.34–7.50 (m, 5 H), 7.59–7.74 (m, 1 H), 7.92 (tt, <i>J</i> = 7.68, 1.93 Hz, 1 H), 8.54 (dd, <i>J</i> = 4.73, 1.58 Hz, 1 H), 8.79 (dd, <i>J</i> = 7.57, 1.89 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 374 [M + H]<sup>+</sup>.</div><div class="NLM_p">The diastereomers of <i>rac</i>-<b>91</b> were separated by chiral SFC. Isomer 1 (eluted first): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.18–2.28 (m, 1 H), 3.16–3.24 (m, 1 H), 3.29 (s, 3 H), 3.68 (s, 3 H), 4.24 (s, 1 H), 5.96–6.16 (m, 2 H), 6.75–6.83 (m, 2 H), 7.29–7.41 (m, 3 H), 7.43–7.53 (m, 3 H), 7.76 (t, <i>J</i> = 1.64 Hz, 1 H), 7.98 (d, <i>J</i> = 0.76 Hz, 1 H), 8.56 (dd, <i>J</i> = 4.80, 1.52 Hz, 1 H), 8.81 (dd, <i>J</i> = 2.27, 0.76 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 374.2 [M + H]<sup>+</sup>. 100% de.</div><div class="NLM_p">Isomer 2 (eluted second): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.23 (dd, <i>J</i> = 12.63, 8.08 Hz, 1 H), 3.20 (dd, <i>J</i> = 12.51, 6.95 Hz, 1 H), 3.29 (s, 3 H), 3.67 (s, 3 H), 4.24 (t, <i>J</i> = 7.45 Hz, 1 H), 5.92–6.16 (m, 2 H), 6.74–6.83 (m, 2 H), 7.29–7.41 (m, 3 H), 7.43–7.53 (m, 3 H), 7.76 (t, <i>J</i> = 1.64 Hz, 1 H), 7.94–8.03 (m, 1 H), 8.56 (dd, <i>J</i> = 4.80, 1.52 Hz, 1 H), 8.81 (dd, <i>J</i> = 2.27, 0.76 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 374.2 [M + H]<sup>+</sup>. 94.3% de.</div><div class="NLM_p">Isomer 3 (eluted third): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.22 (dd, <i>J</i> = 12.76, 7.71 Hz, 1 H), 3.21 (dd, <i>J</i> = 12.76, 6.95 Hz, 1 H), 3.27 (s, 3 H), 3.65–3.70 (m, 3 H), 4.26 (t, <i>J</i> = 7.33 Hz, 1 H), 6.07 (br s, 2 H), 6.77–6.83 (m, 2 H), 7.32–7.50 (m, 6 H), 7.65 (t, <i>J</i> = 1.64 Hz, 1 H), 7.94–8.00 (m, 1 H), 8.55 (dd, <i>J</i> = 4.67, 1.64 Hz, 1 H), 8.79 (d, <i>J</i> = 1.77 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 374.2 [M + H]<sup>+</sup>. 100% de.</div><div class="NLM_p last">Isomer 4 (eluted forth): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.23 (dd, <i>J</i> = 12.76, 7.71 Hz, 1 H), 3.22 (dd, <i>J</i> = 12.88, 7.07 Hz, 1 H), 3.28 (s, 3 H), 3.69 (s, 3 H), 4.27 (t, <i>J</i> = 7.33 Hz, 1 H), 5.99–6.14 (m, 2 H), 6.79–6.83 (m, 2 H), 7.33–7.51 (m, 6 H), 7.66 (t, <i>J</i> = 1.64 Hz, 1 H), 7.96–8.00 (m, 1 H), 8.56 (dd, <i>J</i> = 4.67, 1.64 Hz, 1 H), 8.80 (dd, <i>J</i> = 2.40, 0.63 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 374.1 [M + H]<sup>+</sup>.  98.2% de.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 4-(3′-Methoxybiphenyl-3-yl)-4,5-dimethyl-4<i>H</i>-imidazol-2-amine (<b>98</b>)</h3><div class="NLM_p last">Compound <b>95</b> (0.89 g, 3.7 mmol) was taken up in DCM (10 mL). <i>O</i>-(9<i>H</i>-Fluoren-9-yl)methyl carbonizothiocyanatidate (1.0 g, 3.7 mmol) was added, and the mixture was stirred at room temperature for 2 h. The solvent was evaporated to yield intermediate <b>96</b>. Ammonia (7 M in MeOH) (32 mL, 1.5 mol) was added, and the mixture was stirred at room temperature for 2 h. <i>tert</i>-Butyl hydroperoxide (7.5 mL, 55 mmol) was added, and the mixture was stirred for 3 days. The product was isolated by RP-HPLC and purified by column chromatography using MeOH (with 7 M NH<sub>3</sub>) 0–10% in DCM to yield 64 mg of <b>97</b> (MS (ES+) <i>m</i>/<i>z</i> 266, 268 [M + H]<sup>+</sup>). This material was taken up in DME (1 mL) and water (0.5 mL). 3-Methoxyphenylboronic acid (35.8 mg, 0.24 mmol), bis(triphenylphosphine)palladium(II) chloride (15 mg, 0.02 mmol), and sodium carbonate (1 M) (0.54 mL, 0.54 mmol) were added, and the mixture was heated to 80 °C for 2 h. The reaction mixture was filtered and extracted with DCM. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and the solvent was evaporated. The product was purified by column chromatography using MeOH (with 7 M NH<sub>3</sub>) 0–10% in DCM to yield 44 mg (4%) of the title compound over several steps. <sup>1</sup>H NMR (500 MHz, MeOD) δ ppm 1.71 (s, 3 H), 2.14 (s, 3 H), 3.82 (s, 3 H), 6.90 (dd, <i>J</i> = 8.20, 2.21 Hz, 1 H), 7.08 (t, <i>J</i> = 2.05 Hz, 1 H), 7.12 (d, <i>J</i> = 7.57 Hz, 1 H), 7.26 (d, <i>J</i> = 7.88 Hz, 1 H), 7.32 (t, <i>J</i> = 7.88 Hz, 1 H), 7.40 (t, <i>J</i> = 7.88 Hz, 1 H), 7.44 (t, <i>J</i> = 1.58 Hz, 1 H), 7.50 (d, <i>J</i> = 7.57 Hz, 1 H). MS (ES+) <i>m</i>/<i>z</i> 294 [M + H]<sup>+</sup>.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> BACE-1 TR-FRET Assay</h3><div class="NLM_p last">The soluble part of human β-secretase (AA1-AA460) diluted in reaction buffer (sodium acetate, CHAPS, Triton X-100, EDTA pH 4.5) was mixed with the test compound diluted in DMSO. After a preincubation period of 10 min for the substrate (europium)CEVNLDAEFK(Qsy7) was added and the mixture allowed to proceed for 15 min at room temperature. The reaction was stopped by addition of 7 μL of sodium acetate, pH 9. The fluorescence of the product was measured on a Victor II plate reader with an excitation wavelength of 340 nm and an emission wavelength of 615 nm. The final concentration of the enzyme was 2.7 μg/mL. The final concentration of substrate was 100 nM. Reported values are the mean of <i>n</i> ≥ 2 determinations, with standard deviation up to 10%.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Cell sAPPβ Release Assay</h3><div class="NLM_p last">SH-SY5Y cells (human neuroblastoma cell line) were cultured in DMEM/F-12 with Glutamax, 10% FCS, and 1% nonessential amino acids. The test compound was incubated with cells for 16 h at 37 °C, 5% CO<sub>2</sub>. Meso Scale Discovery (MSD) plates were used for the detection of sAPPβ release. MSD sAPPβ plates were blocked in 3% BSA in Tris wash buffer for 1 h at room temperature and washed 4 times in Tris buffer. After incubation, 20 μL of medium was transferred to the preblocked and washed 384-well MSD sAPPβ microplate, incubated with shaking at room temperature for 2 h followed by washing 4 times in Tris buffer. Then 10 μL of detection antibody was added (1 nM) followed by incubation with shaking at room temperature for 2 h followed by washing 4 times in Tris buffer. An amount of 40 μL of Read Buffer was added per well, and the plates were read in a SECTOR imager. In addition, the cells incubated with test compound were further lysed and analyzed for any cytotoxic effects of the compounds using the ViaLight Plus cell proliferation/cytotoxicity kit (Cambrex BioScience) according to the manufacturer’s instructions. Reported values are the mean of <i>n</i> ≥ 2 determinations, with standard deviation up to 10%.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Permeability Assays</h3><div class="NLM_p last">Caco-2 cells were grown for 14–21 days to achieve confluency and polarization before being used for transport experiments. For both apical to basolateral (A–B) and basolateral to apical (B–A) transport directions, the pH was adjusted to 7.4. All compounds were investigated at 10 μM. Buffer volumes in the 24-well plates were 0.20 mL on the apical side and 0.80 mL on the basolateral side. Samples were withdrawn after 30 or 60 min. The integrity of the epithelial cell monolayer was monitored by measuring the passive transmembrane diffusion of [<sup>14</sup>C]mannitol. Concentrations of compounds in donor and receiver samples were analyzed by liquid chromatography–tandem mass spectrometry. Liquid scintillation was used for analysis of [<sup>14</sup>C]mannitol. The apparent permeability coefficient <i>P</i><sub>app</sub> was calculated according to <i>P</i><sub>app</sub> = (d<i>Q</i>/d<i>t</i>)/(<i>AC</i><sub>0</sub>), where d<i>Q</i>/d<i>t</i> is the slope at 30 or 60 min of the graph of the cumulative amount transported vs time, <i>A</i> is the surface area of the membrane, and <i>C</i><sub>0</sub> is the starting concentration.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> MDCK-MDR1</h3><div class="NLM_p last">Efflux data were generated using a Transwell assay as described by LeDonne et al.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> with minor adaptations. Cells were sown at 400000–600000 cells per well in a 96-well plate and cultured for 3–5 days. When the compound was tested at 1 μM, the efflux incubation time was 2.5 h; this was shortened to 60 min when the compound concentration was 10 μM. In each format the compounds were classified as low, medium, or high efflux.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Plasma Protein and Brain Tissue Binding. Brain and Plasma Exposure</h3><div class="NLM_p">Plasma protein and brain tissue binding were performed as previously described.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Compounds were added to mouse plasma to a final concentration of 10 μM. An aliquot of 180 μL was transferred to a dialysis plate with phosphate buffer on the other site and incubated for 18 h at 37 °C. Proteins were removed from aliquots (50 μL) of plasma and buffer samples, and internal standard was added. Analysis was done with LC–MS/MS. The unbound fraction in plasma was calculated from the ratio of the MS area of compound in buffer divided by sum of the areas of compound in buffer and plasma. Recovery and stability in plasma were controlled for.</div><div class="NLM_p last">To determine brain tissue binding, 300 μm thick coronal rat brain slices were incubated for 5 h in 10 mL of an artificial interstitial fluid buffer containing 1 μM compound. Following the incubation, slices were weighted and homogenized, proteins were removed, and LC–MS/MS analysis was performed. The unbound fraction in brain was calculated as previously described.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64, 65)</a></div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Mice Brain Exposure</h3><div class="NLM_p">All animal experimentations were performed in accordance with relevant guidelines and regulations provided by the Swedish Board of Agriculture. The ethical permissions were provided by an ethical board specializing in animal experimentations, by the Stockholm Norra Animal Research Ethical Board.</div><div class="NLM_p">To study brain exposure, female C57BL/6 mice purchased from Harlan Laboratories, The Netherlands, were sacrificed 1.5 h after an intravenous (iv) or per oral (po) dose of 30 μmol/kg (dose volume, 4 mL/kg) compounds <b>24a</b> (iv) and <b>37</b> (po) or 50 μmol/kg <b>41</b> (po), all with 5% dimethylacetamide and 0.1 M gluconic acid, or 30 μmol/kg <b>64</b> (iv) with 0.1 M gluconic acid, three mice per compound, respectively. Animals were anesthetized before plasma and brain samples were collected. Plasma was isolated from blood collected by cardiac puncture into EDTA tubes and was centrifuged for 10 min at approximately 3000<i>g</i> at 4 °C within 20 min of sampling. Animals were then sacrificed by decapitation to collect brains.</div><div class="NLM_p last">Briefly, whole brains of mice were homogenized in two volumes (w/v) of Ringer solution. Aliquots of plasma (25 μL) and brain homogenate (50 μL) were precipitated with 150 μL of acetonitrile containing a generic internal standard (200 nmol/L warfarin). Samples were mixed, centrifuged, appropriately diluted with mobile phase, and analyzed on a LC–MS/MS system. Brain exposure was corrected for compound exposure in plasma/blood present in the brain sample, since no brain perfusion was performed, by assuming 1.3% blood/plasma in brain. The total plasma and brain concentrations were converted to free concentrations by multiplying with the unbound fraction, and the ratio of free concentration in brain and plasma <i>C</i><sub>u,br</sub>/<i>C</i><sub>u,pl</sub> was calculated.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Chemical Stability Assay</h3><div class="NLM_p last">The assay involved 100 μM compound solutions in 0.1 M phosphate buffer at pH 1, 7.4, and 9 as well in FRET buffer (pH 4.5) in the presence of 5% DMSO and in pure methanol and DMSO. Samples were stored at room temperature in the dark at 37 °C and gently shaken (∼300 rpm). The samples were analyzed after 24 and 96 h (∼4 days).</div></div><div id="sec5_33_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Protein Crystallography. Protein Expression, Purification, and Crystallization</h3><div class="NLM_p last">Human BACE, CID1328 14-453, was cloned, expressed, refolded, activated, and purified according to previously published protocols.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The protein buffer was exchanged to 20 mM Tris, pH 8.5, and 150 mM NaCl and concentrated to 3.5 mg/mL. Concentrated protein was mixed 1:1 with a stock of 11% PEG6k, 100 mM sodium acetate, pH 5.0, at room temperature and crystallized using vapor diffusion techniques in combination with seeding. The crystals were soaked with 10 mM <b>19b</b>, <b>41</b>, <b>83</b>, and <b>91</b> in 10% DMSO, 18% PEG6000, 90 mM sodium acetate, pH 4.85, 18 mM Tris, pH 8.5, and 135 mM NaCl for 24 h and flash frozen in liquid nitrogen using 20% glycerol as a cryoprotectant.</div></div><div id="sec5_33_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Data Collection and Refinement</h3><div class="NLM_p">Data of soaked crystals were collected on a Rigaku FR-E+ SuperBright rotating anode and a HTC imaging plate to resolutions between 1.5 and 1.8 Å. All data were indexed and integrated with MOSFLM<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> and scaled with SCALA<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> in space group <i>P</i>212121, with cell dimensions of about [48,76,105], giving a Matthews coefficient of 2.2 Å<sup>3</sup>/Da with one monomer per asymmetric unit. The structures of <b>19b</b>, <b>41</b>, <b>83</b>, and <b>91</b> were solved by rigid body refinement of a previously determined BACE-1 structure based on the published <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKN">1FKN</a> structure<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> using Refmac5.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The initial models were further refined by alternative cycles of model rebuilding in Coot<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> and refinement in Refmac5 and AutoBuster.<a onclick="showRef(event, 'ref50 ref68'); return false;" href="javascript:void(0);" class="ref ref50 ref68">(50, 68)</a></div><div class="NLM_p last">The four compounds were placed in the refined omit maps by Flynn.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Final refinement of the BACE–inhibitor complexes was performed in Refmac5 and AutoBuster. The resulting 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> maps can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a–d. Full data collection and refinement statistics can be found in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S1.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76"><a href="/doi/suppl/10.1021/jm3011349">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and analytical data for intermediates 2-(3-bromophenyl)-2-ethyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4(3<i>H</i>)-one, <b>11a</b>–<b>c</b>, <b>16</b>, <b>18</b>, <b>26</b>, <b>28</b>, <b>29</b>, <b>32</b>, <b>33</b>, <b>39</b>, <b>40</b>, <b>43</b>–<b>46</b>, <b>49</b>–<b>53</b>, <b>67</b>, <b>68</b>, <b>79</b>, <b>82</b>, <b>84</b>, <b>88</b>–<b>90</b>, and <b>95</b>; Tables S1 and S2. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3011349/suppl_file/jm3011349_si_001.pdf">jm3011349_si_001.pdf (347.55 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3011349" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ylva Gravenfors</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ef9683998ec1889d8e998a8189809d9caf87809b828e8683c18c8082"><span class="__cf_email__" data-cfemail="88f1e4fee9a6effae9feede6eee7fafbc8e0e7fce5e9e1e4a6ebe7e5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tobias Ginman</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenny Viklund</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonas Malmström</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Blid</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rikard Emond</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rickard Forsblom</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anh Johansson</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annika Kers</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fredrik Lake</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Sehgelmeble</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin J. Sterky</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margareta Bergh</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anders Lindgren</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrik Johansson</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fredrik Jeppsson</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johanna Fälting</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fredrik Rahm</span> - <span class="hlFld-Affiliation affiliation">†Department
of Medicinal Chemistry, ‡Department of Neuroscience, and §Department of DMPK, AstraZeneca R&D Södertälje, SE-151
85, Södertälje, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Discovery Sciences, AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d8665e6553-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Jörg Holenz and Juliette Janson for valuable proofreading of the manuscript. We thank the Physiochemical Characterization Team and the Analytical & Purification Sciences Team at the Department of Medicinal Chemistry at AstraZeneca Södertälje, Sweden, for physiochemical characterization, enantiomer separations and purity determinations. We thank Elin Hagström and Johan Meuller for FRET and sAPPβ measurements. We thank Carolina Sandman and Carrie Tsoi for Caco-2 measurements, Sara Rohdin and Jenny Johansson for doing the in vivo experiment and bioanalysis, respectively, and Maria Sandberg-Ställ for the determination of free fraction in brain. In addition, we thank Anna Aagaard for crystallization and we thank Safety Assessment Screening Centre at AstraZeneca Alderly Park for hERG assessments.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i78" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i78"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i79" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i79"> Abbreviations Used</h2><tr><td class="NLM_term">BACE</td><td class="NLM_def"><p class="first last">β-site APP-cleaving enzyme</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid-β precursor protein</p></td></tr><tr><td class="NLM_term">cPr</td><td class="NLM_def"><p class="first last">cyclopropyl</p></td></tr><tr><td class="NLM_term">sAPPβ</td><td class="NLM_def"><p class="first last">soluble amyloid-β precursor protein</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">pTSA</td><td class="NLM_def"><p class="first last">4-methylbenzenesulfonic acid</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamic</p></td></tr><tr><td class="NLM_term">DEA</td><td class="NLM_def"><p class="first last">diethylamine</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">isopropanol</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">permeability glycoprotein</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reverse phase</p></td></tr><tr><td class="NLM_term">HMDO</td><td class="NLM_def"><p class="first last">hexamethyldisiloxane</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetics</p></td></tr><tr><td class="NLM_term">R&D</td><td class="NLM_def"><p class="first last">research and development</p></td></tr><tr><td class="NLM_term">μM</td><td class="NLM_def"><p class="first last">micromolar (micromoles per liter)</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar (nanomoles per liter)</p></td></tr><tr><td class="NLM_term">PS1</td><td class="NLM_def"><p class="first last">presenilin 1</p></td></tr><tr><td class="NLM_term">Asp</td><td class="NLM_def"><p class="first last">aspartatic acid</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebral spine fluid</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence energy transfer</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">nd</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration at 50% inhibition</p></td></tr><tr><td class="NLM_term">Perm</td><td class="NLM_def"><p class="first last">permeability</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">trp</td><td class="NLM_def"><p class="first last">tryptophan</p></td></tr><tr><td class="NLM_term">tyr</td><td class="NLM_def"><p class="first last">tyrosine</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u</sub></td><td class="NLM_def"><p class="first last">fraction unbound</p></td></tr><tr><td class="NLM_term">LC</td><td class="NLM_def"><p class="first last">liquid chromatography</p></td></tr><tr><td class="NLM_term">ES</td><td class="NLM_def"><p class="first last">electrospray</p></td></tr><tr><td class="NLM_term">APCI</td><td class="NLM_def"><p class="first last">atmospheric pressure chemical ionization</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">PDA</td><td class="NLM_def"><p class="first last">photodiode array</p></td></tr><tr><td class="NLM_term">mg</td><td class="NLM_def"><p class="first last">milligram</p></td></tr><tr><td class="NLM_term">sat.</td><td class="NLM_def"><p class="first last">saturated</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco's modified Eagle medium</p></td></tr><tr><td class="NLM_term">MSD</td><td class="NLM_def"><p class="first last">Meso Scale Discovery</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">Tris</td><td class="NLM_def"><p class="first last">2-amino-2-hydroxymethylpropane-1,3-diol</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 71 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span> </span><span class="NLM_article-title">2012 Alzheimer’s disease facts and figures</span>.  <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.jalz.2012.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22404854" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2012+Alzheimer%E2%80%99s+disease+facts+and+figures.+Alzheimer%27s+Dementia+2012%2C+8%2C+131%E2%80%93168."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.02.001%26sid%3Dliteratum%253Aachs%26atitle%3D2012%2520Alzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2012%26volume%3D8%26spage%3D131%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid deposition as the central event in the aetiology of Alzheimer’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+deposition+as+the+central+event+in+the+aetiology+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520deposition%2520as%2520the%2520central%2520event%2520in%2520the%2520aetiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lgB6Y9yJwFtwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as β-secretase</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0lgB6Y9yJwFtwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520%25CE%25B2-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span><span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein β-secretase from human brain</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1038%2F990114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=10591214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1MXotFKlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=J.+P.+Andersonauthor=R.+Barbourauthor=G.+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=H.+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=V.+John&title=Purification+and+cloning+of+amyloid+precursor+protein+%CE%B2-secretase+from+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and cloning of amyloid precursor protein β-secretase from human brain</span></div><div class="casAuthors">Sinha, Sukanto; Anderson, John P.; Barbour, Robin; Basi, Guriqbal S.; Caccavello, Russell; Davis, David; Doan, Minhtam; Dovey, Harry F.; Frigon, Normand; Hong, Jin; Jacobson-Croak, Kirsten; Jewett, Nancy; Keim, Pamela; Knops, Jeroen; Lieberburg, Ivan; Power, Michael; Tan, Hua; Tatsuno, Gwen; Tung, Jay; Schenk, Dale; Seubert, Peter; Suomensaari, Susanna M.; Wang, Shuwen; Walker, Donald; Zhao, Jun; McConlogue, Lisa; John, Varghese</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">6761</span>),
    <span class="NLM_cas:pages">537-540</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Proteolytic processing of the amyloid precursor protein (APP) generates amyloid β (AP) peptide, which is thought to be causal for the pathol. and subsequent cognitive decline in Alzheimer's disease.  Cleavage by β-secretase at the amino terminus of the Aβ peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of β-cleaved sol. APP, and a corresponding cell-assocd. carboxy-terminal fragment.  Cleavage of the C-terminal fragment by γ-secretase(s) leads to the formation of Aβ.  The pathogenic mutation K670M671 → N670L671 at the β-secretase cleavage site in APP, which was discovered in a Swedish family with familial Alzheimer's disease, leads to increased β-secretase cleavage of the mutant substrate.  Here the authors describe a membrane-bound enzyme activity that cleaves full-length APP at the β-secretase cleavage site, and find it to be the predominant β-cleavage activity in human brain.  The authors have purified this enzyme activity to homogeneity from human brain using a new substrate analog inhibitor of the enzyme activity, and show that the purified enzyme has all the properties predicted for β-secretase.  Cloning and expression of the enzyme reveals that human brain β-secretase is a new membrane-bound aspartic proteinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDI4TZ3cM4orVg90H21EOLACvtfcHk0lgqXpihMEArXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFKlsrc%253D&md5=819ccc5a27ec4c56128d6b6944878c42</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F990114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990114%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B2-secretase%2520from%2520human%2520brain%26jtitle%3DNature%2520%2528London%2529%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lgqXpihMEArXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashler, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1038%2F990107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=10591213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity</span></div><div class="casAuthors">Yan, Riqiang; Bienkowski, Michael J.; Shuck, Mary E.; Miao, Huiyi; Tory, Monica C.; Pauley, Adele M.; Brashler, John R.; Stratman, Nancy C.; Mathews, W. Rodney; Buhl, Allen E.; Carter, Donald B.; Tomasselli, Alfredo G.; Parodi, Luis A.; Heinrikson, Robert L.; Gurney, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">6761</span>),
    <span class="NLM_cas:pages">533-537</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Mutations in the gene encoding the amyloid protein precursor (APP) cause autosomal dominant Alzheimer's disease.  Cleavage of APP by unidentified proteases, referred to as β- and γ-secretases, generates the amyloid β-peptide, the main component of the amyloid plaques found in Alzheimer's disease patients.  The disease-causing mutations flank the protease cleavage sites in APP and facilitate its cleavage.  Here the authors identify a new membrane-bound aspartyl protease (Asp2) with β-secretase activity.  The Asp2 gene is expressed widely in brain and other tissues.  Decreasing the expression of Asp2 in cells reduces amyloid β-peptide prodn. and blocks the accumulation of the carboxy-terminal APP fragment that is created by β-secretase cleavage.  Solubilized Asp2 protein cleaves a synthetic APP peptide substrate at the β-secretase site, and the rate of cleavage is increased tenfold by a mutation assocd. with early-onset Alzheimer's disease in Sweden.  Thus, Asp2 is a new protein target for drugs that are designed to block the prodn. of amyloid β-peptide peptide and the consequent formation of amyloid plaque in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd6iE74jtk5LVg90H21EOLACvtfcHk0lj3xCiz-5M25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D&md5=96af7cd9b7c3315de029937497f04616</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990107%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520activity%26jtitle%3DNature%2520%2528London%2529%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dashti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1456</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=1456-1460&author=X.+Linauthor=G.+Koelschauthor=S.+Wuauthor=D.+Downsauthor=A.+Dashtiauthor=J.+Tang&title=Human+aspartic+protease+memapsin+2+cleaves+the+%CE%B2-secretase+site+of+%CE%B2-amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DDashti%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DHuman%2520aspartic%2520protease%2520memapsin%25202%2520cleaves%2520the%2520%25CE%25B2-secretase%2520site%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D1456%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span> </span><span class="NLM_article-title">Mutant genes in familial Alzheimer’s disease and transgenic models</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1146%2Fannurev.neuro.21.1.479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=9530504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=479-505&author=D.+L.+Priceauthor=S.+S.+Sisodia&title=Mutant+genes+in+familial+Alzheimer%E2%80%99s+disease+and+transgenic+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant genes in familial Alzheimer's disease and transgenic models</span></div><div class="casAuthors">Price, Donald L.; Sisodia, Sangram S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-505</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 163 refs.  The most common cause of dementia occurring in mid- to late-life is Alzheimer's disease (AD).  Some cases of AD, particularly those of early onset, are familial and inherited as autosomal dominant disorders linked to the presence of mutant genes that encode the amyloid precursor protein (APP) or the presenilins (PS1 or PS2).  These mutant gene products cause dysfunction/death of vulnerable populations of nerve cells important in memory, higher cognitive processes, and behavior.  AD affects 7-10% of individuals >65 yr of age and perhaps 40% of individuals >80 yr of age.  For the late-onset cases, the principal risk factors are age and apolipoprotein (apoE) allele type, with apoE4 allele being a susceptibility factor.  In this review, we briefly discuss the clin. syndrome of AD and the neurobiol./neuropathol. of the disease and then focus attention on mutant genes linked to autosomal dominant familial AD (FAD), the biol. of the proteins encoded by these genes, and the recent exciting progress in investigations of genetically engineered animal models that express these mutant genes and develop some features of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUt4ulmJ7ErVg90H21EOLACvtfcHk0lhbDnXOfBl3fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D&md5=fa1bf9dbad95faabcd6854eca46bad83</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.21.1.479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.21.1.479%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26atitle%3DMutant%2520genes%2520in%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520transgenic%2520models%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1998%26volume%3D21%26spage%3D479%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">A mutation in <i>APP</i> protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonsson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lhbDnXOfBl3fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, S.</span><span> </span><span class="NLM_article-title">BACE inhibitors as potential drugs for the treatment of Alzheimer’s disease: focus on bioactivity</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=91-106&author=G.+Evinauthor=G.+Lesseneauthor=S.+Wilkins&title=BACE+inhibitors+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+focus+on+bioactivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DWilkins%26aufirst%3DS.%26atitle%3DBACE%2520inhibitors%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520focus%2520on%2520bioactivity%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D91%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Probst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2006–2011)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1517%2F13543776.2012.681302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22512789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=511-540&author=G.+Probstauthor=Y.+Xu&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282006%E2%80%932011%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)</span></div><div class="casAuthors">Probst, Gary; Xu, Ying-zi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-540</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease is a devastating neurodegenerative disorder for which no disease-modifying therapy exists.  The amyloid hypothesis, which implicates Aβ as the toxin initiating a biol. cascade leading to neurodegeneration, is the most prominent theory concerning the underlying cause of the disease.  BACE1 is one of two aspartyl proteinases that generate Aβ, thus inhibition of BACE1 has the potential to ameliorate the progression of Alzheimer's disease by abating the prodn. of Aβ.  Areas covered: This review chronicles small-mol. BACE1 inhibitors as described in the patent literature between 2006 and 2011 and their potential use as disease-modifying treatments for Alzheimer's disease.  Over the past half a dozen years, numerous BACE1 inhibitors have been published in the patent applications, but often these contain a paltry amt. of pertinent biol. data (e.g. potency, selectivity, and efficacy).  Fortunately, numerous relevant publications contg. important data have appeared in the journal literature during this period.  The goal in this effort was to create an amalgam of the two records to add value to this review.  Expert opinion: The pharmaceutical industry has made tremendous progress in the development of small-mol. BACE1 inhibitors that lower Aβ in the central nervous system.  Assuming the amyloid hypothesis is veracious, we anticipate a disease-modifying therapy to combat Alzheimer's disease is near.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89KaCi3q5Z7Vg90H21EOLACvtfcHk0lg3RnyeZOjcOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D&md5=174bdc47fbca5aa1f8248dbf03ce402b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.681302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.681302%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D511%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+A.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0liw5N7P6lcoDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%2BA.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Berg, S.; Hallberg, J.; Hoegdin, K.; Karlstroem, S.; Kers, A.; Plobeck, N.; Rakos, L.</span>WO2008076043A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berg%2C+S.%3B+Hallberg%2C+J.%3B+Hoegdin%2C+K.%3B+Karlstroem%2C+S.%3B+Kers%2C+A.%3B+Plobeck%2C+N.%3B+Rakos%2C+L.WO2008076043A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DS.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Berg, S.; Hallberg, J.; Hoegdin, K.; Karlstroem, S.; Kers, A.; Plobeck, N.; Rakos, L.</span>WO2008076044A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berg%2C+S.%3B+Hallberg%2C+J.%3B+Hoegdin%2C+K.%3B+Karlstroem%2C+S.%3B+Kers%2C+A.%3B+Plobeck%2C+N.%3B+Rakos%2C+L.WO2008076044A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DS.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Berg, S.; Holenz, J.; Karlstroem, S.; Kihlstroem, J.; Lindstroem, J.; Rakos, L.</span>WO2008076046A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berg%2C+S.%3B+Holenz%2C+J.%3B+Karlstroem%2C+S.%3B+Kihlstroem%2C+J.%3B+Lindstroem%2C+J.%3B+Rakos%2C+L.WO2008076046A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DS.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Berg, S.; Karlstroem, S.; Kolmodin, K.; Lindstroem, J.; Nystroem, J.; Sehgelmeble, F.; Soederman, P.</span>WO2008076045A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berg%2C+S.%3B+Karlstroem%2C+S.%3B+Kolmodin%2C+K.%3B+Lindstroem%2C+J.%3B+Nystroem%2C+J.%3B+Sehgelmeble%2C+F.%3B+Soederman%2C+P.WO2008076045A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DS.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Burrows, J. N.; Hellberg, S.; Hogdin, K.; Karlstrom, S.; Kolmodin, K.; Lindstrom, J.; Slivo, C.</span>US20080287460A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Burrows%2C+J.+N.%3B+Hellberg%2C+S.%3B+Hogdin%2C+K.%3B+Karlstrom%2C+S.%3B+Kolmodin%2C+K.%3B+Lindstrom%2C+J.%3B+Slivo%2C+C.US20080287460A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Swahn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.+M.+Swahnauthor=J.+Holenzauthor=J.+Kihlstromauthor=K.+Kolmodinauthor=J.+Lindstromauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstromauthor=S.+Bergauthor=J.+Faltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.+L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstrom%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstrom%26aufirst%3DM.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFalting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Swahn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Öhberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-secretase (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9346</span><span class="NLM_x">–</span> <span class="NLM_lpage">9361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.+M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+%C3%96hbergauthor=A.+Kersauthor=K.+Bogarauthor=M.+Berghauthor=L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-secretase+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3D%25C3%2596hberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginman, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strömberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9297</span><span class="NLM_x">–</span> <span class="NLM_lpage">9311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.+M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28A%CE%B2%29+lowering+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0lh6yKsfbBCfQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBell, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0liqitRifEcqpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of aminopiperazinones as beta-secretase (BACE) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7255</span><span class="NLM_x">–</span> <span class="NLM_lpage">7260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.bmcl.2011.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22071305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFSqt7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7255-7260&author=G.+Tresadernauthor=F.+Delgadoauthor=O.+Delgadoauthor=H.+Gijsenauthor=G.+J.+Macdonaldauthor=D.+Moecharsauthor=F.+Romboutsauthor=R.+Alexanderauthor=J.+Spurlinoauthor=M.+Van+Goolauthor=J.+A.+Vegaauthor=A.+A.+Trabanco&title=Rational+design+and+synthesis+of+aminopiperazinones+as+beta-secretase+%28BACE%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors</span></div><div class="casAuthors">Tresadern, Gary; Delgado, Francisca; Delgado, Oscar; Gijsen, Harrie; Macdonald, Gregor J.; Moechars, Dieder; Rombouts, Frederik; Alexander, Richard; Spurlino, John; Van Gool, Michiel; Vega, Juan Antonio; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7255-7260</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aminopiperazinone inhibitors of BACE were identified by rational design.  Structure based design guided idea prioritization and initial racemic hit I showed good activity.  Modification in decoration and chiral sepn. resulted in the 40 nM inhibitor, (-)-II, which showed in vivo redn. of amyloid beta peptides.  The crystal structure of (R)-I with BACE showed a binding mode driven by interaction with the catalytic aspartate dyad and distribution of the biaryl amide decoration towards S1 and S3 pockets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHSIy3VkZzlLVg90H21EOLACvtfcHk0liqitRifEcqpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFSqt7fF&md5=f8f1f7b83fae2fba7f2d0e553a8cb49d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DF.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520aminopiperazinones%2520as%2520beta-secretase%2520%2528BACE%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7255%26epage%3D7260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0liqitRifEcqpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=233-240&author=Z.+Zhu&title=Iminoheterocycle+as+a+druggable+motif%3A+BACE1+inhibitors+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DIminoheterocycle%2520as%2520a%2520druggable%2520motif%253A%2520BACE1%2520inhibitors%2520and%2520beyond%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D233%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lgBxKXWYoOG2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">A general pattern for substrate recognition by P-glycoprotein</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1046%2Fj.1432-1327.1998.2510252.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=9492291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1cXnvV2rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1998&pages=252-261&author=A.+Seelig&title=A+general+pattern+for+substrate+recognition+by+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">A general pattern for substrate recognition by P-glycoprotein</span></div><div class="casAuthors">Seelig, Anna</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">P-glycoprotein actively transports a wide variety of chem. diverse compds. out of the cell.  Based on a comparison of a hundred compds. previously tested as P-glycoprotein substrates, we suggest that a set of well-defined structural elements is required for an interaction with P-glycoprotein.  The recognition elements are formed by two (type I unit) or three electron donor groups (type II unit) with a fixed spatial sepn.  Type I units consist of two electron donor groups with a spatial sepn. of 2.5±0.3 Å.  Type II units contain either two electron donor groups with a spatial sepn. of 4.6±0.6 Å or three electron donor groups with a spatial sepn. of the outer two groups of 4.6±0.6 Å.  All mols. that contain at least one type I or one type II unit are predicted to be P-glycoprotein substrates.  The binding to P-glycoprotein increases with the strength and the no. of electron donor or hydrogen bonding acceptor groups forming the type I and type II units.  Correspondingly, a high percentage of amino acids with hydrogen bonding donor side chains is found in the transmembrane sequences of P-glycoprotein relevant for substrate interaction.  Mols. that minimally contain one type II unit are predicted to be inducers of P-glycoprotein over-expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFKQQl0_dmRLVg90H21EOLACvtfcHk0liJW0juGKF2WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvV2rsg%253D%253D&md5=0c36abaa7371c9073254cb2e38e543ce</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1998.2510252.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1998.2510252.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DA%2520general%2520pattern%2520for%2520substrate%2520recognition%2520by%2520P-glycoprotein%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1998%26volume%3D251%26spage%3D252%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopedota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Recent advances in medicinal chemistry and pharmaceutical technology—strategies for drug delivery to the brain</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.2174%2F156802609787521571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=19200004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=182-196&author=N.+Denoraauthor=A.+Trapaniauthor=V.+Laquintanaauthor=A.+Lopedotaauthor=G.+Trapani&title=Recent+advances+in+medicinal+chemistry+and+pharmaceutical+technology%E2%80%94strategies+for+drug+delivery+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in medicinal chemistry and pharmaceutical technology - strategies for drug delivery to the brain</span></div><div class="casAuthors">Denora, Nunzio; Trapani, Adriana; Laquintana, Valentino; Lopedota, Angela; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-196</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This paper provides a mini-review of some recent approaches for the treatment of brain pathologies examg. both medicinal chem. and pharmaceutical technol. contributions.  Medicinal chem.-based strategies are essentially aimed at the chem. modification of low mol. wt. drugs in order to increase their lipophilicity or the design of appropriate prodrugs, although this review will focus primarily on the use of prodrugs and not analog development.  Recently, interest has been focused on the design and evaluation of prodrugs that are capable of exploiting one or more of the various endogenous transport systems at the level of the blood brain barrier (BBB).  The technol. strategies are essentially non-invasive methods of drug delivery to malignancies of the central nervous system (CNS) and are based on the use of nanosystems (colloidal carriers) such as liposomes, polymeric nanoparticles, solid lipid nanoparticles, polymeric micelles and dendrimers.  The biodistribution of these nanocarriers can be manipulated by modifying their surface physico-chem. properties or by coating them with surfactants and polyethylene-glycols (PEGs).  Liposomes, surfactant coated polymeric nanoparticles, and solid lipid nanoparticles are promising systems for delivery of drugs to tumors of the CNS.  This mini-review discusses issues concerning the scope and limitations of both the medicinal chem. and technol. approaches.  Based on the current findings, it can be concluded that crossing of the BBB and drug delivery to CNS is extremely complex and requires a multidisciplinary approach such as a close collaboration and common efforts among researchers of several scientific areas, particularly medicinal chemists, biologists and pharmaceutical technologists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKLD3NcuTLa7Vg90H21EOLACvtfcHk0liJW0juGKF2WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSgtb0%253D&md5=61feb73997d2974a7c792cdf8c47608a</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.2174%2F156802609787521571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609787521571%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DLopedota%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DRecent%2520advances%2520in%2520medicinal%2520chemistry%2520and%2520pharmaceutical%2520technology%25E2%2580%2594strategies%2520for%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2009%26volume%3D9%26spage%3D182%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quagliato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solvibile, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6597</span><span class="NLM_x">–</span> <span class="NLM_lpage">6605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.bmcl.2010.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=20880704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6597-6605&author=M.+S.+Malamasauthor=A.+Robichaudauthor=J.+Erdeiauthor=D.+Quagliatoauthor=W.+Solvibileauthor=P.+Zhouauthor=K.+Morrisauthor=J.+Turnerauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=S.+Jacobsenauthor=P.+Reinhartauthor=D.+Riddellauthor=M.+Pangalos&title=Design+and+synthesis+of+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors+with+enhanced+brain+permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability</span></div><div class="casAuthors">Malamas, Michael S.; Robichaud, Albert; Erdei, Jim; Quagliato, Dominick; Solvibile, William; Zhou, Ping; Morris, Koi; Turner, Jim; Wagner, Erik; Fan, Kristi; Olland, Andrea; Jacobsen, Steve; Reinhart, Peter; Riddell, David; Pangalos, Menelas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6597-6605</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit good brain permeability (40-70%), low nanomolar potency for BACE1, and demonstrate >100-fold selectivity for the structurally related aspartyl proteases cathepsin D, renin and pepsin.  Alkyl and alkoxy groups at the meta-position of the P1 Ph, which extend toward the S3 region of the enzyme, have contributed to the ligand's reduced affinity for the efflux transporter protein P-gp, and decreased topol. polar surface area, thus resulting in enhanced brain permeability.  A fluorine substitution at the para-position of the P1 Ph has contributed to 100-fold decrease of CYP3A4 inhibition and enhancement of compd. metabolic stability.  The plasma and brain protein binding properties of these new analogs are affected by substitutions at the P1 Ph moiety.  Higher compd. protein binding was obsd. in the brain than in the plasma.  Two structurally diverse potent BACE1 inhibitors (84 and 89) reduced 30% plasma Aβ40 in the Tg2576 mice in vivo model at 30 mg/kg po.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSYkNat5QUjrVg90H21EOLACvtfcHk0lgeGnXlOx44FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7I&md5=848a1bfa79278b0c7a72749f9be45ad8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DRobichaud%26aufirst%3DA.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DQuagliato%26aufirst%3DD.%26aulast%3DSolvibile%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DMorris%26aufirst%3DK.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DReinhart%26aufirst%3DP.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DPangalos%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520enhanced%2520brain%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6597%26epage%3D6605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Roden, D. M.</span><span> </span><span class="NLM_article-title">Drug-induced prolongation of the QT interval</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1056%2FNEJMra032426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=14999113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1013-1022&author=D.+M.+Roden&title=Drug-induced+prolongation+of+the+QT+interval"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced prolongation of the QT interval</span></div><div class="casAuthors">Roden, Dan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1022</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8PoMXlMg57Vg90H21EOLACvtfcHk0lgeGnXlOx44FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D&md5=a020a545700649d9914ed8dc61910244</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1056%2FNEJMra032426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra032426%26sid%3Dliteratum%253Aachs%26aulast%3DRoden%26aufirst%3DD.%2BM.%26atitle%3DDrug-induced%2520prolongation%2520of%2520the%2520QT%2520interval%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1013%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Diller, J. D.</span><span> </span><span class="NLM_article-title">In silico hERG modelling: challenges and progress</span> <span class="citation_source-journal">Curr. Comput.-Aided Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.2174%2F157340909788451928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVWrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=106-121&author=J.+D.+Diller&title=In+silico+hERG+modelling%3A+challenges+and+progress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">In silico hERG modeling: challenges and progress</span></div><div class="casAuthors">Diller, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Computer-Aided Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-121</span>CODEN:
                <span class="NLM_cas:coden">CCDDAS</span>;
        ISSN:<span class="NLM_cas:issn">1573-4099</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The first generation of in silico hERG models have focused on key driving forces for hERG/ligand binding: basicity and lipophilicity.  While reducing basicity and lipophilicity are typically the first line approaches to eliminating hERG blocking activity, in many programs these are not feasible approaches because basicity and lipophilicity are frequently necessary for achieving good pharmacokinetics or primary target binding.  Thus for the second, generation of in silico hERG models, a focus on understanding the more subtle aspects of hERG binding is necessary.  Thus, the focus of this review is on extg. ideas, either qual. or quant., from the various modeling efforts as to how hERG activity might be eliminated or diminished beyond simply reducing basicity and lipophilicity.  In addn., several areas where key questions around hERG binding have not been adequately addressed by in silico work are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7wUQpyBUN-rVg90H21EOLACvtfcHk0lgeGnXlOx44FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVWrtbY%253D&md5=cc2f2623d70bc07fa408e83185e428fe</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.2174%2F157340909788451928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340909788451928%26sid%3Dliteratum%253Aachs%26aulast%3DDiller%26aufirst%3DJ.%2BD.%26atitle%3DIn%2520silico%2520hERG%2520modelling%253A%2520challenges%2520and%2520progress%26jtitle%3DCurr.%2520Comput.-Aided%2520Drug%2520Des.%26date%3D2009%26volume%3D5%26spage%3D106%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Madden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dod, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godemann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraemer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biniszkiewicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyekjaer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesterkamp, T.</span><span> </span><span class="NLM_article-title">Fragment-based discovery and optimization of BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5329</span><span class="NLM_x">–</span> <span class="NLM_lpage">5333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5329-5333&author=J.+Maddenauthor=J.+R.+Dodauthor=R.+Godemannauthor=J.+Kraemerauthor=M.+Smithauthor=M.+Biniszkiewiczauthor=D.+J.+Hallettauthor=J.+Barkerauthor=J.+D.+Dyekjaerauthor=T.+Hesterkamp&title=Fragment-based+discovery+and+optimization+of+BACE1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMadden%26aufirst%3DJ.%26aulast%3DDod%26aufirst%3DJ.%2BR.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DBiniszkiewicz%26aufirst%3DM.%26aulast%3DHallett%26aufirst%3DD.%2BJ.%26aulast%3DBarker%26aufirst%3DJ.%26aulast%3DDyekjaer%26aufirst%3DJ.%2BD.%26aulast%3DHesterkamp%26aufirst%3DT.%26atitle%3DFragment-based%2520discovery%2520and%2520optimization%2520of%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5329%26epage%3D5333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Zhao, H.</span><span> </span><span class="NLM_article-title">Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.drudis.2006.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=17275735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtleisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=149-155&author=H.+Zhao&title=Scaffold+selection+and+scaffold+hopping+in+lead+generation%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective</span></div><div class="casAuthors">Zhao, Hongyu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">149-155</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hit selection and lead generation are crucial for the success of the resource-demanding lead-optimization phase in drug discovery, and represent a major research area of medicinal chem. today.  Ligand-binding efficiency, ligand complexity, ligand-target profile complementarity and chem. tractability are important parameters in hit selection.  As synthesis and assay throughput improve, a large no. of analogs based on the same scaffold can be rapidly synthesized and tested.  Consequently, more chem. resources could be devoted to scaffold modifications to expand the candidate pool in lead generation.  Most recently discovered druggable targets are promiscuous toward lipophilic ligands, and the hydrophobic portions of hit compds. should be preferentially modified in analog and scaffold design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_G4HUVC1fQrVg90H21EOLACvtfcHk0ljsNvkANRvdNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtleisbo%253D&md5=a9ffb13a77e3bb18d5c432f3286d4608</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DScaffold%2520selection%2520and%2520scaffold%2520hopping%2520in%2520lead%2520generation%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D149%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Segall, M. D.</span><span> </span><span class="NLM_article-title">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1292</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.2174%2F138161212799436430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22316157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1292-1310&author=M.+D.+Segall&title=Multi-parameter+optimization%3A+identifying+high+quality+compounds+with+a+balance+of+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span></div><div class="casAuthors">Segall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1292-1310</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A successful, efficacious and safe drug must have a balance of properties, including potency against its intended target, appropriate absorption, distribution, metab., and elimination (ADME) properties and an acceptable safety profile.  Achieving this balance of, often conflicting, requirements is a major challenge in drug discovery.  Approaches to simultaneously optimizing many factors in a design are broadly described under the term "multi-parameter optimization" (MPO).  In this review, we will describe how MPO can be applied to efficiently design and select high quality compds. and describe the range of methods that have been employed in drug discovery, including; simple "rules of thumb" such as Lipinski's rule; desirability functions; Pareto optimization; and probabilistic approaches that take into consideration the uncertainty in all drug discovery data due to predictive error and exptl. variability.  We will explore how these methods have been applied to predicted and exptl. data to reduce attrition and improve the productivity of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPFOVyg2ehWbVg90H21EOLACvtfcHk0ljsNvkANRvdNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D&md5=43f90ad751fd2c0bc47715f465ef31b3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F138161212799436430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436430%26sid%3Dliteratum%253Aachs%26aulast%3DSegall%26aufirst%3DM.%2BD.%26atitle%3DMulti-parameter%2520optimization%253A%2520identifying%2520high%2520quality%2520compounds%2520with%2520a%2520balance%2520of%2520properties%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D1292%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lusher, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azevedo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boiten, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Schaik, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vlieg, J.</span><span> </span><span class="NLM_article-title">A molecular informatics view on best practice in multi-parameter compound optimization</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=555-568&author=S.+J.+Lusherauthor=R.+McGuireauthor=R.+Azevedoauthor=J.+W.+Boitenauthor=R.+C.+van+Schaikauthor=J.+de+Vlieg&title=A+molecular+informatics+view+on+best+practice+in+multi-parameter+compound+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLusher%26aufirst%3DS.%2BJ.%26aulast%3DMcGuire%26aufirst%3DR.%26aulast%3DAzevedo%26aufirst%3DR.%26aulast%3DBoiten%26aufirst%3DJ.%2BW.%26aulast%3Dvan%2BSchaik%26aufirst%3DR.%2BC.%26aulast%3Dde%2BVlieg%26aufirst%3DJ.%26atitle%3DA%2520molecular%2520informatics%2520view%2520on%2520best%2520practice%2520in%2520multi-parameter%2520compound%2520optimization%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D555%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Viklund, J.; Kolmodin, K.; Nordvall, G.; Swahn, B.-M.; Svensson, M.; Gravenfors, Y.; Rahm, F.</span><span> </span><span class="NLM_article-title">Creation of novel cores for β-secreatse (BACE-1) inhibitors: a multi-parameter lead generation strategy</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Viklund%2C+J.%3B+Kolmodin%2C+K.%3B+Nordvall%2C+G.%3B+Swahn%2C+B.-M.%3B+Svensson%2C+M.%3B+Gravenfors%2C+Y.%3B+Rahm%2C+F.+Creation+of+novel+cores+for+%CE%B2-secreatse+%28BACE-1%29+inhibitors%3A+a+multi-parameter+lead+generation+strategy.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DViklund%26aufirst%3DJ.%26atitle%3DCreation%2520of%2520novel%2520cores%2520for%2520%25CE%25B2-secreatse%2520%2528BACE-1%2529%2520inhibitors%253A%2520a%2520multi-parameter%2520lead%2520generation%2520strategy" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Roos, K.; Viklund, J.; Meuller, J.; Kaspersson, K.; Svensson, M.</span><span> </span><span class="NLM_article-title">Potency prediction of β-secretase (BACE-1) inhibitors using density functional methods</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Roos%2C+K.%3B+Viklund%2C+J.%3B+Meuller%2C+J.%3B+Kaspersson%2C+K.%3B+Svensson%2C+M.+Potency+prediction+of+%CE%B2-secretase+%28BACE-1%29+inhibitors+using+density+functional+methods.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoos%26aufirst%3DK.%26atitle%3DPotency%2520prediction%2520of%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520using%2520density%2520functional%2520methods" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&issue=3&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0lgsXbRonycLUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26issue%3D3%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Suzuki, S.; Kooriyama, Y.</span>WO2011077726A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Suzuki%2C+S.%3B+Kooriyama%2C+Y.WO2011077726A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DS.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Trabanco-Suarez, A. A.; Rombouts, F. J. R.; Tresadern, G. J.; Van Gool, M. L. M.; Macdonald, G. J.; Martinez Lamenca, C.; Gijsen, H. J. M.</span>WO2011154431A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Trabanco-Suarez%2C+A.+A.%3B+Rombouts%2C+F.+J.+R.%3B+Tresadern%2C+G.+J.%3B+Van+Gool%2C+M.+L.+M.%3B+Macdonald%2C+G.+J.%3B+Martinez+Lamenca%2C+C.%3B+Gijsen%2C+H.+J.+M.WO2011154431A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco-Suarez%26aufirst%3DA.%2BA.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Dillard, L. W.; Yuan, J.; Leftheris, K.; Venkatraman, S.; Wu, G.; Jia, L.; Xu, Z.; Cacatian, S.; Morales-Ramos, A.; Singh, S.; Zheng, Y.</span>WO2011106414A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dillard%2C+L.+W.%3B+Yuan%2C+J.%3B+Leftheris%2C+K.%3B+Venkatraman%2C+S.%3B+Wu%2C+G.%3B+Jia%2C+L.%3B+Xu%2C+Z.%3B+Cacatian%2C+S.%3B+Morales-Ramos%2C+A.%3B+Singh%2C+S.%3B+Zheng%2C+Y.WO2011106414A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDillard%26aufirst%3DL.%2BW.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Albert, J.; Chessari, G.; Congreve, M. S.; Edwards, P.; Murray, C.; Patel, S.; Sylvester, M.</span>WO2007058583A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Albert%2C+J.%3B+Chessari%2C+G.%3B+Congreve%2C+M.+S.%3B+Edwards%2C+P.%3B+Murray%2C+C.%3B+Patel%2C+S.%3B+Sylvester%2C+M.WO2007058583A2%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DJ.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiya, M.</span><span> </span><span class="NLM_article-title">Catalytic hydrogenation of tetrahydro-4<i>H</i>-1,3-oxazin-4-ones and 4-oxazolidinones</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1762</span><span class="NLM_x">–</span> <span class="NLM_lpage">1767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1972&pages=1762-1767&author=K.+Itoauthor=M.+Sekiya&title=Catalytic+hydrogenation+of+tetrahydro-4H-1%2C3-oxazin-4-ones+and+4-oxazolidinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DK.%26aulast%3DSekiya%26aufirst%3DM.%26atitle%3DCatalytic%2520hydrogenation%2520of%2520tetrahydro-4H-1%252C3-oxazin-4-ones%2520and%25204-oxazolidinones%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1972%26volume%3D20%26spage%3D1762%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Jalce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figadere, B.</span><span> </span><span class="NLM_article-title">Synthesis and use of achiral oxazolidine-2-thiones in selective preparation of trans 2,5-disubstituted tetrahydrofurans</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=378-386&author=G.+Jalceauthor=X.+Franckauthor=B.+Figadere&title=Synthesis+and+use+of+achiral+oxazolidine-2-thiones+in+selective+preparation+of+trans+2%2C5-disubstituted+tetrahydrofurans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJalce%26aufirst%3DG.%26aulast%3DFranck%26aufirst%3DX.%26aulast%3DFigadere%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520use%2520of%2520achiral%2520oxazolidine-2-thiones%2520in%2520selective%2520preparation%2520of%2520trans%25202%252C5-disubstituted%2520tetrahydrofurans%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2009%26spage%3D378%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span> </span><span class="NLM_article-title">An improved and mild Wenker synthesis of aziridines</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">3423</span><span class="NLM_x">–</span> <span class="NLM_lpage">3428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKjsLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=3423-3428&author=X.+Liauthor=N.+Chenauthor=J.+Xu&title=An+improved+and+mild+Wenker+synthesis+of+aziridines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">An improved and mild Wenker synthesis of aziridines</span></div><div class="casAuthors">Li, Xinyao; Chen, Ning; Xu, Jianxi</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3423-3428</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The conventional Wenker synthesis of aziridines from vicinal amino alcs. was modified by employing mild reaction conditions.  Amino alcs. were converted into their hydrogen sulfates with ClSO3H.  The sulfates were cyclized with NaOH, and even with non-nucleophilic Na2CO3.  The improved method extends the scope of the typical Wenker synthesis and is applicable to unstable amino alcs. in hot H2SO4 and to unstable sulfates, which favor elimination and OH- displacement in the presence of strong base.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI9mzGf035ZrVg90H21EOLACvtfcHk0lgsXbRonycLUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKjsLjN&md5=e32b5db1383a12cca4b9a43477167d12</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DAn%2520improved%2520and%2520mild%2520Wenker%2520synthesis%2520of%2520aziridines%26jtitle%3DSynthesis%26date%3D2010%26spage%3D3423%26epage%3D3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Cohen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, B. L.</span><span> </span><span class="NLM_article-title">Synthesis of 2-amino-5,6-dihydro-4<i>H</i>-1,3-thiazines and related compounds by acid catalyzed cyclization of allylic isothiuronium salts</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1977&pages=717-723&author=N.+Cohenauthor=B.+L.+Banner&title=Synthesis+of+2-amino-5%2C6-dihydro-4H-1%2C3-thiazines+and+related+compounds+by+acid+catalyzed+cyclization+of+allylic+isothiuronium+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DN.%26aulast%3DBanner%26aufirst%3DB.%2BL.%26atitle%3DSynthesis%2520of%25202-amino-5%252C6-dihydro-4H-1%252C3-thiazines%2520and%2520related%2520compounds%2520by%2520acid%2520catalyzed%2520cyclization%2520of%2520allylic%2520isothiuronium%2520salts%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1977%26volume%3D14%26spage%3D717%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Davies, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stove, E. R.</span><span> </span><span class="NLM_article-title">Some consequences of the additive property of the activated azomethine group</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1949</span><span class="NLM_x">, </span> <span class="NLM_fpage">2633</span><span class="NLM_x">–</span> <span class="NLM_lpage">2637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1949&pages=2633-2637&author=W.+Daviesauthor=T.+H.+Ramsayauthor=E.+R.+Stove&title=Some+consequences+of+the+additive+property+of+the+activated+azomethine+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DW.%26aulast%3DRamsay%26aufirst%3DT.%2BH.%26aulast%3DStove%26aufirst%3DE.%2BR.%26atitle%3DSome%2520consequences%2520of%2520the%2520additive%2520property%2520of%2520the%2520activated%2520azomethine%2520group%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1949%26spage%3D2633%26epage%3D2637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Malamas, M. S.; Erdei, J. J.; Fobare, W. F.; Quagliato, D. A.; Antane, S. A.; Robichaud, A. J.</span>US 20070072925,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Malamas%2C+M.+S.%3B+Erdei%2C+J.+J.%3B+Fobare%2C+W.+F.%3B+Quagliato%2C+D.+A.%3B+Antane%2C+S.+A.%3B+Robichaud%2C+A.+J.US+20070072925%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Mukherjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span> </span><span class="NLM_article-title">Chemoselectivities in the platinum-catalyzed hydrative carbocyclizations of oxo-alkyne-nitrile functionalities</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">660</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol1029047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosVartA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=660-663&author=A.+Mukherjeeauthor=R.+Liu&title=Chemoselectivities+in+the+platinum-catalyzed+hydrative+carbocyclizations+of+oxo-alkyne-nitrile+functionalities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselectivities in the Platinum-Catalyzed Hydrative Carbocyclizations of Oxo-Alkyne-Nitrile Functionalities</span></div><div class="casAuthors">Mukherjee, Anupam; Liu, Rai-Shung</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">660-663</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two new hydrative carbocyclizations of oxa-alkyne-nitrile functionalities are reported to produce distinct nitrogen-contg. heterocycles.  Protracted heating of oxoalkynyl nitrile substrates with PtCl2/CO/H2O in hot 1,4-dioxane gave 2,3-dihydro-1H-pyrido[1.2-b]-isoquinolin-4(6H)-ones, e.g., I.  In this hydration reaction, dicarbonyl nitrile intermediates were isolated efficiently after a brief period, and they were subjected to an NHC-based crossed benzoin coupling to give spiro alcs. that further reacted with TfOH to give spiro[indene-2,2'-piperidine]-1,6'(3H)-diones, e.g., II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBp8wW3X8rGrVg90H21EOLACvtfcHk0lgnkrOI4oV4xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosVartA%253D%253D&md5=980685e8b903e8ed08d58dc95d8b5f6e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fol1029047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol1029047%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DR.%26atitle%3DChemoselectivities%2520in%2520the%2520platinum-catalyzed%2520hydrative%2520carbocyclizations%2520of%2520oxo-alkyne-nitrile%2520functionalities%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D660%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.</span><span> </span><span class="NLM_article-title">Stereochemical studies. VII. Thermal rearrangement of α-hydroxy imines to α-amino ketones using optically active open chain compounds</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1971&pages=227-246&author=H.+Mizunoauthor=S.+Terashimaauthor=S.+Yamada&title=Stereochemical+studies.+VII.+Thermal+rearrangement+of+%CE%B1-hydroxy+imines+to+%CE%B1-amino+ketones+using+optically+active+open+chain+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DTerashima%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DS.%26atitle%3DStereochemical%2520studies.%2520VII.%2520Thermal%2520rearrangement%2520of%2520%25CE%25B1-hydroxy%2520imines%2520to%2520%25CE%25B1-amino%2520ketones%2520using%2520optically%2520active%2520open%2520chain%2520compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1971%26volume%3D19%26spage%3D227%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Bridgland-Taylor, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orme, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henthorn, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heapy, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Gerges, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, C. E.</span><span> </span><span class="NLM_article-title">Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.vascn.2006.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=16563806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=189-199&author=M.+H.+Bridgland-Taylorauthor=A.+C.+Hargreavesauthor=A.+Easterauthor=A.+Ormeauthor=D.+C.+Henthornauthor=M.+Dingauthor=A.+M.+Davisauthor=B.+G.+Smallauthor=C.+G.+Heapyauthor=N.+Abi-Gergesauthor=F.+Perssonauthor=I.+Jacobsonauthor=M.+Sullivanauthor=N.+Albertsonauthor=T.+G.+Hammondauthor=E.+Sullivanauthor=J.+P.+Valentinauthor=C.+E.+Pollard&title=Optimisation+and+validation+of+a+medium-throughput+electrophysiology-based+hERG+assay+using+IonWorks+HT"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span></div><div class="casAuthors">Bridgland-Taylor, M. H.; Hargreaves, A. C.; Easter, A.; Orme, A.; Henthorn, D. C.; Ding, M.; Davis, A. M.; Small, B. G.; Heapy, C. G.; Abi-Gerges, N.; Persson, F.; Jacobson, I.; Sullivan, M.; Albertson, N.; Hammond, T. G.; Sullivan, E.; Valentin, J.-P.; Pollard, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: Regulatory and competitive pressure to reduce the QT interval prolongation risk of potential new drugs has led to focus on methods to test for inhibition of the human ether-a-go-go-related gene (hERG)-encoded K+ channel, the primary mol. target underlying this safety issue.  Here we describe the validation of a method that combines medium-throughput with direct assessment of channel function.  Methods: The electrophysiol. and pharmacol. properties of hERG were compared using two methods: conventional, low-throughput electrophysiol. and planar-array-based, medium-throughput electrophysiol. (IonWorks HT).  A pharmacol. comparison was also made between IonWorks HT and an indirect assay (Rb+ efflux).  Results: Basic electrophysiol. properties of hERG were similar whether recorded conventionally (HEK cells) or using IonWorks HT (CHO cells): for example, tail current V1/2 - 12.1 ± 5.0 mV (32) for conventional and - 9.5 ± 6.0 mV (46) for IonWorks HT (mean ± S.D. (n)).  A key finding was that as the no. of cells per well was increased in IonWorks HT, the potency reported for a given compd. decreased.  Using the lowest possible cell concn. (250,000 cells/mL) and 89 compds. spanning a broad potency range, the pIC50 values from IonWorks HT (CHO-hERG) were found to correlate well with those obtained using conventional methodol. (HEK-hERG)(r = 0.90; p < 0.001).  Further validation using CHO-hERG cells with both methods confirmed the correlation (r = 0.94; p < 0.001).  In contrast, a comparison of IonWorks HT and Rb+ efflux data with 649 compds. using CHO-hERG cells showed that the indirect assay consistently reported compds. as being, on av., 6-fold less potent, though the differences varied depending on chem. series.  Discussion: The main finding of this work is that providing a relatively low cell concn. is used in IonWorks HT, the potency information generated correlates well with that detd. using conventional electrophysiol.  The effect on potency of increasing cell concn. may relate to a reduced free concn. of test compd. owing to partitioning into cell membranes.  In summary, the IonWorks HT hERG assay can generate pIC50 values based on a direct assessment of channel function in a timeframe short enough to influence chem. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcBXhwRw0nLVg90H21EOLACvtfcHk0ljeJv1--QAQcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D&md5=730258a42517947c0b972ca87cef46b6</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2006.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2006.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DBridgland-Taylor%26aufirst%3DM.%2BH.%26aulast%3DHargreaves%26aufirst%3DA.%2BC.%26aulast%3DEaster%26aufirst%3DA.%26aulast%3DOrme%26aufirst%3DA.%26aulast%3DHenthorn%26aufirst%3DD.%2BC.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DSmall%26aufirst%3DB.%2BG.%26aulast%3DHeapy%26aufirst%3DC.%2BG.%26aulast%3DAbi-Gerges%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DJacobson%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DAlbertson%26aufirst%3DN.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DSullivan%26aufirst%3DE.%26aulast%3DValentin%26aufirst%3DJ.%2BP.%26aulast%3DPollard%26aufirst%3DC.%2BE.%26atitle%3DOptimisation%2520and%2520validation%2520of%2520a%2520medium-throughput%2520electrophysiology-based%2520hERG%2520assay%2520using%2520IonWorks%2520HT%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D189%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmen, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagard, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. A.</span><span> </span><span class="NLM_article-title">High-throughput screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2639</span><span class="NLM_x">–</span> <span class="NLM_lpage">2648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1002%2Frcm.1229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=14648902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2639-2648&author=H.+Wanauthor=A.+G.+Holmenauthor=Y.+Wangauthor=W.+Lindbergauthor=M.+Englundauthor=M.+B.+Nagardauthor=R.+A.+Thompson&title=High-throughput+screening+of+pKa+values+of+pharmaceuticals+by+pressure-assisted+capillary+electrophoresis+and+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry</span></div><div class="casAuthors">Wan, Hong; Holmen, Anders G.; Wang, Yudong; Lindberg, Walter; Englund, Marie; Nagard, Mats B.; Thompson, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2639-2648</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A high-throughput pKa screening method based on pressure-assisted capillary electrophoresis (CE) and mass spectrometry (MS) is presented.  Effects of buffer type and ionic strength on sensitivity and pKa values were investigated.  Influence of DMSO concn. present in the sample on effective mobility measurement was examd.  A series of ten volatile buffers, covering a pH range from 2.5 to 10.5 with the same ionic strength, was employed.  The application of volatile background electrolytes resulted in significant signal increase as compared with commonly used non-volatile phosphate buffers.  In general, the CE/MS system provided a ten-fold higher sensitivity than conventional UV detection.  The newly developed CE/MS method offers high-throughput capacity by pooling a no. of compds. into a single sample.  Simultaneous measurement of more than 50 compds. was readily achieved in less than 150 min.  The measured pKa values are consistent with the published data obtained from the CE/UV method and are also in good agreement with data generated by other methods.  Other advantages of using CE/MS for pKa screening are illustrated with typical examples, including poorly sol. compds. and non-UV-absorbing compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgfrtqeDn-8LVg90H21EOLACvtfcHk0ljeJv1--QAQcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSiurs%253D&md5=28bdb030bf255c19b5f98de12d5d9310</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Frcm.1229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1229%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DHolmen%26aufirst%3DA.%2BG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLindberg%26aufirst%3DW.%26aulast%3DEnglund%26aufirst%3DM.%26aulast%3DNagard%26aufirst%3DM.%2BB.%26aulast%3DThompson%26aufirst%3DR.%2BA.%26atitle%3DHigh-throughput%2520screening%2520of%2520pKa%2520values%2520of%2520pharmaceuticals%2520by%2520pressure-assisted%2520capillary%2520electrophoresis%2520and%2520mass%2520spectrometry%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2003%26volume%3D17%26spage%3D2639%26epage%3D2648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, W.</span><span> </span><span class="NLM_article-title">Rapid screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis combined with short-end injection</span> <span class="citation_source-journal">J. Chromatogr., A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">979</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=979&publication_year=2002&pages=369-377&author=H.+Wanauthor=A.+Holmenauthor=M.+Nagardauthor=W.+Lindberg&title=Rapid+screening+of+pKa+values+of+pharmaceuticals+by+pressure-assisted+capillary+electrophoresis+combined+with+short-end+injection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DHolmen%26aufirst%3DA.%26aulast%3DNagard%26aufirst%3DM.%26aulast%3DLindberg%26aufirst%3DW.%26atitle%3DRapid%2520screening%2520of%2520pKa%2520values%2520of%2520pharmaceuticals%2520by%2520pressure-assisted%2520capillary%2520electrophoresis%2520combined%2520with%2520short-end%2520injection%26jtitle%3DJ.%2520Chromatogr.%252C%2520A%26date%3D2002%26volume%3D979%26spage%3D369%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogDoct: a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+a+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neutral+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520a%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neutral%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Hann, M. M.</span><span> </span><span class="NLM_article-title">Molecular obesity, potency and other addictions in drug discovery</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1039%2Fc1md00017a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=349-355&author=M.+M.+Hann&title=Molecular+obesity%2C+potency+and+other+addictions+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular obesity, potency and other addictions in drug discovery</span></div><div class="casAuthors">Hann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Despite the increase in global biol. and chem. knowledge the discovery of effective and safe new drugs seems to become harder rather than easier.  Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learned from our failures.  This perspective reflects on some of the learnings of recent years in relation to the causes of attrition.  The term Mol. Obesity is introduced to describe our tendency to build potency into mols. by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlF7TPy6fHLVg90H21EOLACvtfcHk0ljaEwDEB_n5gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D&md5=954870db4b1d9e846612c3bb256582f7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1039%2Fc1md00017a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00017a%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520obesity%252C%2520potency%2520and%2520other%2520addictions%2520in%2520drug%2520discovery%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D349%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katharine, H.,M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery of aminoheterocycles as a novel β-secretase inhibitor class: pH dependence on binding activity part 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2977</span><span class="NLM_x">–</span> <span class="NLM_lpage">2980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2977-2980&author=S.+J.+Stachelauthor=C.+A.+Coburnauthor=D.+Rushauthor=K.+L.+G.+Jonesauthor=H.+Zhuauthor=H.+Rajapakseauthor=S.+L.+Grahamauthor=A.+Simonauthor=H.%2CM.+Katharineauthor=T.+J.+Allisonauthor=S.+K.+Munshiauthor=A.+S.+Espesethauthor=P.+Zuckauthor=D.+Colussiauthor=A.+Wolfeauthor=B.+L.+Pietrakauthor=M.+Laiauthor=J.+P.+Vacca&title=Discovery+of+aminoheterocycles+as+a+novel+%CE%B2-secretase+inhibitor+class%3A+pH+dependence+on+binding+activity+part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DRush%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DRajapakse%26aufirst%3DH.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DKatharine%26aufirst%3DH.%252CM.%26aulast%3DAllison%26aufirst%3DT.%2BJ.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520aminoheterocycles%2520as%2520a%2520novel%2520%25CE%25B2-secretase%2520inhibitor%2520class%253A%2520pH%2520dependence%2520on%2520binding%2520activity%2520part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2977%26epage%3D2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4689</span><span class="NLM_x">–</span> <span class="NLM_lpage">4695</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0498252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=4689-4695&author=L.+Hongauthor=J.+Tang&title=Flap+position+of+free+memapsin+2+%28beta-secretase%29%2C+a+model+for+flap+opening+in+aspartic+protease+catalysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fbi0498252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0498252%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DFlap%2520position%2520of%2520free%2520memapsin%25202%2520%2528beta-secretase%2529%252C%2520a%2520model%2520for%2520flap%2520opening%2520in%2520aspartic%2520protease%2520catalysis%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D4689%26epage%3D4695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=150-153&author=L.+Hongauthor=G.+Koelschauthor=X.+Linauthor=S.+Wuauthor=S.+Terzyanauthor=A.+K.+Ghoshauthor=X.+C.+Zhangauthor=J.+Tang&title=Structure+of+the+protease+domain+of+memapsin+2+%28beta-secretase%29+complexed+with+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BC.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520protease%2520domain%2520of%2520memapsin%25202%2520%2528beta-secretase%2529%2520complexed%2520with%2520inhibitor%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D150%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Crystal structure of memapsin 2 (beta-secretase) in complex with an inhibitor OM00-3</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">10963</span><span class="NLM_x">–</span> <span class="NLM_lpage">10967</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi026232n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=10963-10967&author=L.+Hongauthor=R.+T.+Turnerauthor=G.+Koelschauthor=D.+Shinauthor=A.+K.+Ghoshauthor=J.+Tang&title=Crystal+structure+of+memapsin+2+%28beta-secretase%29+in+complex+with+an+inhibitor+OM00-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbi026232n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi026232n%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DCrystal%2520structure%2520of%2520memapsin%25202%2520%2528beta-secretase%2529%2520in%2520complex%2520with%2520an%2520inhibitor%2520OM00-3%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D10963%26epage%3D10967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deinum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Beer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H.</span><span> </span><span class="NLM_article-title">Discovery of a novel warhead against beta-secretase through fragment-based lead generation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5903</span><span class="NLM_x">–</span> <span class="NLM_lpage">5911</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070825k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5903-5911&author=S.+Geschwindnerauthor=L.+L.+Olssonauthor=J.+S.+Albertauthor=J.+Deinumauthor=P.+D.+Edwardsauthor=T.+de+Beerauthor=R.+H.+Folmer&title=Discovery+of+a+novel+warhead+against+beta-secretase+through+fragment-based+lead+generation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm070825k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070825k%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DDeinum%26aufirst%3DJ.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3Dde%2BBeer%26aufirst%3DT.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520warhead%2520against%2520beta-secretase%2520through%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5903%26epage%3D5911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span> </span><span class="NLM_article-title">A quantitative assessment of hERG liability as a function of lipophilicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=17239590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitative+assessment+of+hERG+liability+as+a+function+of+lipophilicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative assessment of hERG liability as a function of lipophilicity</span></div><div class="casAuthors">Waring, Michael J.; Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1759-1764</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The impact of lipophilicity as a factor contributing to hERG potency is assessed for a large dataset of compds. of differing ionization type.  This dataset is derived from compds. tested in the Ionworks-based in vitro electrophysiol. hERG assay at AstraZeneca.  Using logistic regression, a quantification of the risk assocd. with increasing lipophilicity is presented.  The anticipated differences between acidic, basic and neutral compds. are apparent in the data but lipophilicity is shown to be a stronger driver for hERG potency than might have been expected.  Simple rules defining target lipophilicity values for minimizing hERG liability are derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCr9mVGL2-LVg90H21EOLACvtfcHk0lizl8GQLqJuBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D&md5=3819e045d7b773f129773f1ff567b980</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lixukr3_sQ75w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">LeDonne, N. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rissolo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulgarelli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tini, L.</span><span> </span><span class="NLM_article-title">Use of structure–activity landscape index curves and curve integrals to evaluate the performance of multiple machine learning prediction models</span> <span class="citation_source-journal">J. Cheminf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1186%2F1758-2946-3-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitFyit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=7&author=N.+C.+LeDonneauthor=K.+Rissoloauthor=J.+Bulgarelliauthor=L.+Tini&title=Use+of+structure%E2%80%93activity+landscape+index+curves+and+curve+integrals+to+evaluate+the+performance+of+multiple+machine+learning+prediction+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Use of structure-activity landscape index curves and curve integrals to evaluate the performance of multiple machine learning prediction models</span></div><div class="casAuthors">LeDonne, Norman C., Jr.; Rissolo, Kevin; Bulgarelli, James; Tini, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: Std. approaches to address the performance of predictive models that used common statistical measurements for the entire data set provide an overview of the av. performance of the models across the entire predictive space, but give little insight into applicability of the model across the prediction space.  Guha and Van Drie recently proposed the use of structure-activity landscape index (SALI) curves via the SALI curve integral (SCI) as a means to map the predictive power of computational models within the predictive space.  This approach evaluates model performance by assessing the accuracy of pairwise predictions, comparing compd. pairs in a manner similar to that done by medicinal chemists.  Results: The SALI approach was used to evaluate the performance of continuous prediction models for MDR1-MDCK in vitro efflux potential.  Efflux models were built with ADMET Predictor neural net, support vector machine, kernel partial least squares, and multiple linear regression engines, as well as SIMCA-P+ partial least squares, and random forest from Pipeline Pilot as implemented by AstraZeneca, using mol. descriptors from SimulationsPlus and AstraZeneca.  Conclusion: The results indicate that the choice of training sets used to build the prediction models is of great importance in the resulting model quality and that the SCI values calcd. for these models were very similar to their Kendall τ values, leading to our suggestion of an approach to use this SALI/SCI paradigm to evaluate predictive model performance that will allow more informed decisions regarding model utility.  The use of SALI graphs and curves provides an addnl. level of quality assessment for predictive models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Id6r_IMYBrVg90H21EOLACvtfcHk0lixukr3_sQ75w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitFyit7o%253D&md5=4dfebef8c41a954bdf84e2443bd63bb6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-3-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-3-7%26sid%3Dliteratum%253Aachs%26aulast%3DLeDonne%26aufirst%3DN.%2BC.%26aulast%3DRissolo%26aufirst%3DK.%26aulast%3DBulgarelli%26aufirst%3DJ.%26aulast%3DTini%26aufirst%3DL.%26atitle%3DUse%2520of%2520structure%25E2%2580%2593activity%2520landscape%2520index%2520curves%2520and%2520curve%2520integrals%2520to%2520evaluate%2520the%2520performance%2520of%2520multiple%2520machine%2520learning%2520prediction%2520models%26jtitle%3DJ.%2520Cheminf.%26date%3D2011%26volume%3D3%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Borgegard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jureus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabirsh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klintenberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stromberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parpal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinowsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesater, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span> </span><span class="NLM_article-title">First and second generation gamma-secretase modulators (GSMs) modulate amyloid-beta (Abeta) peptide production through different mechanisms</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">11810</span><span class="NLM_x">–</span> <span class="NLM_lpage">11819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=11810-11819&author=T.+Borgegardauthor=A.+Jureusauthor=F.+Olssonauthor=S.+Rosqvistauthor=A.+Sabirshauthor=D.+Rotticciauthor=K.+Paulsenauthor=R.+Klintenbergauthor=H.+Yanauthor=M.+Waldmanauthor=K.+Strombergauthor=J.+Nordauthor=J.+Johanssonauthor=A.+Regnerauthor=S.+Parpalauthor=D.+Malinowskyauthor=A.+C.+Radesaterauthor=T.+Liauthor=R.+Singhauthor=H.+Erikssonauthor=J.+Lundkvist&title=First+and+second+generation+gamma-secretase+modulators+%28GSMs%29+modulate+amyloid-beta+%28Abeta%29+peptide+production+through+different+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgegard%26aufirst%3DT.%26aulast%3DJureus%26aufirst%3DA.%26aulast%3DOlsson%26aufirst%3DF.%26aulast%3DRosqvist%26aufirst%3DS.%26aulast%3DSabirsh%26aufirst%3DA.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DPaulsen%26aufirst%3DK.%26aulast%3DKlintenberg%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWaldman%26aufirst%3DM.%26aulast%3DStromberg%26aufirst%3DK.%26aulast%3DNord%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DRegner%26aufirst%3DA.%26aulast%3DParpal%26aufirst%3DS.%26aulast%3DMalinowsky%26aufirst%3DD.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DEriksson%26aufirst%3DH.%26aulast%3DLundkvist%26aufirst%3DJ.%26atitle%3DFirst%2520and%2520second%2520generation%2520gamma-secretase%2520modulators%2520%2528GSMs%2529%2520modulate%2520amyloid-beta%2520%2528Abeta%2529%2520peptide%2520production%2520through%2520different%2520mechanisms%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D11810%26epage%3D11819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducrozet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title">Development of a high-throughput brain slice method for studying drug distribution in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1226</span><span class="NLM_x">–</span> <span class="NLM_lpage">1233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1226-1233&author=M.+Fridenauthor=F.+Ducrozetauthor=B.+Middletonauthor=M.+Antonssonauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaes&title=Development+of+a+high-throughput+brain+slice+method+for+studying+drug+distribution+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DDucrozet%26aufirst%3DF.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DAntonsson%26aufirst%3DM.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520high-throughput%2520brain%2520slice%2520method%2520for%2520studying%2520drug%2520distribution%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1226%26epage%3D1233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungqvist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title">Improved measurement of drug exposure in the brain using drug-specific correction for residual blood</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1038%2Fjcbfm.2009.200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=19756019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Sg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=150-161&author=M.+Fridenauthor=H.+Ljungqvistauthor=B.+Middletonauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaes&title=Improved+measurement+of+drug+exposure+in+the+brain+using+drug-specific+correction+for+residual+blood"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Improved measurement of drug exposure in the brain using drug-specific correction for residual blood</span></div><div class="casAuthors">Friden, Markus; Ljungqvist, Helena; Middleton, Brian; Bredberg, Ulf; Hammarlund-Udenaes, Margareta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-161</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A major challenge assocd. with the detn. of the unbound brain-to-plasma concn. ratio of a drug (Kp,uu,brain), is the error assocd. with correction for the drug in various vascular spaces of the brain, i.e., in residual blood.  The apparent brain vascular spaces of plasma water (Vwater, 10.3 μL/g brain), plasma proteins (Vprotein, 7.99 μL/g brain), and the vol. of erythrocytes (Ver, 2.13 μL/g brain) were detd. and incorporated into a novel, drug-specific correction model that took the drug-unbound fraction in the plasma (fu,p) into account.  The correction model was successfully applied for the detn. of Kp,uu,brain for indomethacin, loperamide, and moxalactam, which had potential problems assocd. with correction.  The influence on correction of the drug assocd. with erythrocytes was shown to be minimal.  Therefore, it is proposed that correction for residual blood can be performed using an effective plasma space in the brain (Veff), which is calcd. from the measured fu,p of the particular drug as well as from the ests. of Vwater and Vprotein, which are provided in this study.  Furthermore, the results highlight the value of detg. Kp,uu,brain with statistical precision to enable appropriate interpretation of brain exposure for drugs that appear to be restricted to the brain vascular spaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdAwudBZex47Vg90H21EOLACvtfcHk0lhN6o_26xztCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Sg&md5=e55b0e2ec8254fdd498061cf3a1dd015</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2009.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2009.200%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DLjungqvist%26aufirst%3DH.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DImproved%2520measurement%2520of%2520drug%2520exposure%2520in%2520the%2520brain%2520using%2520drug-specific%2520correction%2520for%2520residual%2520blood%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2010%26volume%3D30%26spage%3D150%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span> </span><span class="NLM_article-title">Apo and inhibitor complex structures of BACE (beta-secretase)</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+inhibitor+complex+structures+of+BACE+%28beta-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520inhibitor%2520complex%2520structures%2520of%2520BACE%2520%2528beta-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span> </span><span class="NLM_article-title">Recent changes to the MOSFLM package for processing film and image plate data</span> <span class="citation_source-journal">Jt. CCP4+ESF-EAMCB Newslett. Protein Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1992&pages=27&author=A.+G.+W.+Leslie&title=Recent+changes+to+the+MOSFLM+package+for+processing+film+and+image+plate+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DRecent%2520changes%2520to%2520the%2520MOSFLM%2520package%2520for%2520processing%2520film%2520and%2520image%2520plate%2520data%26jtitle%3DJt.%2520CCP4%252BESF-EAMCB%2520Newslett.%2520Protein%2520Crystallogr.%26date%3D1992%26volume%3D26%26spage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span>Collaborative Computational Project 4 SCALA,<span class="NLM_x"> </span><span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Collaborative+Computational+Project+4+SCALA%2C+1994."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lj7VepTtnY8iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lj7VepTtnY8iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Wlodek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skillman, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, A.</span><span> </span><span class="NLM_article-title">Automated ligand placement and refinement with a combined force field and shape potential</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">D62</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D62&publication_year=2006&pages=741-749&author=S.+Wlodekauthor=A.+G.+Skillmanauthor=A.+Nicholls&title=Automated+ligand+placement+and+refinement+with+a+combined+force+field+and+shape+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWlodek%26aufirst%3DS.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DNicholls%26aufirst%3DA.%26atitle%3DAutomated%2520ligand%2520placement%2520and%2520refinement%2520with%2520a%2520combined%2520force%2520field%2520and%2520shape%2520potential%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3DD62%26spage%3D741%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29'],'ref30':['cit30a','cit30b'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 34 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Bryan Li, Richard W. Barnhart, Amelie Dion, Steven Guinness, Alan Happe, Cheryl M. Hayward, Jeffrey Kohrt, Teresa Makowski, Mark Maloney, Jade D. Nelson, Asaad Nematalla, J. Christopher McWilliams, Zhihui Peng, Jeffrey Raggon, John Sagal, Gerald A. Weisenburger, Denghui Bao, Miguel Gonzalez, Jiangping Lu, Mark D. McLaws, Jian Tao, <span class="NLM_string-name hlFld-ContribAuthor">Baolin Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor—Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (6)
                                     , 1440-1453. <a href="https://doi.org/10.1021/acs.oprd.1c00126" title="DOI URL">https://doi.org/10.1021/acs.oprd.1c00126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.1c00126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.1c00126%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252Bof%252Ba%252BSecond%252BGeneration%252B%2525CE%2525B2-Amyloid-Cleaving%252BEnzyme%252BInhibitor%2525E2%252580%252594Improving%252Bthe%252BRobustness%252Bof%252Ba%252BHalogen-Metal%252BExchange%252BUsing%252BContinuous%252BStirred-Tank%252BReactors%26aulast%3DLi%26aufirst%3DBryan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12042021%26date%3D24052021%26volume%3D25%26issue%3D6%26spage%3D1440%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vandana Jaiswal, Biplab Mondal, Kuldeep Singh, Dinabandhu Das, <span class="NLM_string-name hlFld-ContribAuthor">Jaideep Saha</span>. </span><span class="cited-content_cbyCitation_article-title">[3 + 2]-Annulation of Azaoxyallyl Cations and Thiocarbonyls for the Assembly of Thiazolidin-4-ones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (15)
                                     , 5848-5852. <a href="https://doi.org/10.1021/acs.orglett.9b01933" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01933%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3D%25255B3%252B%25252B%252B2%25255D-Annulation%252Bof%252BAzaoxyallyl%252BCations%252Band%252BThiocarbonyls%252Bfor%252Bthe%252BAssembly%252Bof%252BThiazolidin-4-ones%26aulast%3DJaiswal%26aufirst%3DVandana%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05062019%26date%3D11072019%26volume%3D21%26issue%3D15%26spage%3D5848%26epage%3D5852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Brian
T. O’Neill, Elizabeth M. Beck, Christopher R. Butler, Charles E. Nolan, Cathleen Gonzales, Lei Zhang, Shawn D. Doran, Kimberly Lapham, Leanne M. Buzon, Jason K. Dutra, Gabriela Barreiro, Xinjun Hou, Luis A. Martinez-Alsina, Bruce N. Rogers, Anabella Villalobos, John C. Murray, Kevin Ogilvie, Erik A. LaChapelle, Cheng Chang, Lorraine F. Lanyon, Claire M. Steppan, Ashley Robshaw, Katherine Hales, Germaine G. Boucher, Karamjeet Pandher, Christopher Houle, Claude W. Ambroise, David Karanian, David Riddell, Kelly R. Bales, <span class="NLM_string-name hlFld-ContribAuthor">Michael A. Brodney</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4476-4504. <a href="https://doi.org/10.1021/acs.jmedchem.8b00246" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00246</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00246%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BClinical%252BCandidate%252BPF-06751979%25253A%252BA%252BPotent%25252C%252BBrain%252BPenetrant%25252C%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitor%252BLacking%252BHypopigmentation%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DBrian%2BT.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13022018%26date%3D17042018%26date%3D03042018%26volume%3D61%26issue%3D10%26spage%3D4476%26epage%3D4504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Patrik Johansson, Karin Kaspersson, Ian K. Gurrell, Elisabeth Bäck, Susanna Eketjäll, Clay W. Scott, Gvido Cebers, Philip Thorne, Michael J. McKenzie, Haydn Beaton, Paul Davey, Karin Kolmodin, Jörg Holenz, Mark E. Duggan, Samantha Budd Haeberlein, <span class="NLM_string-name hlFld-ContribAuthor">Roland W. Bürli</span>. </span><span class="cited-content_cbyCitation_article-title">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3491-3502. <a href="https://doi.org/10.1021/acs.jmedchem.7b01716" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01716%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DToward%252B%2525CE%2525B2-Secretase-1%252BInhibitors%252Bwith%252BImproved%252BIsoform%252BSelectivity%26aulast%3DJohansson%26aufirst%3DPatrik%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21112017%26date%3D10042018%26date%3D04042018%26volume%3D61%26issue%3D8%26spage%3D3491%26epage%3D3502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henrik  Keränen</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Myriam  Ciordia</span>, <span class="hlFld-ContribAuthor ">Francisca  Delgado</span>, <span class="hlFld-ContribAuthor ">Thomas B.  Steinbrecher</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Herman W. T.  van Vlijmen</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, and <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>  . </span><span class="cited-content_cbyCitation_article-title">Acylguanidine Beta Secretase 1 Inhibitors: A Combined Experimental and Free Energy Perturbation Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2017,</strong> <em>13 </em>
                                    (3)
                                     , 1439-1453. <a href="https://doi.org/10.1021/acs.jctc.6b01141" title="DOI URL">https://doi.org/10.1021/acs.jctc.6b01141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.6b01141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.6b01141%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DAcylguanidine%252BBeta%252BSecretase%252B1%252BInhibitors%25253A%252BA%252BCombined%252BExperimental%252Band%252BFree%252BEnergy%252BPerturbation%252BStudy%26aulast%3DKer%25C3%25A4nen%26aufirst%3DHenrik%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D22112016%26date%3D03022017%26date%3D14032017%26date%3D19012017%26volume%3D13%26issue%3D3%26spage%3D1439%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Art D.  Bochevarov</span>, <span class="hlFld-ContribAuthor ">Mark A.  Watson</span>, and <span class="hlFld-ContribAuthor ">Jeremy R.  Greenwood</span>  , <span class="hlFld-ContribAuthor ">Dean M.  Philipp</span>  . </span><span class="cited-content_cbyCitation_article-title">Multiconformation, Density Functional Theory-Based pKa Prediction in Application to Large, Flexible Organic Molecules with Diverse Functional Groups. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2016,</strong> <em>12 </em>
                                    (12)
                                     , 6001-6019. <a href="https://doi.org/10.1021/acs.jctc.6b00805" title="DOI URL">https://doi.org/10.1021/acs.jctc.6b00805</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.6b00805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.6b00805%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DMulticonformation%25252C%252BDensity%252BFunctional%252BTheory-Based%252BpKa%252BPrediction%252Bin%252BApplication%252Bto%252BLarge%25252C%252BFlexible%252BOrganic%252BMolecules%252Bwith%252BDiverse%252BFunctional%252BGroups%26aulast%3DBochevarov%26aufirst%3DArt%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15082016%26date%3D29112016%26date%3D13122016%26date%3D10112016%26volume%3D12%26issue%3D12%26spage%3D6001%26epage%3D6019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jack D.  Scott</span>, <span class="hlFld-ContribAuthor ">Sarah W.  Li</span>, <span class="hlFld-ContribAuthor ">Andrew P. J.  Brunskill</span>, <span class="hlFld-ContribAuthor ">Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Kathleen  Cox</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, <span class="hlFld-ContribAuthor ">Mark  Forman</span>, <span class="hlFld-ContribAuthor ">Eric J.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Robert A.  Hodgson</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Qin  Jiang</span>, <span class="hlFld-ContribAuthor ">Ulrich  Iserloh</span>, <span class="hlFld-ContribAuthor ">Irina  Kazakevich</span>, <span class="hlFld-ContribAuthor ">Reshma  Kuvelkar</span>, <span class="hlFld-ContribAuthor ">Hong  Mei</span>, <span class="hlFld-ContribAuthor ">John  Meredith</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Misiaszek</span>, <span class="hlFld-ContribAuthor ">Peter  Orth</span>, <span class="hlFld-ContribAuthor ">Lana M.  Rossiter</span>, <span class="hlFld-ContribAuthor ">Meagan  Slater</span>, <span class="hlFld-ContribAuthor ">Julie  Stone</span>, <span class="hlFld-ContribAuthor ">Corey O.  Strickland</span>, <span class="hlFld-ContribAuthor ">Johannes H.  Voigt</span>, <span class="hlFld-ContribAuthor ">Ganfeng  Wang</span>, <span class="hlFld-ContribAuthor ">Hongwu  Wang</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">William J.  Greenlee</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, and <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10435-10450. <a href="https://doi.org/10.1021/acs.jmedchem.6b00307" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252B3-Imino-1%25252C2%25252C4-thiadiazinane%252B1%25252C1-Dioxide%252BDerivative%252BVerubecestat%252B%252528MK-8931%252529%2525E2%252580%252593A%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DScott%26aufirst%3DJack%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26022016%26date%3D18112016%26date%3D08122016%26volume%3D59%26issue%3D23%26spage%3D10435%26epage%3D10450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mihirbaran  Mandal</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Misiaszek</span>, <span class="hlFld-ContribAuthor ">Guoqing  Li</span>, <span class="hlFld-ContribAuthor ">Alexei  Buevich</span>, <span class="hlFld-ContribAuthor ">John P.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Xiaoxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Robert D.  Mazzola</span>, <span class="hlFld-ContribAuthor ">Peter  Orth</span>, <span class="hlFld-ContribAuthor ">Corey  Strickland</span>, <span class="hlFld-ContribAuthor ">Johannes  Voigt</span>, <span class="hlFld-ContribAuthor ">Hongwu  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Michael  Grzelak</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Reshma  Kuvelkar</span>, <span class="hlFld-ContribAuthor ">Prescott T.  Leach</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Maria S.  Michener</span>, <span class="hlFld-ContribAuthor ">Brad  Smith</span>, <span class="hlFld-ContribAuthor ">Kathleen  Cox</span>, <span class="hlFld-ContribAuthor ">Diane  Grotz</span>, <span class="hlFld-ContribAuthor ">Leonard  Favreau</span>, <span class="hlFld-ContribAuthor ">Kaushik  Mitra</span>, <span class="hlFld-ContribAuthor ">Irina  Kazakevich</span>, <span class="hlFld-ContribAuthor ">Brian A.  McKittrick</span>, <span class="hlFld-ContribAuthor ">William  Greenlee</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, and <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 3231-3248. <a href="https://doi.org/10.1021/acs.jmedchem.5b01995" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01995</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01995%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252Ban%252BIminoheterocyclic%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE%252529%252BInhibitor%252Bthat%252BLowers%252BCentral%252BA%2525CE%2525B2%252Bin%252BNonhuman%252BPrimates%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D23122015%26date%3D22032016%26date%3D14042016%26date%3D03032016%26volume%3D59%26issue%3D7%26spage%3D3231%26epage%3D3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik J. R.  Rombouts</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Oscar  Delgado</span>, <span class="hlFld-ContribAuthor ">Carolina  Martínez-Lamenca</span>, <span class="hlFld-ContribAuthor ">Michiel  Van Gool</span>, <span class="hlFld-ContribAuthor ">Aránzazu  García-Molina</span>, <span class="hlFld-ContribAuthor ">Sergio A.  Alonso de Diego</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Hana  Prokopcova</span>, <span class="hlFld-ContribAuthor ">José Manuel  Alonso</span>, <span class="hlFld-ContribAuthor ">Nigel  Austin</span>, <span class="hlFld-ContribAuthor ">Herman  Borghys</span>, <span class="hlFld-ContribAuthor ">Sven  Van Brandt</span>, <span class="hlFld-ContribAuthor ">Michel  Surkyn</span>, <span class="hlFld-ContribAuthor ">Michel  De Cleyn</span>, <span class="hlFld-ContribAuthor ">Ann  Vos</span>, <span class="hlFld-ContribAuthor ">Richard  Alexander</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, <span class="hlFld-ContribAuthor ">Dieder  Moechars</span>, <span class="hlFld-ContribAuthor ">Harrie  Gijsen</span>, and <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>  . </span><span class="cited-content_cbyCitation_article-title">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (20)
                                     , 8216-8235. <a href="https://doi.org/10.1021/acs.jmedchem.5b01101" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C4-Oxazine%252B%2525CE%2525B2-Secretase%252B1%252B%252528BACE1%252529%252BInhibitors%25253A%252BFrom%252BHit%252BGeneration%252Bto%252BOrally%252BBioavailable%252BBrain%252BPenetrant%252BLeads%26aulast%3DRombouts%26aufirst%3DFrederik%2BJ.%2BR.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D14072015%26date%3D10102015%26date%3D22102015%26date%3D17092015%26volume%3D58%26issue%3D20%26spage%3D8216%26epage%3D8235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Geschwindner</span>, <span class="hlFld-ContribAuthor ">Johan  Ulander</span>, and <span class="hlFld-ContribAuthor ">Patrik  Johansson</span>  . </span><span class="cited-content_cbyCitation_article-title">Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (16)
                                     , 6321-6335. <a href="https://doi.org/10.1021/jm501511f" title="DOI URL">https://doi.org/10.1021/jm501511f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501511f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501511f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLigand%252BBinding%252BThermodynamics%252Bin%252BDrug%252BDiscovery%25253A%252BStill%252Ba%252BHot%252BTip%25253F%26aulast%3DGeschwindner%26aufirst%3DStefan%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D01102014%26date%3D11052015%26date%3D27082015%26date%3D27042015%26volume%3D58%26issue%3D16%26spage%3D6321%26epage%3D6335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Beck</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Butler</span>, <span class="hlFld-ContribAuthor ">Gabriela  Barreiro</span>, <span class="hlFld-ContribAuthor ">Eric F.  Johnson</span>, <span class="hlFld-ContribAuthor ">David  Riddell</span>, <span class="hlFld-ContribAuthor ">Kevin  Parris</span>, <span class="hlFld-ContribAuthor ">Charles E.  Nolan</span>, <span class="hlFld-ContribAuthor ">Ying  Fan</span>, <span class="hlFld-ContribAuthor ">Kevin  Atchison</span>, <span class="hlFld-ContribAuthor ">Cathleen  Gonzales</span>, <span class="hlFld-ContribAuthor ">Ashley E.  Robshaw</span>, <span class="hlFld-ContribAuthor ">Shawn D.  Doran</span>, <span class="hlFld-ContribAuthor ">Mark W.  Bundesmann</span>, <span class="hlFld-ContribAuthor ">Leanne  Buzon</span>, <span class="hlFld-ContribAuthor ">Jason  Dutra</span>, <span class="hlFld-ContribAuthor ">Kevin  Henegar</span>, <span class="hlFld-ContribAuthor ">Erik  LaChapelle</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>, <span class="hlFld-ContribAuthor ">Bruce N.  Rogers</span>, <span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>, <span class="hlFld-ContribAuthor ">Ricardo  Lira</span>, <span class="hlFld-ContribAuthor ">Luis  Martinez-Alsina</span>, <span class="hlFld-ContribAuthor ">Peter  Mikochik</span>, <span class="hlFld-ContribAuthor ">John C.  Murray</span>, <span class="hlFld-ContribAuthor ">Kevin  Ogilvie</span>, <span class="hlFld-ContribAuthor ">Loren  Price</span>, <span class="hlFld-ContribAuthor ">Subas M.  Sakya</span>, <span class="hlFld-ContribAuthor ">Aijia  Yu</span>, <span class="hlFld-ContribAuthor ">Yong  Zhang</span>, and <span class="hlFld-ContribAuthor ">Brian T.  O’Neill</span>  . </span><span class="cited-content_cbyCitation_article-title">Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug–Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (7)
                                     , 3223-3252. <a href="https://doi.org/10.1021/acs.jmedchem.5b00191" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUtilizing%252BStructures%252Bof%252BCYP2D6%252Band%252BBACE1%252BComplexes%252BTo%252BReduce%252BRisk%252Bof%252BDrug%2525E2%252580%252593Drug%252BInteractions%252Bwith%252Ba%252BNovel%252BSeries%252Bof%252BCentrally%252BEfficacious%252BBACE1%252BInhibitors%26aulast%3DBrodney%26aufirst%3DMichael%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D02022015%26date%3D01042015%26date%3D09042015%26date%3D17032015%26volume%3D58%26issue%3D7%26spage%3D3223%26epage%3D3252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">James  Brown</span>, <span class="hlFld-ContribAuthor ">Ted C.  Judd</span>, <span class="hlFld-ContribAuthor ">Patricia  Lopez</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Qian</span>, <span class="hlFld-ContribAuthor ">Timothy S.  Powers</span>, <span class="hlFld-ContribAuthor ">Jian Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Robert T.  Dunn, II</span>, <span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Scott  Harried</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Yi  Luo</span>, <span class="hlFld-ContribAuthor ">Ana Elena  Minatti</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Hugo M.  Vargas</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Xiao Mei  Zheng</span>, and <span class="hlFld-ContribAuthor ">Stephen  Wood</span>  . </span><span class="cited-content_cbyCitation_article-title">An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (2)
                                     , 210-215. <a href="https://doi.org/10.1021/ml500458t" title="DOI URL">https://doi.org/10.1021/ml500458t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500458t%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAn%252BOrally%252BAvailable%252BBACE1%252BInhibitor%252BThat%252BAffords%252BRobust%252BCNS%252BA%2525CE%2525B2%252BReduction%252Bwithout%252BCardiovascular%252BLiabilities%26aulast%3DCheng%26aufirst%3DYuan%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D06112014%26date%3D29122014%26date%3D07012015%26date%3D12022015%26date%3D29122014%26volume%3D6%26issue%3D2%26spage%3D210%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwangseo  Park</span>, <span class="hlFld-ContribAuthor ">Yongje  Shin</span>, <span class="hlFld-ContribAuthor ">Hyeonjeong  Choe</span>, and <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>  . </span><span class="cited-content_cbyCitation_article-title">Computational Design and Discovery of Nanomolar Inhibitors of IκB Kinase β. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2015,</strong> <em>137 </em>
                                    (1)
                                     , 337-348. <a href="https://doi.org/10.1021/ja510636t" title="DOI URL">https://doi.org/10.1021/ja510636t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja510636t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja510636t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DComputational%252BDesign%252Band%252BDiscovery%252Bof%252BNanomolar%252BInhibitors%252Bof%252BI%2525CE%2525BAB%252BKinase%252B%2525CE%2525B2%26aulast%3DPark%26aufirst%3DHwangseo%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D16102014%26date%3D02012015%26date%3D14012015%26date%3D16122014%26volume%3D137%26issue%3D1%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jenny  Viklund</span>, <span class="hlFld-ContribAuthor ">Karin  Kolmodin</span>, <span class="hlFld-ContribAuthor ">Gunnar  Nordvall</span>, <span class="hlFld-ContribAuthor ">Britt-Marie  Swahn</span>, <span class="hlFld-ContribAuthor ">Mats  Svensson</span>, <span class="hlFld-ContribAuthor ">Ylva  Gravenfors</span>, and <span class="hlFld-ContribAuthor ">Fredrik  Rahm</span>  . </span><span class="cited-content_cbyCitation_article-title">Creation of Novel Cores for β-Secretase (BACE-1) Inhibitors: A Multiparameter Lead Generation Strategy. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (4)
                                     , 440-445. <a href="https://doi.org/10.1021/ml5000433" title="DOI URL">https://doi.org/10.1021/ml5000433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5000433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5000433%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCreation%252Bof%252BNovel%252BCores%252Bfor%252B%2525CE%2525B2-Secretase%252B%252528BACE-1%252529%252BInhibitors%25253A%252BA%252BMultiparameter%252BLead%252BGeneration%252BStrategy%26aulast%3DViklund%26aufirst%3DJenny%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D29012014%26date%3D03022014%26date%3D10022014%26date%3D10042014%26date%3D03022014%26volume%3D5%26issue%3D4%26spage%3D440%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Roos</span>, <span class="hlFld-ContribAuthor ">Jenny  Viklund</span>, <span class="hlFld-ContribAuthor ">Johan  Meuller</span>, <span class="hlFld-ContribAuthor ">Karin  Kaspersson</span>, and <span class="hlFld-ContribAuthor ">Mats  Svensson</span>  . </span><span class="cited-content_cbyCitation_article-title">Potency Prediction of β-Secretase (BACE-1) Inhibitors Using Density Functional Methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (3)
                                     , 818-825. <a href="https://doi.org/10.1021/ci400374z" title="DOI URL">https://doi.org/10.1021/ci400374z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400374z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400374z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPotency%252BPrediction%252Bof%252B%2525CE%2525B2-Secretase%252B%252528BACE-1%252529%252BInhibitors%252BUsing%252BDensity%252BFunctional%252BMethods%26aulast%3DRoos%26aufirst%3DKatarina%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D28062013%26date%3D24022014%26date%3D24032014%26date%3D23012014%26volume%3D54%26issue%3D3%26spage%3D818%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thai-Son  Tran</span>, <span class="hlFld-ContribAuthor ">Minh-Tri  Le</span>, <span class="hlFld-ContribAuthor ">Thi-Cam-Vi  Nguyen</span>, <span class="hlFld-ContribAuthor ">The-Huan  Tran</span>, <span class="hlFld-ContribAuthor ">Thanh-Dao  Tran</span>, <span class="hlFld-ContribAuthor ">Khac-Minh  Thai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, In Silico and In Vitro Evaluation for Acetylcholinesterase and BACE-1 Inhibitory Activity of Some N-Substituted-4-Phenothiazine-Chalcones. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (17)
                                     , 3916. <a href="https://doi.org/10.3390/molecules25173916" title="DOI URL">https://doi.org/10.3390/molecules25173916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25173916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25173916%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BIn%252BSilico%252Band%252BIn%252BVitro%252BEvaluation%252Bfor%252BAcetylcholinesterase%252Band%252BBACE-1%252BInhibitory%252BActivity%252Bof%252BSome%252BN-Substituted-4-Phenothiazine-Chalcones%26aulast%3DTran%26aufirst%3DThai-Son%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D17%26spage%3D3916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thai-Son  Tran</span>, <span class="hlFld-ContribAuthor ">Minh-Tri  Le</span>, <span class="hlFld-ContribAuthor ">Thanh-Dao  Tran</span>, <span class="hlFld-ContribAuthor ">The-Huan  Tran</span>, <span class="hlFld-ContribAuthor ">Khac-Minh  Thai</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Curcumin and Flavonoid Derivatives with Acetylcholinesterase and Beta-Secretase Inhibitory Activities Using in Silico Approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (16)
                                     , 3644. <a href="https://doi.org/10.3390/molecules25163644" title="DOI URL">https://doi.org/10.3390/molecules25163644</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25163644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25163644%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%252Bof%252BCurcumin%252Band%252BFlavonoid%252BDerivatives%252Bwith%252BAcetylcholinesterase%252Band%252BBeta-Secretase%252BInhibitory%252BActivities%252BUsing%252Bin%252BSilico%252BApproaches%26aulast%3DTran%26aufirst%3DThai-Son%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D16%26spage%3D3644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aldo  Peschiulli</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ann  Vos</span>, <span class="hlFld-ContribAuthor ">Harrie JM  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (8)
                                     , 126999. <a href="https://doi.org/10.1016/j.bmcl.2020.126999" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126999%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3%25252C3-Difluoro-3%25252C4%25252C5%25252C6-tetrahydropyridin-2-amines%25253A%252BPotent%252Band%252Bpermeable%252BBACE-1%252Binhibitors%26aulast%3DPeschiulli%26aufirst%3DAldo%26date%3D2020%26volume%3D30%26issue%3D8%26spage%3D126999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiwei  Zhu</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Fiedler</span>, <span class="hlFld-ContribAuthor ">Matthew L.  Hibert</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a carbon-11 radiolabeled BACE1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (2)
                                     , 262-267. <a href="https://doi.org/10.1007/s00044-019-02480-9" title="DOI URL">https://doi.org/10.1007/s00044-019-02480-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02480-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02480-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Bof%252Ba%252Bcarbon-11%252Bradiolabeled%252BBACE1%252Binhibitor%26aulast%3DZhu%26aufirst%3DYiwei%26date%3D2020%26date%3D2019%26volume%3D29%26issue%3D2%26spage%3D262%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francisco Javier  Pérez-Areales</span>, <span class="hlFld-ContribAuthor ">Nibal  Betari</span>, <span class="hlFld-ContribAuthor ">Antonio  Viayna</span>, <span class="hlFld-ContribAuthor ">Caterina  Pont</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">José Fernando  Rinaldi Alvarenga</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Lamuela-Raventós</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Francisco Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein–huprine hybrids. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (10)
                                     , 965-981. <a href="https://doi.org/10.4155/fmc-2017-0049" title="DOI URL">https://doi.org/10.4155/fmc-2017-0049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0049%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bmultitarget%252Bbiological%252Bprofiling%252Bof%252Bsecond-generation%252Banti-Alzheimer%252Brhein%2525E2%252580%252593huprine%252Bhybrids%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DFrancisco%2BJavier%26date%3D2017%26volume%3D9%26issue%3D10%26spage%3D965%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">H.J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 326-383. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13809-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13809-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B2-Secretase%252B%252528BACE%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D326%26epage%3D383%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J  Romero-Durán</span>, <span class="hlFld-ContribAuthor ">Edgar  Lopez-Castro</span>, <span class="hlFld-ContribAuthor ">Xerardo  García-Mera</span>, <span class="hlFld-ContribAuthor ">Humberto  Gonzalez-Díaz</span>. </span><span class="cited-content_cbyCitation_article-title">High-Order Perturbation Theory Models of Drug-Target Interactomes for Proteins Expressed on Networks of Hippocampus Brain Region of Alzheimer Disease Patients. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 269-299. <a href="https://doi.org/10.1201/9781315368863-12" title="DOI URL">https://doi.org/10.1201/9781315368863-12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1201/9781315368863-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1201%2F9781315368863-12%26sid%3Dliteratum%253Aachs%26atitle%3DHigh-Order%252BPerturbation%252BTheory%252BModels%252Bof%252BDrug-Target%252BInteractomes%252Bfor%252BProteins%252BExpressed%252Bon%252BNetworks%252Bof%252BHippocampus%252BBrain%252BRegion%252Bof%252BAlzheimer%252BDisease%252BPatients%26aulast%3DRomero-Dur%25C3%25A1n%26aufirst%3DJ%26date%3D2016%26date%3D2017%26spage%3D269%26epage%3D299%26pub%3DCRC%2520Press%26atitle%3DBiopolymers%252Bfor%252BMedical%252BApplications%26aulast%3DRuso%26aufirst%3DJuan%26date%3D2016%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dirk  Weigelt</span>, <span class="hlFld-ContribAuthor ">Ismet  Dorange</span>. </span><span class="cited-content_cbyCitation_article-title">Lead Generation Based on Compound Collection Screening. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 93-132. <a href="https://doi.org/10.1002/9783527677047.ch05" title="DOI URL">https://doi.org/10.1002/9783527677047.ch05</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527677047.ch05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527677047.ch05%26sid%3Dliteratum%253Aachs%26atitle%3DLead%252BGeneration%252BBased%252Bon%252BCompound%252BCollection%252BScreening%26aulast%3DWeigelt%26aufirst%3DDirk%26date%3D2016%26date%3D2016%26spage%3D93%26epage%3D132%26pub%3DWiley%26atitle%3DLead%252BGeneration%26aulast%3DHolenz%26aufirst%3DJ%25C3%25B6rg%26date%3D2016%26date%3D2016%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel K.  Chambers</span>, <span class="hlFld-ContribAuthor ">Tanweer A.  Khan</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Brad E.  Sleebs</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amino heterocycle aspartyl protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (22)
                                     , 4970-4985. <a href="https://doi.org/10.1039/C5OB01842K" title="DOI URL">https://doi.org/10.1039/C5OB01842K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB01842K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB01842K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bamino%252Bheterocycle%252Baspartyl%252Bprotease%252Binhibitors%26aulast%3DChambers%26aufirst%3DRachel%2BK.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D22%26spage%3D4970%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Mateu</span>, <span class="hlFld-ContribAuthor ">Myriam  Ciordia</span>, <span class="hlFld-ContribAuthor ">Oscar  Delgado</span>, <span class="hlFld-ContribAuthor ">María  Sánchez-Roselló</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Michiel  Van Gool</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Santos  Fustero</span>. </span><span class="cited-content_cbyCitation_article-title">A Versatile Approach to CF
              3
              -Containing 2-Pyrrolidones by Tandem Michael Addition-Cyclization: Exemplification in the Synthesis of Amidine Class BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2015,</strong> <em>21 </em>
                                    (33)
                                     , 11719-11726. <a href="https://doi.org/10.1002/chem.201501662" title="DOI URL">https://doi.org/10.1002/chem.201501662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201501662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201501662%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DA%252BVersatile%252BApproach%252Bto%252BCF%252B3%252B-Containing%252B2-Pyrrolidones%252Bby%252BTandem%252BMichael%252BAddition-Cyclization%25253A%252BExemplification%252Bin%252Bthe%252BSynthesis%252Bof%252BAmidine%252BClass%252BBACE1%252BInhibitors%26aulast%3DMateu%26aufirst%3DNatalia%26date%3D2015%26date%3D2015%26volume%3D21%26issue%3D33%26spage%3D11719%26epage%3D11726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyong  Ma</span>, <span class="hlFld-ContribAuthor ">Hailong  Liu</span>, <span class="hlFld-ContribAuthor ">Chunchun  Zhang</span>, <span class="hlFld-ContribAuthor ">Xueli  Zheng</span>, <span class="hlFld-ContribAuthor ">Maolian  Yuan</span>, <span class="hlFld-ContribAuthor ">Haiyan  Fu</span>, <span class="hlFld-ContribAuthor ">Ruixiang  Li</span>, <span class="hlFld-ContribAuthor ">Hua  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Synthesis of Symmetrical 2,6-Diarylpyridines
              via
              Palladium/Copper-Catalyzed Sequential Decarboxylative and Direct CH Arylation. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2015,</strong> <em>357 </em>
                                    (6)
                                     , 1143-1148. <a href="https://doi.org/10.1002/adsc.201400900" title="DOI URL">https://doi.org/10.1002/adsc.201400900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201400900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201400900%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DOne-Pot%252BSynthesis%252Bof%252BSymmetrical%252B2%25252C6-Diarylpyridines%252Bvia%252BPalladium%25252FCopper-Catalyzed%252BSequential%252BDecarboxylative%252Band%252BDirect%252BC%2525EF%2525A3%2525BFH%252BArylation%26aulast%3DMa%26aufirst%3DZhiyong%26date%3D2015%26date%3D2015%26volume%3D357%26issue%3D6%26spage%3D1143%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esteban Gabriel  Vega-Hissi</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Tosso</span>, <span class="hlFld-ContribAuthor ">Ricardo Daniel  Enriz</span>, <span class="hlFld-ContribAuthor ">Lucas Joel  Gutierrez</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular insight into the interaction mechanisms of amino-2
              H
              -imidazole derivatives with BACE1 protease: A QM/MM and QTAIM study. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Quantum Chemistry</span><span> <strong>2015,</strong> <em>115 </em>
                                    (6)
                                     , 389-397. <a href="https://doi.org/10.1002/qua.24854" title="DOI URL">https://doi.org/10.1002/qua.24854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/qua.24854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fqua.24854%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Quantum%2520Chemistry%26atitle%3DMolecular%252Binsight%252Binto%252Bthe%252Binteraction%252Bmechanisms%252Bof%252Bamino-2%252BH%252B-imidazole%252Bderivatives%252Bwith%252BBACE1%252Bprotease%25253A%252BA%252BQM%25252FMM%252Band%252BQTAIM%252Bstudy%26aulast%3DVega-Hissi%26aufirst%3DEsteban%2BGabriel%26date%3D2015%26date%3D2014%26volume%3D115%26issue%3D6%26spage%3D389%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lixia  Liu</span>, <span class="hlFld-ContribAuthor ">Huailin  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">[HCo(CO)
              4
              ]-Catalyzed Three-component Cycloaddition of Epoxides, Imines, and Carbon Monoxide: Facile Construction of 1,3-Oxazinan-4-ones. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2014,</strong> <em>126 </em>
                                    (37)
                                     , 10023-10027. <a href="https://doi.org/10.1002/ange.201403998" title="DOI URL">https://doi.org/10.1002/ange.201403998</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201403998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201403998%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3D%25255BHCo%252528CO%252529%252B4%252B%25255D-Catalyzed%252BThree-component%252BCycloaddition%252Bof%252BEpoxides%25252C%252BImines%25252C%252Band%252BCarbon%252BMonoxide%25253A%252BFacile%252BConstruction%252Bof%252B1%25252C3-Oxazinan-4-ones%26aulast%3DLiu%26aufirst%3DLixia%26date%3D2014%26date%3D2014%26volume%3D126%26issue%3D37%26spage%3D10023%26epage%3D10027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lixia  Liu</span>, <span class="hlFld-ContribAuthor ">Huailin  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">[HCo(CO)
              4
              ]-Catalyzed Three-component Cycloaddition of Epoxides, Imines, and Carbon Monoxide: Facile Construction of 1,3-Oxazinan-4-ones. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2014,</strong> <em>53 </em>
                                    (37)
                                     , 9865-9869. <a href="https://doi.org/10.1002/anie.201403998" title="DOI URL">https://doi.org/10.1002/anie.201403998</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201403998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201403998%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3D%25255BHCo%252528CO%252529%252B4%252B%25255D-Catalyzed%252BThree-component%252BCycloaddition%252Bof%252BEpoxides%25252C%252BImines%25252C%252Band%252BCarbon%252BMonoxide%25253A%252BFacile%252BConstruction%252Bof%252B1%25252C3-Oxazinan-4-ones%26aulast%3DLiu%26aufirst%3DLixia%26date%3D2014%26date%3D2014%26volume%3D53%26issue%3D37%26spage%3D9865%26epage%3D9869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pakornwit  Sarnpitak</span>, <span class="hlFld-ContribAuthor ">Prashant  Mujumdar</span>, <span class="hlFld-ContribAuthor ">Christophe  Morisseau</span>, <span class="hlFld-ContribAuthor ">Sung Hee  Hwang</span>, <span class="hlFld-ContribAuthor ">Bruce  Hammock</span>, <span class="hlFld-ContribAuthor ">Vladimir  Iurchenko</span>, <span class="hlFld-ContribAuthor ">Sergey  Zozulya</span>, <span class="hlFld-ContribAuthor ">Antonis  Gavalas</span>, <span class="hlFld-ContribAuthor ">Athina  Geronikaki</span>, <span class="hlFld-ContribAuthor ">Yan  Ivanenkov</span>, <span class="hlFld-ContribAuthor ">Mikhail  Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>84 </em>, 160-172. <a href="https://doi.org/10.1016/j.ejmech.2014.07.023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252Borally%252Bavailable%25252C%252Bselective%252BCOX-2%252Binhibitors%252Bbased%252Bon%252B2-imidazoline%252Bcore%26aulast%3DSarnpitak%26aufirst%3DPakornwit%26date%3D2014%26volume%3D84%26spage%3D160%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Hana  Prokopcova</span>, <span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (9)
                                     , 2033-2045. <a href="https://doi.org/10.1016/j.bmcl.2014.03.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.03.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bevolution%252Bof%252Bamidine-based%252Bbrain%252Bpenetrant%252BBACE1%252Binhibitors%26aulast%3DOehlrich%26aufirst%3DDaniel%26date%3D2014%26volume%3D24%26issue%3D9%26spage%3D2033%26epage%3D2045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maged M.  Henary</span>, <span class="hlFld-ContribAuthor ">Tyler L.  Dost</span>, <span class="hlFld-ContribAuthor ">Eric A.  Owens</span>, <span class="hlFld-ContribAuthor ">Surendra Reddy  Punganuru</span>. </span><span class="cited-content_cbyCitation_article-title">Combining BACE1 Inhibition with Metal Chelation as Possible Therapy for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 547-565. <a href="https://doi.org/10.1016/B978-0-12-803959-5.50011-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-803959-5.50011-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803959-5.50011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803959-5.50011-8%26sid%3Dliteratum%253Aachs%26atitle%3DCombining%252BBACE1%252BInhibition%252Bwith%252BMetal%252BChelation%252Bas%252BPossible%252BTherapy%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHenary%26aufirst%3DMaged%2BM.%26date%3D2014%26spage%3D547%26epage%3D565%26pub%3DElsevier%26atitle%3DDrug%252BDesign%252Band%252BDiscovery%252Bin%252BAlzheimer%252527s%252BDisease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabian  Brockmeyer</span>, <span class="hlFld-ContribAuthor ">Robin  Schoemaker</span>, <span class="hlFld-ContribAuthor ">Marc  Schmidtmann</span>, <span class="hlFld-ContribAuthor ">Jürgen  Martens</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent reaction for the first synthesis of 2,2-dialkyl- and 2-alkyl-2-aralkyl-5,6-diaryl-2H-1,3-thiazines as scaffolds for various 3,4-dihydro-2H-1,3-thiazine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (28)
                                     , 5168-5181. <a href="https://doi.org/10.1039/C4OB00866A" title="DOI URL">https://doi.org/10.1039/C4OB00866A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB00866A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB00866A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DMulticomponent%252Breaction%252Bfor%252Bthe%252Bfirst%252Bsynthesis%252Bof%252B2%25252C2-dialkyl-%252Band%252B2-alkyl-2-aralkyl-5%25252C6-diaryl-2H-1%25252C3-thiazines%252Bas%252Bscaffolds%252Bfor%252Bvarious%252B3%25252C4-dihydro-2H-1%25252C3-thiazine%252Bderivatives%26aulast%3DBrockmeyer%26aufirst%3DFabian%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D28%26spage%3D5168%26epage%3D5181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">ShouYi  Xuan</span>, <span class="hlFld-ContribAuthor ">Hu  Liang</span>, <span class="hlFld-ContribAuthor ">Zhi  Wang</span>, <span class="hlFld-ContribAuthor ">AiXia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Classification of blocker and non-blocker of hERG potassium ion channel using a support vector machine. </span><span class="cited-content_cbyCitation_journal-name">Science China Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (10)
                                     , 1413-1423. <a href="https://doi.org/10.1007/s11426-013-4946-1" title="DOI URL">https://doi.org/10.1007/s11426-013-4946-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11426-013-4946-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11426-013-4946-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520China%2520Chemistry%26atitle%3DClassification%252Bof%252Bblocker%252Band%252Bnon-blocker%252Bof%252BhERG%252Bpotassium%252Bion%252Bchannel%252Busing%252Ba%252Bsupport%252Bvector%252Bmachine%26aulast%3DXuan%26aufirst%3DShouYi%26date%3D2013%26date%3D2013%26volume%3D56%26issue%3D10%26spage%3D1413%26epage%3D1423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0033.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of five amidine or guanidine core structures developed into lead series.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21">(13-21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Amidine substructure with the “core” indicated on green background (A = any atom). The R1 and R2 substituents (and a phenyl group) added to each core were selected to allow for match pair analyses.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The R2-substituent in the meta position is a common feature of known BACE-1 inhibitors for reaching into the S3 subpocket of the active site.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Core structures representing the compounds included in this report, divided into four structural subgroups: <b>A</b>, six-membered bicyclic cores; <b>B</b>, six-membered monocyclic cores; <b>C</b>, five-membered bicyclic cores; <b>D</b>, five-membered monocyclic cores. <b>B-ref</b> represents a compound that has reached clinical phase I studies.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> During this work, five of the cores (<b>A-3</b>, <b>B-1</b>, <b>B-2</b>, <b>B-3</b>, and <b>C-1</b>) were independently published by others.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Core Subtypes <b>A-1</b> and <b>A-2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>p</i>-toluenesulfonic acid monohydrate, toluene, reflux, Dean–Stark; (b) P<sub>2</sub>S<sub>5</sub>, pyridine, 120 °C; (c) NH<sub>3</sub> (7 M in MeOH), <i>t</i>-BuOOH (aq) (70%); (d) PCl<sub>5</sub>, POCl<sub>3</sub>, 50 °C; (e) MeONH<sub>3</sub>Cl, DIPEA, DMF, 90 °C; (f) zinc, AcOH, rt; (g) pyrimidine-5-ylboronic acid or pyridine-3-ylboronic acid, bis(triphenylphosphine)palladium(II) chloride, Na<sub>2</sub>CO<sub>3</sub> (1 M aq), DME/H<sub>2</sub>O (2:1), 80 °C.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>11a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) standard Suzuki–Miyaura conditions using the corresponding boronic acid, a source of palladium(II), and a base. The reaction was run in an aqueous solvent mixture at 80 °C.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>11a</b>, NH<sub>3</sub> (7 M in MeOH), 150 °C; (b) P<sub>2</sub>S<sub>5</sub>, pyridine, 120 °C; (c) NH<sub>3</sub> (7 M in MeOH), 90 °C.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Core Subtype <b>B-1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-hydroxypropanamide, pTSA, toluene, reflux, Dean–Stark; (b) P<sub>2</sub>S<sub>5</sub>, HMDO, 1,2-dichloroethane, 110 °C; (c) NH<sub>3</sub> (7 M in MeOH), 40 °C; (d) 3-methoxyphenylboronic acid or 3-chlorophenylboronic acid, [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloride dichloromethane complex, cesium carbonate, DME/H<sub>2</sub>O/EtOH (6:3:1), 120 °C.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Core Subtype <b>B-2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ammonium hydroxide 25%, rt; (b) <b>11a</b> or <b>11b</b>, pTSA, toluene, reflux, Dean–Stark; (c) P<sub>2</sub>S<sub>5</sub>, HMDO, 1,2-dichloroethane, 110 °C; (d) NH<sub>3</sub> (7 M in MeOH), rt.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compound <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, EtOH, 70 °C; (b) Ba(OH)<sub>2</sub>, water, 150 °C; (c) NaBH<sub>4</sub>, I<sub>2</sub>, THF, 0 °C to reflux; (d) (1) chloroacetyl chloride, DIPEA, THF, 0 °C to rt, (2) KOH, water, rt to 60 °C; (e) P<sub>2</sub>S<sub>5</sub>, HMDO, 100 °C; (f) NH<sub>3</sub> (7 M in MeOH), 40 °C.</p></p></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) chlorosulfonic acid, Et<sub>2</sub>O, rt; (b) NaOH (aq), toluene, reflux; (c) methyl 2-mercaptoacetate, DIPEA, DMF, 60 °C; (d) P<sub>2</sub>S<sub>5</sub>, HMDO, 100 °C; (e) NH<sub>3</sub> (7 M in MeOH), 50 °C.</p></p></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compound <b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) vinylmagnesium bromide, 2-Me-THF, −78 °C to rt; (b) thiourea, HCl, AcOH, 45 °C; (c) MeSO<sub>3</sub>H, TFA, rt.</p></p></figure><figure data-id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Compound <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-methyl-2-propanesulfinamide, titanium(IV) ethoxide, 2-Me-THF, reflux; (b) (1) 2-methyl-1,3-thiazole-4-carbonitrile, 2,2,6,6-tetramethylpiperidineylmagnesium chloride, lithium chloride (1 M in toluene/THF), THF, −25 °C to rt; (2) HCl (1 M in Et<sub>2</sub>O), MeOH, rt; (c) pyrimidine-5-ylboronic acid, [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) chloride, K<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O/EtOH (6:3:1), 100 °C.</p></p></figure><figure data-id="sch10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Compound <b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride, isopropylmagnesium chloride (2 M in THF), 2-Me-THF, −30 °C; (b) 1,3-dibromobenzene, <i>n</i>-butyllithium (1.6 M in hexanes), 2-Me-THF, −78 to −30 °C; (c) 4-methoxyphenylmagnesium bromide (1 M in THF), copper(I) iodide, 2-Me-THF, 0 °C to rt; (d) thiourea, acetic acid, 100 °C; (e) pyrimidine-5-boronic acid, bis(triphenylphosphine)palladium(II) chloride, sodium carbonate (1 M aq), DME/H<sub>2</sub>O (2:1), 80 °C.</p></p></figure><figure data-id="sch11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0021.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Compounds (<i>R</i>*,<i>S</i>*)-<b>54</b> and (<i>R</i>*,<i>R</i>*)-<b>54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 7 M NH<sub>3</sub> in MeOH, 90 °C, 3 days, 99%; (b) DIPEA, THF/DMF (1:1), di-<i>tert</i>-butyl dicarbonate, rt, on, quant; (c) P<sub>2</sub>S<sub>5</sub>, HMDO, THF, 110 °C, 30 min, 71%; (d) 5 M HCl in <i>i</i>-PrOH, MeOH, rt, on, 67%; (e) 3′-bromoacetophenone (<b>1</b>), 7 M NH<sub>3</sub> in MeOH, 50 °C, on, 29%; (f) 5-fluoropyridin-3-ylboronic acid, cat. (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub>, sat. NaHCO<sub>3</sub>, DME/H<sub>2</sub>O (2:1), 80 °C, 1.5 h, (<i>3R*</i>,8a<i>S</i>*) 15% and (<i>3R*</i>,8a<i>R</i>*) 23%.</p></p></figure><figure data-id="sch12" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0022.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Synthesis of Compound <b>58</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>11b</b>, NH<sub>3</sub> (7 M in MeOH), 150 °C; (b) P<sub>2</sub>S<sub>5</sub>, pyridine, 120 °C; (c) NH<sub>3</sub> (7 M in MeOH), 60 °C.</p></p></figure><figure data-id="sch13" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0023.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Synthesis of Compound <b>64</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) pyridine-3-ylboronic acid, bis(triphenylphosphine)palladium(II) chloride, sodium carbonate (1 M aq), DME/H<sub>2</sub>O (2:1), 80 °C; (b) <i>n</i>-BuLi, 4-methoxybenzonitrile, Et<sub>2</sub>O, −78 °C to rt; (c) methyl 2-mercaptoacetate, dimethylamine hydrochloride, rt; (d) P<sub>2</sub>S<sub>5</sub>, pyridine, 120 °C; (e) NH<sub>3</sub> (7 M in MeOH), 60 °C.</p></p></figure><figure data-id="sch14" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0024.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Synthesis of Compound <b>71</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethylamine (70% in water), rt; (b) NaHCO<sub>3</sub> (aq), benzyl chloroformate, dioxane, 0 °C to rt; (c) P<sub>2</sub>S<sub>5</sub>, dioxane, 95 °C; (d) HBr (33% in AcOH), rt; (e) <b>11c</b>, NH<sub>3</sub> (7 M in MeOH), 60 °C.</p></p></figure><figure data-id="sch15" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0025.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 15. Synthesis of Compound <b>77</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaHCO<sub>3</sub> (aq), benzyl chloroformate, dioxane, 0 °C to rt; (b) P<sub>2</sub>S<sub>5</sub>, dioxane, 95 °C; (c) HBr (33% in AcOH), rt; (d) bromide <b>11b</b>, NH<sub>3</sub> (7 M in MeOH), rt; (e) (1) Ac<sub>2</sub>O, TEA, (2) NH<sub>3</sub> (7 M in MeOH).</p></p></figure><figure data-id="sch16" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0026.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 16. Synthesis of Compound <b>83</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch16"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaCN, acrylonitrile, MeCN, rt; (b) 1-bromo-4-methoxybenzene, <i>n</i>-BuLi, THF, −78 °C to 5 °C; (c) MsOH, 60 °C; (d) pyrimidine-5-ylboronic acid, bis(triphenylphosphine)palladium(II) chloride, sodium carbonate (1 M aq), DME/H<sub>2</sub>O (2:1), 80 °C; (e) (1) P<sub>2</sub>S<sub>5</sub>, pyridine, 120 °C, (2) NH<sub>3</sub> (7 M in MeOH), <i>t</i>-BuOOH (70%), rt.</p></p></figure><figure data-id="sch17" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0027.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 17. Synthesis of Compound <b>91</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch17"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) hydroxylamine hydrochloride, pyridine, MeOH, 50 °C; (b) DCC, DMSO, TFA, benzene, 0 °C to rt; (c) methyl acrylate, 150 °C; (d) H<sub>2</sub>SO<sub>4</sub>, MeOH, 60 °C; (e) Mo(CO)<sub>6</sub>, MeCN, water, reflux; (f) MeI, Ag<sub>2</sub>O, MeCN, 40 °C; (g) pyridin-3-ylboronic acid, tetrakis(triphenylphosphine)palladium, K<sub>2</sub>CO<sub>3</sub>, dioxane, water, 90 °C; (h) (1) P<sub>2</sub>S<sub>5</sub>, pyridine, 115 °C, (2) NH<sub>3</sub> (7 M in MeOH), <i>t</i>-BuOOH (70% in water), rt.</p></p></figure><figure data-id="sch18" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0028.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 18. Synthesis of Compound <b>98</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=sch18"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ac<sub>2</sub>O, TEA, DCM, 0 °C to rt; (b) NaH, toluene, reflux; (c) conc HCl, reflux; (d) Fmoc isothiocyanate, DCM, rt; (e) (1) NH<sub>3</sub> (7 M in MeOH), rt, (2) <i>t</i>-BuOOH (70%), rt; (f) 3-methoxyphenylboronic acid, bis(triphenylphosphine)palladium(II) chloride, sodium carbonate (1 M aq), DME/H<sub>2</sub>O (2:1), 80 °C.</p></p></figure><figure data-id="fig4" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. From a p<i>K</i><sub>a</sub> of 6 to a p<i>K</i><sub>a</sub> of 8.5, there was a linear correlation between p<i>K</i><sub>a</sub> and increase in potency, going from the enzymatic assay to the cell assay, where the potency difference is calculated as pIC<sub>50</sub>(cellular assay) – pIC<sub>50</sub>(TR-FRET). Data on previously published compounds are in agreement with these results (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compounds with monocyclic six-membered cores had the highest LEs, while compounds with five-membered cores reached the highest enzymatic activities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Crystal structures representing four of the cyclic amidine cores, in complex with BACE-1: (a) compound <b>19b</b>, 1.6 Å resolution; (b) compound <b>41</b>, 1.6 Å resolution; (c) compound <b>83</b>, 1.8 Å resolution; (d) compound <b>91</b>, 1.5 Å resolution. (e) Superimposition of a five- and six-membered core showing the angle difference for the R1 substituent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. An enrichment of highly hERG active compounds was observed in the area with high p<i>K</i><sub>a</sub> and eLogD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Overview of all compounds in this report. Overall permeability was compared to MW, p<i>K</i><sub>a</sub>, and eLogD .</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/medium/jm-2012-011349_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Matched pair analysis for compounds <b>24b</b>, <b>34</b>, and <b>37</b>, all belonging to core subtype <b>B</b> and containing one sulfur atom in the core structure. The asterisk (∗) indicates that the experimental p<i>K</i><sub>a</sub> was measured for compound <b>24a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm3011349/production/images/large/jm-2012-011349_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011349&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 71 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span> </span><span class="NLM_article-title">2012 Alzheimer’s disease facts and figures</span>.  <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.jalz.2012.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22404854" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=2012+Alzheimer%E2%80%99s+disease+facts+and+figures.+Alzheimer%27s+Dementia+2012%2C+8%2C+131%E2%80%93168."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.02.001%26sid%3Dliteratum%253Aachs%26atitle%3D2012%2520Alzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2012%26volume%3D8%26spage%3D131%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid deposition as the central event in the aetiology of Alzheimer’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+deposition+as+the+central+event+in+the+aetiology+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520deposition%2520as%2520the%2520central%2520event%2520in%2520the%2520aetiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0ljP2e24t7NPuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as β-secretase</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0ljP2e24t7NPuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520%25CE%25B2-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span><span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein β-secretase from human brain</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1038%2F990114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=10591214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1MXotFKlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=J.+P.+Andersonauthor=R.+Barbourauthor=G.+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=H.+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=V.+John&title=Purification+and+cloning+of+amyloid+precursor+protein+%CE%B2-secretase+from+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and cloning of amyloid precursor protein β-secretase from human brain</span></div><div class="casAuthors">Sinha, Sukanto; Anderson, John P.; Barbour, Robin; Basi, Guriqbal S.; Caccavello, Russell; Davis, David; Doan, Minhtam; Dovey, Harry F.; Frigon, Normand; Hong, Jin; Jacobson-Croak, Kirsten; Jewett, Nancy; Keim, Pamela; Knops, Jeroen; Lieberburg, Ivan; Power, Michael; Tan, Hua; Tatsuno, Gwen; Tung, Jay; Schenk, Dale; Seubert, Peter; Suomensaari, Susanna M.; Wang, Shuwen; Walker, Donald; Zhao, Jun; McConlogue, Lisa; John, Varghese</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">6761</span>),
    <span class="NLM_cas:pages">537-540</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Proteolytic processing of the amyloid precursor protein (APP) generates amyloid β (AP) peptide, which is thought to be causal for the pathol. and subsequent cognitive decline in Alzheimer's disease.  Cleavage by β-secretase at the amino terminus of the Aβ peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of β-cleaved sol. APP, and a corresponding cell-assocd. carboxy-terminal fragment.  Cleavage of the C-terminal fragment by γ-secretase(s) leads to the formation of Aβ.  The pathogenic mutation K670M671 → N670L671 at the β-secretase cleavage site in APP, which was discovered in a Swedish family with familial Alzheimer's disease, leads to increased β-secretase cleavage of the mutant substrate.  Here the authors describe a membrane-bound enzyme activity that cleaves full-length APP at the β-secretase cleavage site, and find it to be the predominant β-cleavage activity in human brain.  The authors have purified this enzyme activity to homogeneity from human brain using a new substrate analog inhibitor of the enzyme activity, and show that the purified enzyme has all the properties predicted for β-secretase.  Cloning and expression of the enzyme reveals that human brain β-secretase is a new membrane-bound aspartic proteinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDI4TZ3cM4orVg90H21EOLACvtfcHk0ljP2e24t7NPuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFKlsrc%253D&md5=819ccc5a27ec4c56128d6b6944878c42</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F990114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990114%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B2-secretase%2520from%2520human%2520brain%26jtitle%3DNature%2520%2528London%2529%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lh0oyhNRNhBUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashler, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity</span> <span class="citation_source-journal">Nature (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1038%2F990107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=10591213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity</span></div><div class="casAuthors">Yan, Riqiang; Bienkowski, Michael J.; Shuck, Mary E.; Miao, Huiyi; Tory, Monica C.; Pauley, Adele M.; Brashler, John R.; Stratman, Nancy C.; Mathews, W. Rodney; Buhl, Allen E.; Carter, Donald B.; Tomasselli, Alfredo G.; Parodi, Luis A.; Heinrikson, Robert L.; Gurney, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">6761</span>),
    <span class="NLM_cas:pages">533-537</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Mutations in the gene encoding the amyloid protein precursor (APP) cause autosomal dominant Alzheimer's disease.  Cleavage of APP by unidentified proteases, referred to as β- and γ-secretases, generates the amyloid β-peptide, the main component of the amyloid plaques found in Alzheimer's disease patients.  The disease-causing mutations flank the protease cleavage sites in APP and facilitate its cleavage.  Here the authors identify a new membrane-bound aspartyl protease (Asp2) with β-secretase activity.  The Asp2 gene is expressed widely in brain and other tissues.  Decreasing the expression of Asp2 in cells reduces amyloid β-peptide prodn. and blocks the accumulation of the carboxy-terminal APP fragment that is created by β-secretase cleavage.  Solubilized Asp2 protein cleaves a synthetic APP peptide substrate at the β-secretase site, and the rate of cleavage is increased tenfold by a mutation assocd. with early-onset Alzheimer's disease in Sweden.  Thus, Asp2 is a new protein target for drugs that are designed to block the prodn. of amyloid β-peptide peptide and the consequent formation of amyloid plaque in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd6iE74jtk5LVg90H21EOLACvtfcHk0lh0oyhNRNhBUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D&md5=96af7cd9b7c3315de029937497f04616</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990107%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520activity%26jtitle%3DNature%2520%2528London%2529%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dashti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1456</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=1456-1460&author=X.+Linauthor=G.+Koelschauthor=S.+Wuauthor=D.+Downsauthor=A.+Dashtiauthor=J.+Tang&title=Human+aspartic+protease+memapsin+2+cleaves+the+%CE%B2-secretase+site+of+%CE%B2-amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DDashti%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DHuman%2520aspartic%2520protease%2520memapsin%25202%2520cleaves%2520the%2520%25CE%25B2-secretase%2520site%2520of%2520%25CE%25B2-amyloid%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D1456%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span> </span><span class="NLM_article-title">Mutant genes in familial Alzheimer’s disease and transgenic models</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1146%2Fannurev.neuro.21.1.479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=9530504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=479-505&author=D.+L.+Priceauthor=S.+S.+Sisodia&title=Mutant+genes+in+familial+Alzheimer%E2%80%99s+disease+and+transgenic+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant genes in familial Alzheimer's disease and transgenic models</span></div><div class="casAuthors">Price, Donald L.; Sisodia, Sangram S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-505</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 163 refs.  The most common cause of dementia occurring in mid- to late-life is Alzheimer's disease (AD).  Some cases of AD, particularly those of early onset, are familial and inherited as autosomal dominant disorders linked to the presence of mutant genes that encode the amyloid precursor protein (APP) or the presenilins (PS1 or PS2).  These mutant gene products cause dysfunction/death of vulnerable populations of nerve cells important in memory, higher cognitive processes, and behavior.  AD affects 7-10% of individuals >65 yr of age and perhaps 40% of individuals >80 yr of age.  For the late-onset cases, the principal risk factors are age and apolipoprotein (apoE) allele type, with apoE4 allele being a susceptibility factor.  In this review, we briefly discuss the clin. syndrome of AD and the neurobiol./neuropathol. of the disease and then focus attention on mutant genes linked to autosomal dominant familial AD (FAD), the biol. of the proteins encoded by these genes, and the recent exciting progress in investigations of genetically engineered animal models that express these mutant genes and develop some features of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUt4ulmJ7ErVg90H21EOLACvtfcHk0lgpRCjF86Lfbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D&md5=fa1bf9dbad95faabcd6854eca46bad83</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.21.1.479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.21.1.479%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26atitle%3DMutant%2520genes%2520in%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520transgenic%2520models%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1998%26volume%3D21%26spage%3D479%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">A mutation in <i>APP</i> protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonsson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lgpRCjF86Lfbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, S.</span><span> </span><span class="NLM_article-title">BACE inhibitors as potential drugs for the treatment of Alzheimer’s disease: focus on bioactivity</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=91-106&author=G.+Evinauthor=G.+Lesseneauthor=S.+Wilkins&title=BACE+inhibitors+as+potential+drugs+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+focus+on+bioactivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DWilkins%26aufirst%3DS.%26atitle%3DBACE%2520inhibitors%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520focus%2520on%2520bioactivity%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D91%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Probst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2006–2011)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1517%2F13543776.2012.681302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22512789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=511-540&author=G.+Probstauthor=Y.+Xu&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282006%E2%80%932011%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)</span></div><div class="casAuthors">Probst, Gary; Xu, Ying-zi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-540</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease is a devastating neurodegenerative disorder for which no disease-modifying therapy exists.  The amyloid hypothesis, which implicates Aβ as the toxin initiating a biol. cascade leading to neurodegeneration, is the most prominent theory concerning the underlying cause of the disease.  BACE1 is one of two aspartyl proteinases that generate Aβ, thus inhibition of BACE1 has the potential to ameliorate the progression of Alzheimer's disease by abating the prodn. of Aβ.  Areas covered: This review chronicles small-mol. BACE1 inhibitors as described in the patent literature between 2006 and 2011 and their potential use as disease-modifying treatments for Alzheimer's disease.  Over the past half a dozen years, numerous BACE1 inhibitors have been published in the patent applications, but often these contain a paltry amt. of pertinent biol. data (e.g. potency, selectivity, and efficacy).  Fortunately, numerous relevant publications contg. important data have appeared in the journal literature during this period.  The goal in this effort was to create an amalgam of the two records to add value to this review.  Expert opinion: The pharmaceutical industry has made tremendous progress in the development of small-mol. BACE1 inhibitors that lower Aβ in the central nervous system.  Assuming the amyloid hypothesis is veracious, we anticipate a disease-modifying therapy to combat Alzheimer's disease is near.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89KaCi3q5Z7Vg90H21EOLACvtfcHk0lgpRCjF86Lfbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D&md5=174bdc47fbca5aa1f8248dbf03ce402b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.681302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.681302%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D511%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+A.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0lgvuCDZihGs9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%2BA.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Berg, S.; Hallberg, J.; Hoegdin, K.; Karlstroem, S.; Kers, A.; Plobeck, N.; Rakos, L.</span>WO2008076043A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berg%2C+S.%3B+Hallberg%2C+J.%3B+Hoegdin%2C+K.%3B+Karlstroem%2C+S.%3B+Kers%2C+A.%3B+Plobeck%2C+N.%3B+Rakos%2C+L.WO2008076043A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DS.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Berg, S.; Hallberg, J.; Hoegdin, K.; Karlstroem, S.; Kers, A.; Plobeck, N.; Rakos, L.</span>WO2008076044A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berg%2C+S.%3B+Hallberg%2C+J.%3B+Hoegdin%2C+K.%3B+Karlstroem%2C+S.%3B+Kers%2C+A.%3B+Plobeck%2C+N.%3B+Rakos%2C+L.WO2008076044A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DS.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Berg, S.; Holenz, J.; Karlstroem, S.; Kihlstroem, J.; Lindstroem, J.; Rakos, L.</span>WO2008076046A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berg%2C+S.%3B+Holenz%2C+J.%3B+Karlstroem%2C+S.%3B+Kihlstroem%2C+J.%3B+Lindstroem%2C+J.%3B+Rakos%2C+L.WO2008076046A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DS.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Berg, S.; Karlstroem, S.; Kolmodin, K.; Lindstroem, J.; Nystroem, J.; Sehgelmeble, F.; Soederman, P.</span>WO2008076045A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berg%2C+S.%3B+Karlstroem%2C+S.%3B+Kolmodin%2C+K.%3B+Lindstroem%2C+J.%3B+Nystroem%2C+J.%3B+Sehgelmeble%2C+F.%3B+Soederman%2C+P.WO2008076045A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DS.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Burrows, J. N.; Hellberg, S.; Hogdin, K.; Karlstrom, S.; Kolmodin, K.; Lindstrom, J.; Slivo, C.</span>US20080287460A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Burrows%2C+J.+N.%3B+Hellberg%2C+S.%3B+Hogdin%2C+K.%3B+Karlstrom%2C+S.%3B+Kolmodin%2C+K.%3B+Lindstrom%2C+J.%3B+Slivo%2C+C.US20080287460A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Swahn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.+M.+Swahnauthor=J.+Holenzauthor=J.+Kihlstromauthor=K.+Kolmodinauthor=J.+Lindstromauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstromauthor=S.+Bergauthor=J.+Faltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.+L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstrom%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstrom%26aufirst%3DM.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFalting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Swahn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Öhberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-secretase (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9346</span><span class="NLM_x">–</span> <span class="NLM_lpage">9361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.+M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+%C3%96hbergauthor=A.+Kersauthor=K.+Bogarauthor=M.+Berghauthor=L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-secretase+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3D%25C3%2596hberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginman, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strömberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9297</span><span class="NLM_x">–</span> <span class="NLM_lpage">9311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.+M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28A%CE%B2%29+lowering+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0lhG0ERYEf98hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBell, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lj8JHfCopx5ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of aminopiperazinones as beta-secretase (BACE) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7255</span><span class="NLM_x">–</span> <span class="NLM_lpage">7260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.bmcl.2011.10.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22071305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFSqt7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7255-7260&author=G.+Tresadernauthor=F.+Delgadoauthor=O.+Delgadoauthor=H.+Gijsenauthor=G.+J.+Macdonaldauthor=D.+Moecharsauthor=F.+Romboutsauthor=R.+Alexanderauthor=J.+Spurlinoauthor=M.+Van+Goolauthor=J.+A.+Vegaauthor=A.+A.+Trabanco&title=Rational+design+and+synthesis+of+aminopiperazinones+as+beta-secretase+%28BACE%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors</span></div><div class="casAuthors">Tresadern, Gary; Delgado, Francisca; Delgado, Oscar; Gijsen, Harrie; Macdonald, Gregor J.; Moechars, Dieder; Rombouts, Frederik; Alexander, Richard; Spurlino, John; Van Gool, Michiel; Vega, Juan Antonio; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7255-7260</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aminopiperazinone inhibitors of BACE were identified by rational design.  Structure based design guided idea prioritization and initial racemic hit I showed good activity.  Modification in decoration and chiral sepn. resulted in the 40 nM inhibitor, (-)-II, which showed in vivo redn. of amyloid beta peptides.  The crystal structure of (R)-I with BACE showed a binding mode driven by interaction with the catalytic aspartate dyad and distribution of the biaryl amide decoration towards S1 and S3 pockets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHSIy3VkZzlLVg90H21EOLACvtfcHk0lj8JHfCopx5ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFSqt7fF&md5=f8f1f7b83fae2fba7f2d0e553a8cb49d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.050%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DF.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520aminopiperazinones%2520as%2520beta-secretase%2520%2528BACE%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7255%26epage%3D7260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0lg2DKTYa4ikKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=233-240&author=Z.+Zhu&title=Iminoheterocycle+as+a+druggable+motif%3A+BACE1+inhibitors+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DIminoheterocycle%2520as%2520a%2520druggable%2520motif%253A%2520BACE1%2520inhibitors%2520and%2520beyond%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D233%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lg2DKTYa4ikKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">A general pattern for substrate recognition by P-glycoprotein</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1046%2Fj.1432-1327.1998.2510252.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=9492291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK1cXnvV2rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1998&pages=252-261&author=A.+Seelig&title=A+general+pattern+for+substrate+recognition+by+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">A general pattern for substrate recognition by P-glycoprotein</span></div><div class="casAuthors">Seelig, Anna</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">252-261</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">P-glycoprotein actively transports a wide variety of chem. diverse compds. out of the cell.  Based on a comparison of a hundred compds. previously tested as P-glycoprotein substrates, we suggest that a set of well-defined structural elements is required for an interaction with P-glycoprotein.  The recognition elements are formed by two (type I unit) or three electron donor groups (type II unit) with a fixed spatial sepn.  Type I units consist of two electron donor groups with a spatial sepn. of 2.5±0.3 Å.  Type II units contain either two electron donor groups with a spatial sepn. of 4.6±0.6 Å or three electron donor groups with a spatial sepn. of the outer two groups of 4.6±0.6 Å.  All mols. that contain at least one type I or one type II unit are predicted to be P-glycoprotein substrates.  The binding to P-glycoprotein increases with the strength and the no. of electron donor or hydrogen bonding acceptor groups forming the type I and type II units.  Correspondingly, a high percentage of amino acids with hydrogen bonding donor side chains is found in the transmembrane sequences of P-glycoprotein relevant for substrate interaction.  Mols. that minimally contain one type II unit are predicted to be inducers of P-glycoprotein over-expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFKQQl0_dmRLVg90H21EOLACvtfcHk0lgemnLGl_rQCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvV2rsg%253D%253D&md5=0c36abaa7371c9073254cb2e38e543ce</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1998.2510252.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1998.2510252.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DA%2520general%2520pattern%2520for%2520substrate%2520recognition%2520by%2520P-glycoprotein%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1998%26volume%3D251%26spage%3D252%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopedota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Recent advances in medicinal chemistry and pharmaceutical technology—strategies for drug delivery to the brain</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.2174%2F156802609787521571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=19200004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=182-196&author=N.+Denoraauthor=A.+Trapaniauthor=V.+Laquintanaauthor=A.+Lopedotaauthor=G.+Trapani&title=Recent+advances+in+medicinal+chemistry+and+pharmaceutical+technology%E2%80%94strategies+for+drug+delivery+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in medicinal chemistry and pharmaceutical technology - strategies for drug delivery to the brain</span></div><div class="casAuthors">Denora, Nunzio; Trapani, Adriana; Laquintana, Valentino; Lopedota, Angela; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-196</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This paper provides a mini-review of some recent approaches for the treatment of brain pathologies examg. both medicinal chem. and pharmaceutical technol. contributions.  Medicinal chem.-based strategies are essentially aimed at the chem. modification of low mol. wt. drugs in order to increase their lipophilicity or the design of appropriate prodrugs, although this review will focus primarily on the use of prodrugs and not analog development.  Recently, interest has been focused on the design and evaluation of prodrugs that are capable of exploiting one or more of the various endogenous transport systems at the level of the blood brain barrier (BBB).  The technol. strategies are essentially non-invasive methods of drug delivery to malignancies of the central nervous system (CNS) and are based on the use of nanosystems (colloidal carriers) such as liposomes, polymeric nanoparticles, solid lipid nanoparticles, polymeric micelles and dendrimers.  The biodistribution of these nanocarriers can be manipulated by modifying their surface physico-chem. properties or by coating them with surfactants and polyethylene-glycols (PEGs).  Liposomes, surfactant coated polymeric nanoparticles, and solid lipid nanoparticles are promising systems for delivery of drugs to tumors of the CNS.  This mini-review discusses issues concerning the scope and limitations of both the medicinal chem. and technol. approaches.  Based on the current findings, it can be concluded that crossing of the BBB and drug delivery to CNS is extremely complex and requires a multidisciplinary approach such as a close collaboration and common efforts among researchers of several scientific areas, particularly medicinal chemists, biologists and pharmaceutical technologists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKLD3NcuTLa7Vg90H21EOLACvtfcHk0lgemnLGl_rQCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSgtb0%253D&md5=61feb73997d2974a7c792cdf8c47608a</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.2174%2F156802609787521571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609787521571%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DLopedota%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DRecent%2520advances%2520in%2520medicinal%2520chemistry%2520and%2520pharmaceutical%2520technology%25E2%2580%2594strategies%2520for%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2009%26volume%3D9%26spage%3D182%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quagliato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solvibile, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6597</span><span class="NLM_x">–</span> <span class="NLM_lpage">6605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.bmcl.2010.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=20880704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6597-6605&author=M.+S.+Malamasauthor=A.+Robichaudauthor=J.+Erdeiauthor=D.+Quagliatoauthor=W.+Solvibileauthor=P.+Zhouauthor=K.+Morrisauthor=J.+Turnerauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=S.+Jacobsenauthor=P.+Reinhartauthor=D.+Riddellauthor=M.+Pangalos&title=Design+and+synthesis+of+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors+with+enhanced+brain+permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability</span></div><div class="casAuthors">Malamas, Michael S.; Robichaud, Albert; Erdei, Jim; Quagliato, Dominick; Solvibile, William; Zhou, Ping; Morris, Koi; Turner, Jim; Wagner, Erik; Fan, Kristi; Olland, Andrea; Jacobsen, Steve; Reinhart, Peter; Riddell, David; Pangalos, Menelas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6597-6605</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit good brain permeability (40-70%), low nanomolar potency for BACE1, and demonstrate >100-fold selectivity for the structurally related aspartyl proteases cathepsin D, renin and pepsin.  Alkyl and alkoxy groups at the meta-position of the P1 Ph, which extend toward the S3 region of the enzyme, have contributed to the ligand's reduced affinity for the efflux transporter protein P-gp, and decreased topol. polar surface area, thus resulting in enhanced brain permeability.  A fluorine substitution at the para-position of the P1 Ph has contributed to 100-fold decrease of CYP3A4 inhibition and enhancement of compd. metabolic stability.  The plasma and brain protein binding properties of these new analogs are affected by substitutions at the P1 Ph moiety.  Higher compd. protein binding was obsd. in the brain than in the plasma.  Two structurally diverse potent BACE1 inhibitors (84 and 89) reduced 30% plasma Aβ40 in the Tg2576 mice in vivo model at 30 mg/kg po.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSYkNat5QUjrVg90H21EOLACvtfcHk0lgemnLGl_rQCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSmsL7I&md5=848a1bfa79278b0c7a72749f9be45ad8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DRobichaud%26aufirst%3DA.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DQuagliato%26aufirst%3DD.%26aulast%3DSolvibile%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DMorris%26aufirst%3DK.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DReinhart%26aufirst%3DP.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DPangalos%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520enhanced%2520brain%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6597%26epage%3D6605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Roden, D. M.</span><span> </span><span class="NLM_article-title">Drug-induced prolongation of the QT interval</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1056%2FNEJMra032426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=14999113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1013-1022&author=D.+M.+Roden&title=Drug-induced+prolongation+of+the+QT+interval"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced prolongation of the QT interval</span></div><div class="casAuthors">Roden, Dan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1022</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8PoMXlMg57Vg90H21EOLACvtfcHk0lh-IUGxYPdWeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D&md5=a020a545700649d9914ed8dc61910244</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1056%2FNEJMra032426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra032426%26sid%3Dliteratum%253Aachs%26aulast%3DRoden%26aufirst%3DD.%2BM.%26atitle%3DDrug-induced%2520prolongation%2520of%2520the%2520QT%2520interval%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1013%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Diller, J. D.</span><span> </span><span class="NLM_article-title">In silico hERG modelling: challenges and progress</span> <span class="citation_source-journal">Curr. Comput.-Aided Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.2174%2F157340909788451928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVWrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=106-121&author=J.+D.+Diller&title=In+silico+hERG+modelling%3A+challenges+and+progress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">In silico hERG modeling: challenges and progress</span></div><div class="casAuthors">Diller, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Computer-Aided Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-121</span>CODEN:
                <span class="NLM_cas:coden">CCDDAS</span>;
        ISSN:<span class="NLM_cas:issn">1573-4099</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The first generation of in silico hERG models have focused on key driving forces for hERG/ligand binding: basicity and lipophilicity.  While reducing basicity and lipophilicity are typically the first line approaches to eliminating hERG blocking activity, in many programs these are not feasible approaches because basicity and lipophilicity are frequently necessary for achieving good pharmacokinetics or primary target binding.  Thus for the second, generation of in silico hERG models, a focus on understanding the more subtle aspects of hERG binding is necessary.  Thus, the focus of this review is on extg. ideas, either qual. or quant., from the various modeling efforts as to how hERG activity might be eliminated or diminished beyond simply reducing basicity and lipophilicity.  In addn., several areas where key questions around hERG binding have not been adequately addressed by in silico work are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7wUQpyBUN-rVg90H21EOLACvtfcHk0lh-IUGxYPdWeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVWrtbY%253D&md5=cc2f2623d70bc07fa408e83185e428fe</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.2174%2F157340909788451928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340909788451928%26sid%3Dliteratum%253Aachs%26aulast%3DDiller%26aufirst%3DJ.%2BD.%26atitle%3DIn%2520silico%2520hERG%2520modelling%253A%2520challenges%2520and%2520progress%26jtitle%3DCurr.%2520Comput.-Aided%2520Drug%2520Des.%26date%3D2009%26volume%3D5%26spage%3D106%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Madden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dod, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godemann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraemer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biniszkiewicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyekjaer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesterkamp, T.</span><span> </span><span class="NLM_article-title">Fragment-based discovery and optimization of BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5329</span><span class="NLM_x">–</span> <span class="NLM_lpage">5333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5329-5333&author=J.+Maddenauthor=J.+R.+Dodauthor=R.+Godemannauthor=J.+Kraemerauthor=M.+Smithauthor=M.+Biniszkiewiczauthor=D.+J.+Hallettauthor=J.+Barkerauthor=J.+D.+Dyekjaerauthor=T.+Hesterkamp&title=Fragment-based+discovery+and+optimization+of+BACE1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMadden%26aufirst%3DJ.%26aulast%3DDod%26aufirst%3DJ.%2BR.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DBiniszkiewicz%26aufirst%3DM.%26aulast%3DHallett%26aufirst%3DD.%2BJ.%26aulast%3DBarker%26aufirst%3DJ.%26aulast%3DDyekjaer%26aufirst%3DJ.%2BD.%26aulast%3DHesterkamp%26aufirst%3DT.%26atitle%3DFragment-based%2520discovery%2520and%2520optimization%2520of%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5329%26epage%3D5333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Zhao, H.</span><span> </span><span class="NLM_article-title">Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.drudis.2006.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=17275735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtleisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=149-155&author=H.+Zhao&title=Scaffold+selection+and+scaffold+hopping+in+lead+generation%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective</span></div><div class="casAuthors">Zhao, Hongyu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">149-155</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hit selection and lead generation are crucial for the success of the resource-demanding lead-optimization phase in drug discovery, and represent a major research area of medicinal chem. today.  Ligand-binding efficiency, ligand complexity, ligand-target profile complementarity and chem. tractability are important parameters in hit selection.  As synthesis and assay throughput improve, a large no. of analogs based on the same scaffold can be rapidly synthesized and tested.  Consequently, more chem. resources could be devoted to scaffold modifications to expand the candidate pool in lead generation.  Most recently discovered druggable targets are promiscuous toward lipophilic ligands, and the hydrophobic portions of hit compds. should be preferentially modified in analog and scaffold design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_G4HUVC1fQrVg90H21EOLACvtfcHk0lh-IUGxYPdWeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtleisbo%253D&md5=a9ffb13a77e3bb18d5c432f3286d4608</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26atitle%3DScaffold%2520selection%2520and%2520scaffold%2520hopping%2520in%2520lead%2520generation%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D149%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Segall, M. D.</span><span> </span><span class="NLM_article-title">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1292</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.2174%2F138161212799436430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22316157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1292-1310&author=M.+D.+Segall&title=Multi-parameter+optimization%3A+identifying+high+quality+compounds+with+a+balance+of+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-parameter optimization: identifying high quality compounds with a balance of properties</span></div><div class="casAuthors">Segall, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1292-1310</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A successful, efficacious and safe drug must have a balance of properties, including potency against its intended target, appropriate absorption, distribution, metab., and elimination (ADME) properties and an acceptable safety profile.  Achieving this balance of, often conflicting, requirements is a major challenge in drug discovery.  Approaches to simultaneously optimizing many factors in a design are broadly described under the term "multi-parameter optimization" (MPO).  In this review, we will describe how MPO can be applied to efficiently design and select high quality compds. and describe the range of methods that have been employed in drug discovery, including; simple "rules of thumb" such as Lipinski's rule; desirability functions; Pareto optimization; and probabilistic approaches that take into consideration the uncertainty in all drug discovery data due to predictive error and exptl. variability.  We will explore how these methods have been applied to predicted and exptl. data to reduce attrition and improve the productivity of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPFOVyg2ehWbVg90H21EOLACvtfcHk0li9H5MFligTGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSqsbk%253D&md5=43f90ad751fd2c0bc47715f465ef31b3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F138161212799436430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212799436430%26sid%3Dliteratum%253Aachs%26aulast%3DSegall%26aufirst%3DM.%2BD.%26atitle%3DMulti-parameter%2520optimization%253A%2520identifying%2520high%2520quality%2520compounds%2520with%2520a%2520balance%2520of%2520properties%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D1292%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lusher, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azevedo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boiten, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Schaik, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vlieg, J.</span><span> </span><span class="NLM_article-title">A molecular informatics view on best practice in multi-parameter compound optimization</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=555-568&author=S.+J.+Lusherauthor=R.+McGuireauthor=R.+Azevedoauthor=J.+W.+Boitenauthor=R.+C.+van+Schaikauthor=J.+de+Vlieg&title=A+molecular+informatics+view+on+best+practice+in+multi-parameter+compound+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLusher%26aufirst%3DS.%2BJ.%26aulast%3DMcGuire%26aufirst%3DR.%26aulast%3DAzevedo%26aufirst%3DR.%26aulast%3DBoiten%26aufirst%3DJ.%2BW.%26aulast%3Dvan%2BSchaik%26aufirst%3DR.%2BC.%26aulast%3Dde%2BVlieg%26aufirst%3DJ.%26atitle%3DA%2520molecular%2520informatics%2520view%2520on%2520best%2520practice%2520in%2520multi-parameter%2520compound%2520optimization%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D555%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Viklund, J.; Kolmodin, K.; Nordvall, G.; Swahn, B.-M.; Svensson, M.; Gravenfors, Y.; Rahm, F.</span><span> </span><span class="NLM_article-title">Creation of novel cores for β-secreatse (BACE-1) inhibitors: a multi-parameter lead generation strategy</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Viklund%2C+J.%3B+Kolmodin%2C+K.%3B+Nordvall%2C+G.%3B+Swahn%2C+B.-M.%3B+Svensson%2C+M.%3B+Gravenfors%2C+Y.%3B+Rahm%2C+F.+Creation+of+novel+cores+for+%CE%B2-secreatse+%28BACE-1%29+inhibitors%3A+a+multi-parameter+lead+generation+strategy.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DViklund%26aufirst%3DJ.%26atitle%3DCreation%2520of%2520novel%2520cores%2520for%2520%25CE%25B2-secreatse%2520%2528BACE-1%2529%2520inhibitors%253A%2520a%2520multi-parameter%2520lead%2520generation%2520strategy" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Roos, K.; Viklund, J.; Meuller, J.; Kaspersson, K.; Svensson, M.</span><span> </span><span class="NLM_article-title">Potency prediction of β-secretase (BACE-1) inhibitors using density functional methods</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Roos%2C+K.%3B+Viklund%2C+J.%3B+Meuller%2C+J.%3B+Kaspersson%2C+K.%3B+Svensson%2C+M.+Potency+prediction+of+%CE%B2-secretase+%28BACE-1%29+inhibitors+using+density+functional+methods.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoos%26aufirst%3DK.%26atitle%3DPotency%2520prediction%2520of%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520using%2520density%2520functional%2520methods" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&issue=3&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0li9H5MFligTGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26issue%3D3%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Suzuki, S.; Kooriyama, Y.</span>WO2011077726A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Suzuki%2C+S.%3B+Kooriyama%2C+Y.WO2011077726A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DS.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Trabanco-Suarez, A. A.; Rombouts, F. J. R.; Tresadern, G. J.; Van Gool, M. L. M.; Macdonald, G. J.; Martinez Lamenca, C.; Gijsen, H. J. M.</span>WO2011154431A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Trabanco-Suarez%2C+A.+A.%3B+Rombouts%2C+F.+J.+R.%3B+Tresadern%2C+G.+J.%3B+Van+Gool%2C+M.+L.+M.%3B+Macdonald%2C+G.+J.%3B+Martinez+Lamenca%2C+C.%3B+Gijsen%2C+H.+J.+M.WO2011154431A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco-Suarez%26aufirst%3DA.%2BA.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Dillard, L. W.; Yuan, J.; Leftheris, K.; Venkatraman, S.; Wu, G.; Jia, L.; Xu, Z.; Cacatian, S.; Morales-Ramos, A.; Singh, S.; Zheng, Y.</span>WO2011106414A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dillard%2C+L.+W.%3B+Yuan%2C+J.%3B+Leftheris%2C+K.%3B+Venkatraman%2C+S.%3B+Wu%2C+G.%3B+Jia%2C+L.%3B+Xu%2C+Z.%3B+Cacatian%2C+S.%3B+Morales-Ramos%2C+A.%3B+Singh%2C+S.%3B+Zheng%2C+Y.WO2011106414A1%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDillard%26aufirst%3DL.%2BW.%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Albert, J.; Chessari, G.; Congreve, M. S.; Edwards, P.; Murray, C.; Patel, S.; Sylvester, M.</span>WO2007058583A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Albert%2C+J.%3B+Chessari%2C+G.%3B+Congreve%2C+M.+S.%3B+Edwards%2C+P.%3B+Murray%2C+C.%3B+Patel%2C+S.%3B+Sylvester%2C+M.WO2007058583A2%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DJ.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiya, M.</span><span> </span><span class="NLM_article-title">Catalytic hydrogenation of tetrahydro-4<i>H</i>-1,3-oxazin-4-ones and 4-oxazolidinones</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1762</span><span class="NLM_x">–</span> <span class="NLM_lpage">1767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1972&pages=1762-1767&author=K.+Itoauthor=M.+Sekiya&title=Catalytic+hydrogenation+of+tetrahydro-4H-1%2C3-oxazin-4-ones+and+4-oxazolidinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DK.%26aulast%3DSekiya%26aufirst%3DM.%26atitle%3DCatalytic%2520hydrogenation%2520of%2520tetrahydro-4H-1%252C3-oxazin-4-ones%2520and%25204-oxazolidinones%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1972%26volume%3D20%26spage%3D1762%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Jalce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franck, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figadere, B.</span><span> </span><span class="NLM_article-title">Synthesis and use of achiral oxazolidine-2-thiones in selective preparation of trans 2,5-disubstituted tetrahydrofurans</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=378-386&author=G.+Jalceauthor=X.+Franckauthor=B.+Figadere&title=Synthesis+and+use+of+achiral+oxazolidine-2-thiones+in+selective+preparation+of+trans+2%2C5-disubstituted+tetrahydrofurans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJalce%26aufirst%3DG.%26aulast%3DFranck%26aufirst%3DX.%26aulast%3DFigadere%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520use%2520of%2520achiral%2520oxazolidine-2-thiones%2520in%2520selective%2520preparation%2520of%2520trans%25202%252C5-disubstituted%2520tetrahydrofurans%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2009%26spage%3D378%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span> </span><span class="NLM_article-title">An improved and mild Wenker synthesis of aziridines</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">3423</span><span class="NLM_x">–</span> <span class="NLM_lpage">3428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKjsLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=3423-3428&author=X.+Liauthor=N.+Chenauthor=J.+Xu&title=An+improved+and+mild+Wenker+synthesis+of+aziridines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">An improved and mild Wenker synthesis of aziridines</span></div><div class="casAuthors">Li, Xinyao; Chen, Ning; Xu, Jianxi</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3423-3428</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The conventional Wenker synthesis of aziridines from vicinal amino alcs. was modified by employing mild reaction conditions.  Amino alcs. were converted into their hydrogen sulfates with ClSO3H.  The sulfates were cyclized with NaOH, and even with non-nucleophilic Na2CO3.  The improved method extends the scope of the typical Wenker synthesis and is applicable to unstable amino alcs. in hot H2SO4 and to unstable sulfates, which favor elimination and OH- displacement in the presence of strong base.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI9mzGf035ZrVg90H21EOLACvtfcHk0ljhodfmrvYVZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKjsLjN&md5=e32b5db1383a12cca4b9a43477167d12</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DAn%2520improved%2520and%2520mild%2520Wenker%2520synthesis%2520of%2520aziridines%26jtitle%3DSynthesis%26date%3D2010%26spage%3D3423%26epage%3D3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Cohen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, B. L.</span><span> </span><span class="NLM_article-title">Synthesis of 2-amino-5,6-dihydro-4<i>H</i>-1,3-thiazines and related compounds by acid catalyzed cyclization of allylic isothiuronium salts</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1977&pages=717-723&author=N.+Cohenauthor=B.+L.+Banner&title=Synthesis+of+2-amino-5%2C6-dihydro-4H-1%2C3-thiazines+and+related+compounds+by+acid+catalyzed+cyclization+of+allylic+isothiuronium+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DN.%26aulast%3DBanner%26aufirst%3DB.%2BL.%26atitle%3DSynthesis%2520of%25202-amino-5%252C6-dihydro-4H-1%252C3-thiazines%2520and%2520related%2520compounds%2520by%2520acid%2520catalyzed%2520cyclization%2520of%2520allylic%2520isothiuronium%2520salts%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1977%26volume%3D14%26spage%3D717%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Davies, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stove, E. R.</span><span> </span><span class="NLM_article-title">Some consequences of the additive property of the activated azomethine group</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1949</span><span class="NLM_x">, </span> <span class="NLM_fpage">2633</span><span class="NLM_x">–</span> <span class="NLM_lpage">2637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1949&pages=2633-2637&author=W.+Daviesauthor=T.+H.+Ramsayauthor=E.+R.+Stove&title=Some+consequences+of+the+additive+property+of+the+activated+azomethine+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DW.%26aulast%3DRamsay%26aufirst%3DT.%2BH.%26aulast%3DStove%26aufirst%3DE.%2BR.%26atitle%3DSome%2520consequences%2520of%2520the%2520additive%2520property%2520of%2520the%2520activated%2520azomethine%2520group%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1949%26spage%3D2633%26epage%3D2637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Malamas, M. S.; Erdei, J. J.; Fobare, W. F.; Quagliato, D. A.; Antane, S. A.; Robichaud, A. J.</span>US 20070072925,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Malamas%2C+M.+S.%3B+Erdei%2C+J.+J.%3B+Fobare%2C+W.+F.%3B+Quagliato%2C+D.+A.%3B+Antane%2C+S.+A.%3B+Robichaud%2C+A.+J.US+20070072925%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Mukherjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span> </span><span class="NLM_article-title">Chemoselectivities in the platinum-catalyzed hydrative carbocyclizations of oxo-alkyne-nitrile functionalities</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">660</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol1029047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosVartA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=660-663&author=A.+Mukherjeeauthor=R.+Liu&title=Chemoselectivities+in+the+platinum-catalyzed+hydrative+carbocyclizations+of+oxo-alkyne-nitrile+functionalities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselectivities in the Platinum-Catalyzed Hydrative Carbocyclizations of Oxo-Alkyne-Nitrile Functionalities</span></div><div class="casAuthors">Mukherjee, Anupam; Liu, Rai-Shung</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">660-663</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two new hydrative carbocyclizations of oxa-alkyne-nitrile functionalities are reported to produce distinct nitrogen-contg. heterocycles.  Protracted heating of oxoalkynyl nitrile substrates with PtCl2/CO/H2O in hot 1,4-dioxane gave 2,3-dihydro-1H-pyrido[1.2-b]-isoquinolin-4(6H)-ones, e.g., I.  In this hydration reaction, dicarbonyl nitrile intermediates were isolated efficiently after a brief period, and they were subjected to an NHC-based crossed benzoin coupling to give spiro alcs. that further reacted with TfOH to give spiro[indene-2,2'-piperidine]-1,6'(3H)-diones, e.g., II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBp8wW3X8rGrVg90H21EOLACvtfcHk0ljhodfmrvYVZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosVartA%253D%253D&md5=980685e8b903e8ed08d58dc95d8b5f6e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fol1029047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol1029047%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DR.%26atitle%3DChemoselectivities%2520in%2520the%2520platinum-catalyzed%2520hydrative%2520carbocyclizations%2520of%2520oxo-alkyne-nitrile%2520functionalities%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D660%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.</span><span> </span><span class="NLM_article-title">Stereochemical studies. VII. Thermal rearrangement of α-hydroxy imines to α-amino ketones using optically active open chain compounds</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1971&pages=227-246&author=H.+Mizunoauthor=S.+Terashimaauthor=S.+Yamada&title=Stereochemical+studies.+VII.+Thermal+rearrangement+of+%CE%B1-hydroxy+imines+to+%CE%B1-amino+ketones+using+optically+active+open+chain+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DTerashima%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DS.%26atitle%3DStereochemical%2520studies.%2520VII.%2520Thermal%2520rearrangement%2520of%2520%25CE%25B1-hydroxy%2520imines%2520to%2520%25CE%25B1-amino%2520ketones%2520using%2520optically%2520active%2520open%2520chain%2520compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1971%26volume%3D19%26spage%3D227%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Bridgland-Taylor, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orme, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henthorn, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heapy, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Gerges, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, C. E.</span><span> </span><span class="NLM_article-title">Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.vascn.2006.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=16563806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=189-199&author=M.+H.+Bridgland-Taylorauthor=A.+C.+Hargreavesauthor=A.+Easterauthor=A.+Ormeauthor=D.+C.+Henthornauthor=M.+Dingauthor=A.+M.+Davisauthor=B.+G.+Smallauthor=C.+G.+Heapyauthor=N.+Abi-Gergesauthor=F.+Perssonauthor=I.+Jacobsonauthor=M.+Sullivanauthor=N.+Albertsonauthor=T.+G.+Hammondauthor=E.+Sullivanauthor=J.+P.+Valentinauthor=C.+E.+Pollard&title=Optimisation+and+validation+of+a+medium-throughput+electrophysiology-based+hERG+assay+using+IonWorks+HT"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span></div><div class="casAuthors">Bridgland-Taylor, M. H.; Hargreaves, A. C.; Easter, A.; Orme, A.; Henthorn, D. C.; Ding, M.; Davis, A. M.; Small, B. G.; Heapy, C. G.; Abi-Gerges, N.; Persson, F.; Jacobson, I.; Sullivan, M.; Albertson, N.; Hammond, T. G.; Sullivan, E.; Valentin, J.-P.; Pollard, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: Regulatory and competitive pressure to reduce the QT interval prolongation risk of potential new drugs has led to focus on methods to test for inhibition of the human ether-a-go-go-related gene (hERG)-encoded K+ channel, the primary mol. target underlying this safety issue.  Here we describe the validation of a method that combines medium-throughput with direct assessment of channel function.  Methods: The electrophysiol. and pharmacol. properties of hERG were compared using two methods: conventional, low-throughput electrophysiol. and planar-array-based, medium-throughput electrophysiol. (IonWorks HT).  A pharmacol. comparison was also made between IonWorks HT and an indirect assay (Rb+ efflux).  Results: Basic electrophysiol. properties of hERG were similar whether recorded conventionally (HEK cells) or using IonWorks HT (CHO cells): for example, tail current V1/2 - 12.1 ± 5.0 mV (32) for conventional and - 9.5 ± 6.0 mV (46) for IonWorks HT (mean ± S.D. (n)).  A key finding was that as the no. of cells per well was increased in IonWorks HT, the potency reported for a given compd. decreased.  Using the lowest possible cell concn. (250,000 cells/mL) and 89 compds. spanning a broad potency range, the pIC50 values from IonWorks HT (CHO-hERG) were found to correlate well with those obtained using conventional methodol. (HEK-hERG)(r = 0.90; p < 0.001).  Further validation using CHO-hERG cells with both methods confirmed the correlation (r = 0.94; p < 0.001).  In contrast, a comparison of IonWorks HT and Rb+ efflux data with 649 compds. using CHO-hERG cells showed that the indirect assay consistently reported compds. as being, on av., 6-fold less potent, though the differences varied depending on chem. series.  Discussion: The main finding of this work is that providing a relatively low cell concn. is used in IonWorks HT, the potency information generated correlates well with that detd. using conventional electrophysiol.  The effect on potency of increasing cell concn. may relate to a reduced free concn. of test compd. owing to partitioning into cell membranes.  In summary, the IonWorks HT hERG assay can generate pIC50 values based on a direct assessment of channel function in a timeframe short enough to influence chem. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcBXhwRw0nLVg90H21EOLACvtfcHk0lgg4nBR2y8auw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D&md5=730258a42517947c0b972ca87cef46b6</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2006.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2006.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DBridgland-Taylor%26aufirst%3DM.%2BH.%26aulast%3DHargreaves%26aufirst%3DA.%2BC.%26aulast%3DEaster%26aufirst%3DA.%26aulast%3DOrme%26aufirst%3DA.%26aulast%3DHenthorn%26aufirst%3DD.%2BC.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DSmall%26aufirst%3DB.%2BG.%26aulast%3DHeapy%26aufirst%3DC.%2BG.%26aulast%3DAbi-Gerges%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DJacobson%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DAlbertson%26aufirst%3DN.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DSullivan%26aufirst%3DE.%26aulast%3DValentin%26aufirst%3DJ.%2BP.%26aulast%3DPollard%26aufirst%3DC.%2BE.%26atitle%3DOptimisation%2520and%2520validation%2520of%2520a%2520medium-throughput%2520electrophysiology-based%2520hERG%2520assay%2520using%2520IonWorks%2520HT%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D189%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmen, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagard, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. A.</span><span> </span><span class="NLM_article-title">High-throughput screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2639</span><span class="NLM_x">–</span> <span class="NLM_lpage">2648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1002%2Frcm.1229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=14648902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2639-2648&author=H.+Wanauthor=A.+G.+Holmenauthor=Y.+Wangauthor=W.+Lindbergauthor=M.+Englundauthor=M.+B.+Nagardauthor=R.+A.+Thompson&title=High-throughput+screening+of+pKa+values+of+pharmaceuticals+by+pressure-assisted+capillary+electrophoresis+and+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry</span></div><div class="casAuthors">Wan, Hong; Holmen, Anders G.; Wang, Yudong; Lindberg, Walter; Englund, Marie; Nagard, Mats B.; Thompson, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2639-2648</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A high-throughput pKa screening method based on pressure-assisted capillary electrophoresis (CE) and mass spectrometry (MS) is presented.  Effects of buffer type and ionic strength on sensitivity and pKa values were investigated.  Influence of DMSO concn. present in the sample on effective mobility measurement was examd.  A series of ten volatile buffers, covering a pH range from 2.5 to 10.5 with the same ionic strength, was employed.  The application of volatile background electrolytes resulted in significant signal increase as compared with commonly used non-volatile phosphate buffers.  In general, the CE/MS system provided a ten-fold higher sensitivity than conventional UV detection.  The newly developed CE/MS method offers high-throughput capacity by pooling a no. of compds. into a single sample.  Simultaneous measurement of more than 50 compds. was readily achieved in less than 150 min.  The measured pKa values are consistent with the published data obtained from the CE/UV method and are also in good agreement with data generated by other methods.  Other advantages of using CE/MS for pKa screening are illustrated with typical examples, including poorly sol. compds. and non-UV-absorbing compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgfrtqeDn-8LVg90H21EOLACvtfcHk0lgg4nBR2y8auw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSiurs%253D&md5=28bdb030bf255c19b5f98de12d5d9310</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Frcm.1229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1229%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DHolmen%26aufirst%3DA.%2BG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLindberg%26aufirst%3DW.%26aulast%3DEnglund%26aufirst%3DM.%26aulast%3DNagard%26aufirst%3DM.%2BB.%26aulast%3DThompson%26aufirst%3DR.%2BA.%26atitle%3DHigh-throughput%2520screening%2520of%2520pKa%2520values%2520of%2520pharmaceuticals%2520by%2520pressure-assisted%2520capillary%2520electrophoresis%2520and%2520mass%2520spectrometry%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2003%26volume%3D17%26spage%3D2639%26epage%3D2648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Wan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, W.</span><span> </span><span class="NLM_article-title">Rapid screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis combined with short-end injection</span> <span class="citation_source-journal">J. Chromatogr., A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">979</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=979&publication_year=2002&pages=369-377&author=H.+Wanauthor=A.+Holmenauthor=M.+Nagardauthor=W.+Lindberg&title=Rapid+screening+of+pKa+values+of+pharmaceuticals+by+pressure-assisted+capillary+electrophoresis+combined+with+short-end+injection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DH.%26aulast%3DHolmen%26aufirst%3DA.%26aulast%3DNagard%26aufirst%3DM.%26aulast%3DLindberg%26aufirst%3DW.%26atitle%3DRapid%2520screening%2520of%2520pKa%2520values%2520of%2520pharmaceuticals%2520by%2520pressure-assisted%2520capillary%2520electrophoresis%2520combined%2520with%2520short-end%2520injection%26jtitle%3DJ.%2520Chromatogr.%252C%2520A%26date%3D2002%26volume%3D979%26spage%3D369%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogDoct: a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+a+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neutral+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520a%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neutral%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Hann, M. M.</span><span> </span><span class="NLM_article-title">Molecular obesity, potency and other addictions in drug discovery</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1039%2Fc1md00017a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=349-355&author=M.+M.+Hann&title=Molecular+obesity%2C+potency+and+other+addictions+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular obesity, potency and other addictions in drug discovery</span></div><div class="casAuthors">Hann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Despite the increase in global biol. and chem. knowledge the discovery of effective and safe new drugs seems to become harder rather than easier.  Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learned from our failures.  This perspective reflects on some of the learnings of recent years in relation to the causes of attrition.  The term Mol. Obesity is introduced to describe our tendency to build potency into mols. by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlF7TPy6fHLVg90H21EOLACvtfcHk0lgfB0tc8aTELw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D&md5=954870db4b1d9e846612c3bb256582f7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1039%2Fc1md00017a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00017a%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520obesity%252C%2520potency%2520and%2520other%2520addictions%2520in%2520drug%2520discovery%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D349%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katharine, H.,M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery of aminoheterocycles as a novel β-secretase inhibitor class: pH dependence on binding activity part 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2977</span><span class="NLM_x">–</span> <span class="NLM_lpage">2980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2977-2980&author=S.+J.+Stachelauthor=C.+A.+Coburnauthor=D.+Rushauthor=K.+L.+G.+Jonesauthor=H.+Zhuauthor=H.+Rajapakseauthor=S.+L.+Grahamauthor=A.+Simonauthor=H.%2CM.+Katharineauthor=T.+J.+Allisonauthor=S.+K.+Munshiauthor=A.+S.+Espesethauthor=P.+Zuckauthor=D.+Colussiauthor=A.+Wolfeauthor=B.+L.+Pietrakauthor=M.+Laiauthor=J.+P.+Vacca&title=Discovery+of+aminoheterocycles+as+a+novel+%CE%B2-secretase+inhibitor+class%3A+pH+dependence+on+binding+activity+part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DRush%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DRajapakse%26aufirst%3DH.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DKatharine%26aufirst%3DH.%252CM.%26aulast%3DAllison%26aufirst%3DT.%2BJ.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520aminoheterocycles%2520as%2520a%2520novel%2520%25CE%25B2-secretase%2520inhibitor%2520class%253A%2520pH%2520dependence%2520on%2520binding%2520activity%2520part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2977%26epage%3D2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4689</span><span class="NLM_x">–</span> <span class="NLM_lpage">4695</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0498252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=4689-4695&author=L.+Hongauthor=J.+Tang&title=Flap+position+of+free+memapsin+2+%28beta-secretase%29%2C+a+model+for+flap+opening+in+aspartic+protease+catalysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fbi0498252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0498252%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DFlap%2520position%2520of%2520free%2520memapsin%25202%2520%2528beta-secretase%2529%252C%2520a%2520model%2520for%2520flap%2520opening%2520in%2520aspartic%2520protease%2520catalysis%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D4689%26epage%3D4695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=150-153&author=L.+Hongauthor=G.+Koelschauthor=X.+Linauthor=S.+Wuauthor=S.+Terzyanauthor=A.+K.+Ghoshauthor=X.+C.+Zhangauthor=J.+Tang&title=Structure+of+the+protease+domain+of+memapsin+2+%28beta-secretase%29+complexed+with+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BC.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520protease%2520domain%2520of%2520memapsin%25202%2520%2528beta-secretase%2529%2520complexed%2520with%2520inhibitor%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D150%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Crystal structure of memapsin 2 (beta-secretase) in complex with an inhibitor OM00-3</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">10963</span><span class="NLM_x">–</span> <span class="NLM_lpage">10967</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi026232n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=10963-10967&author=L.+Hongauthor=R.+T.+Turnerauthor=G.+Koelschauthor=D.+Shinauthor=A.+K.+Ghoshauthor=J.+Tang&title=Crystal+structure+of+memapsin+2+%28beta-secretase%29+in+complex+with+an+inhibitor+OM00-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbi026232n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi026232n%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DCrystal%2520structure%2520of%2520memapsin%25202%2520%2528beta-secretase%2529%2520in%2520complex%2520with%2520an%2520inhibitor%2520OM00-3%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D10963%26epage%3D10967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deinum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Beer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H.</span><span> </span><span class="NLM_article-title">Discovery of a novel warhead against beta-secretase through fragment-based lead generation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5903</span><span class="NLM_x">–</span> <span class="NLM_lpage">5911</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070825k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5903-5911&author=S.+Geschwindnerauthor=L.+L.+Olssonauthor=J.+S.+Albertauthor=J.+Deinumauthor=P.+D.+Edwardsauthor=T.+de+Beerauthor=R.+H.+Folmer&title=Discovery+of+a+novel+warhead+against+beta-secretase+through+fragment-based+lead+generation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm070825k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070825k%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DDeinum%26aufirst%3DJ.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3Dde%2BBeer%26aufirst%3DT.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520warhead%2520against%2520beta-secretase%2520through%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5903%26epage%3D5911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span> </span><span class="NLM_article-title">A quantitative assessment of hERG liability as a function of lipophilicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=17239590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitative+assessment+of+hERG+liability+as+a+function+of+lipophilicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative assessment of hERG liability as a function of lipophilicity</span></div><div class="casAuthors">Waring, Michael J.; Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1759-1764</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The impact of lipophilicity as a factor contributing to hERG potency is assessed for a large dataset of compds. of differing ionization type.  This dataset is derived from compds. tested in the Ionworks-based in vitro electrophysiol. hERG assay at AstraZeneca.  Using logistic regression, a quantification of the risk assocd. with increasing lipophilicity is presented.  The anticipated differences between acidic, basic and neutral compds. are apparent in the data but lipophilicity is shown to be a stronger driver for hERG potency than might have been expected.  Simple rules defining target lipophilicity values for minimizing hERG liability are derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCr9mVGL2-LVg90H21EOLACvtfcHk0lioRa3We1o0QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D&md5=3819e045d7b773f129773f1ff567b980</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lioRa3We1o0QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">LeDonne, N. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rissolo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulgarelli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tini, L.</span><span> </span><span class="NLM_article-title">Use of structure–activity landscape index curves and curve integrals to evaluate the performance of multiple machine learning prediction models</span> <span class="citation_source-journal">J. Cheminf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1186%2F1758-2946-3-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitFyit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=7&author=N.+C.+LeDonneauthor=K.+Rissoloauthor=J.+Bulgarelliauthor=L.+Tini&title=Use+of+structure%E2%80%93activity+landscape+index+curves+and+curve+integrals+to+evaluate+the+performance+of+multiple+machine+learning+prediction+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Use of structure-activity landscape index curves and curve integrals to evaluate the performance of multiple machine learning prediction models</span></div><div class="casAuthors">LeDonne, Norman C., Jr.; Rissolo, Kevin; Bulgarelli, James; Tini, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cheminformatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7</span>CODEN:
                <span class="NLM_cas:coden">JCOHB3</span>;
        ISSN:<span class="NLM_cas:issn">1758-2946</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: Std. approaches to address the performance of predictive models that used common statistical measurements for the entire data set provide an overview of the av. performance of the models across the entire predictive space, but give little insight into applicability of the model across the prediction space.  Guha and Van Drie recently proposed the use of structure-activity landscape index (SALI) curves via the SALI curve integral (SCI) as a means to map the predictive power of computational models within the predictive space.  This approach evaluates model performance by assessing the accuracy of pairwise predictions, comparing compd. pairs in a manner similar to that done by medicinal chemists.  Results: The SALI approach was used to evaluate the performance of continuous prediction models for MDR1-MDCK in vitro efflux potential.  Efflux models were built with ADMET Predictor neural net, support vector machine, kernel partial least squares, and multiple linear regression engines, as well as SIMCA-P+ partial least squares, and random forest from Pipeline Pilot as implemented by AstraZeneca, using mol. descriptors from SimulationsPlus and AstraZeneca.  Conclusion: The results indicate that the choice of training sets used to build the prediction models is of great importance in the resulting model quality and that the SCI values calcd. for these models were very similar to their Kendall τ values, leading to our suggestion of an approach to use this SALI/SCI paradigm to evaluate predictive model performance that will allow more informed decisions regarding model utility.  The use of SALI graphs and curves provides an addnl. level of quality assessment for predictive models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Id6r_IMYBrVg90H21EOLACvtfcHk0lioRa3We1o0QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitFyit7o%253D&md5=4dfebef8c41a954bdf84e2443bd63bb6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-3-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-3-7%26sid%3Dliteratum%253Aachs%26aulast%3DLeDonne%26aufirst%3DN.%2BC.%26aulast%3DRissolo%26aufirst%3DK.%26aulast%3DBulgarelli%26aufirst%3DJ.%26aulast%3DTini%26aufirst%3DL.%26atitle%3DUse%2520of%2520structure%25E2%2580%2593activity%2520landscape%2520index%2520curves%2520and%2520curve%2520integrals%2520to%2520evaluate%2520the%2520performance%2520of%2520multiple%2520machine%2520learning%2520prediction%2520models%26jtitle%3DJ.%2520Cheminf.%26date%3D2011%26volume%3D3%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Borgegard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jureus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabirsh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klintenberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stromberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parpal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinowsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesater, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span> </span><span class="NLM_article-title">First and second generation gamma-secretase modulators (GSMs) modulate amyloid-beta (Abeta) peptide production through different mechanisms</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">11810</span><span class="NLM_x">–</span> <span class="NLM_lpage">11819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=11810-11819&author=T.+Borgegardauthor=A.+Jureusauthor=F.+Olssonauthor=S.+Rosqvistauthor=A.+Sabirshauthor=D.+Rotticciauthor=K.+Paulsenauthor=R.+Klintenbergauthor=H.+Yanauthor=M.+Waldmanauthor=K.+Strombergauthor=J.+Nordauthor=J.+Johanssonauthor=A.+Regnerauthor=S.+Parpalauthor=D.+Malinowskyauthor=A.+C.+Radesaterauthor=T.+Liauthor=R.+Singhauthor=H.+Erikssonauthor=J.+Lundkvist&title=First+and+second+generation+gamma-secretase+modulators+%28GSMs%29+modulate+amyloid-beta+%28Abeta%29+peptide+production+through+different+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgegard%26aufirst%3DT.%26aulast%3DJureus%26aufirst%3DA.%26aulast%3DOlsson%26aufirst%3DF.%26aulast%3DRosqvist%26aufirst%3DS.%26aulast%3DSabirsh%26aufirst%3DA.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DPaulsen%26aufirst%3DK.%26aulast%3DKlintenberg%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWaldman%26aufirst%3DM.%26aulast%3DStromberg%26aufirst%3DK.%26aulast%3DNord%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DRegner%26aufirst%3DA.%26aulast%3DParpal%26aufirst%3DS.%26aulast%3DMalinowsky%26aufirst%3DD.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DEriksson%26aufirst%3DH.%26aulast%3DLundkvist%26aufirst%3DJ.%26atitle%3DFirst%2520and%2520second%2520generation%2520gamma-secretase%2520modulators%2520%2528GSMs%2529%2520modulate%2520amyloid-beta%2520%2528Abeta%2529%2520peptide%2520production%2520through%2520different%2520mechanisms%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D11810%26epage%3D11819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducrozet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title">Development of a high-throughput brain slice method for studying drug distribution in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1226</span><span class="NLM_x">–</span> <span class="NLM_lpage">1233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1226-1233&author=M.+Fridenauthor=F.+Ducrozetauthor=B.+Middletonauthor=M.+Antonssonauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaes&title=Development+of+a+high-throughput+brain+slice+method+for+studying+drug+distribution+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DDucrozet%26aufirst%3DF.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DAntonsson%26aufirst%3DM.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520high-throughput%2520brain%2520slice%2520method%2520for%2520studying%2520drug%2520distribution%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1226%26epage%3D1233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Friden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ljungqvist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarlund-Udenaes, M.</span><span> </span><span class="NLM_article-title">Improved measurement of drug exposure in the brain using drug-specific correction for residual blood</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1038%2Fjcbfm.2009.200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=19756019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Sg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=150-161&author=M.+Fridenauthor=H.+Ljungqvistauthor=B.+Middletonauthor=U.+Bredbergauthor=M.+Hammarlund-Udenaes&title=Improved+measurement+of+drug+exposure+in+the+brain+using+drug-specific+correction+for+residual+blood"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Improved measurement of drug exposure in the brain using drug-specific correction for residual blood</span></div><div class="casAuthors">Friden, Markus; Ljungqvist, Helena; Middleton, Brian; Bredberg, Ulf; Hammarlund-Udenaes, Margareta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-161</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A major challenge assocd. with the detn. of the unbound brain-to-plasma concn. ratio of a drug (Kp,uu,brain), is the error assocd. with correction for the drug in various vascular spaces of the brain, i.e., in residual blood.  The apparent brain vascular spaces of plasma water (Vwater, 10.3 μL/g brain), plasma proteins (Vprotein, 7.99 μL/g brain), and the vol. of erythrocytes (Ver, 2.13 μL/g brain) were detd. and incorporated into a novel, drug-specific correction model that took the drug-unbound fraction in the plasma (fu,p) into account.  The correction model was successfully applied for the detn. of Kp,uu,brain for indomethacin, loperamide, and moxalactam, which had potential problems assocd. with correction.  The influence on correction of the drug assocd. with erythrocytes was shown to be minimal.  Therefore, it is proposed that correction for residual blood can be performed using an effective plasma space in the brain (Veff), which is calcd. from the measured fu,p of the particular drug as well as from the ests. of Vwater and Vprotein, which are provided in this study.  Furthermore, the results highlight the value of detg. Kp,uu,brain with statistical precision to enable appropriate interpretation of brain exposure for drugs that appear to be restricted to the brain vascular spaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdAwudBZex47Vg90H21EOLACvtfcHk0liYODyrafJjVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Sg&md5=e55b0e2ec8254fdd498061cf3a1dd015</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2009.200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2009.200%26sid%3Dliteratum%253Aachs%26aulast%3DFriden%26aufirst%3DM.%26aulast%3DLjungqvist%26aufirst%3DH.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DImproved%2520measurement%2520of%2520drug%2520exposure%2520in%2520the%2520brain%2520using%2520drug-specific%2520correction%2520for%2520residual%2520blood%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2010%26volume%3D30%26spage%3D150%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span> </span><span class="NLM_article-title">Apo and inhibitor complex structures of BACE (beta-secretase)</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+inhibitor+complex+structures+of+BACE+%28beta-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520inhibitor%2520complex%2520structures%2520of%2520BACE%2520%2528beta-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span> </span><span class="NLM_article-title">Recent changes to the MOSFLM package for processing film and image plate data</span> <span class="citation_source-journal">Jt. CCP4+ESF-EAMCB Newslett. Protein Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1992&pages=27&author=A.+G.+W.+Leslie&title=Recent+changes+to+the+MOSFLM+package+for+processing+film+and+image+plate+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DRecent%2520changes%2520to%2520the%2520MOSFLM%2520package%2520for%2520processing%2520film%2520and%2520image%2520plate%2520data%26jtitle%3DJt.%2520CCP4%252BESF-EAMCB%2520Newslett.%2520Protein%2520Crystallogr.%26date%3D1992%26volume%3D26%26spage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span>Collaborative Computational Project 4 SCALA,<span class="NLM_x"> </span><span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Collaborative+Computational+Project+4+SCALA%2C+1994."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0liYODyrafJjVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm3011349&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm3011349&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm3011349&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lil6KiJPMhmYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Wlodek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skillman, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, A.</span><span> </span><span class="NLM_article-title">Automated ligand placement and refinement with a combined force field and shape potential</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">D62</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D62&publication_year=2006&pages=741-749&author=S.+Wlodekauthor=A.+G.+Skillmanauthor=A.+Nicholls&title=Automated+ligand+placement+and+refinement+with+a+combined+force+field+and+shape+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWlodek%26aufirst%3DS.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DNicholls%26aufirst%3DA.%26atitle%3DAutomated%2520ligand%2520placement%2520and%2520refinement%2520with%2520a%2520combined%2520force%2520field%2520and%2520shape%2520potential%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3DD62%26spage%3D741%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b70" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b70','PDB','4b70'); return false;">PDB: 4b70</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b72" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b72','PDB','4b72'); return false;">PDB: 4b72</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b77" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b77','PDB','4b77'); return false;">PDB: 4b77</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b78" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4b78','PDB','4b78'); return false;">PDB: 4b78</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKN','PDB','1FKN'); return false;">PDB: 1FKN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i76"><a href="/doi/suppl/10.1021/jm3011349">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_24554"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and analytical data for intermediates 2-(3-bromophenyl)-2-ethyl-2<i>H</i>-benzo[<i>e</i>][1,3]oxazin-4(3<i>H</i>)-one, <b>11a</b>–<b>c</b>, <b>16</b>, <b>18</b>, <b>26</b>, <b>28</b>, <b>29</b>, <b>32</b>, <b>33</b>, <b>39</b>, <b>40</b>, <b>43</b>–<b>46</b>, <b>49</b>–<b>53</b>, <b>67</b>, <b>68</b>, <b>79</b>, <b>82</b>, <b>84</b>, <b>88</b>–<b>90</b>, and <b>95</b>; Tables S1 and S2. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3011349/suppl_file/jm3011349_si_001.pdf">jm3011349_si_001.pdf (347.55 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3011349&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-11%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm3011349%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3011349" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997798ac9c1985","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
